Pathology Flashcards

1
Q

What is the definition of hyperplasia, hypertrophy, atrophy and metaplasia?

A

Hyperplasia - increase in the number of cells
Hypertrophy - increase in the size of cells
Atrophy - decrease in the size of a cell that has at one time been of normal size
Metaplasia - change of epithelial cell type from one to another at a specific site or location (the epithelium is normal in appearance in an abnormal location)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two types of hyperplasia? Give an example for each

A

Physiological hyperplasia - occurs due to a normal stressor (breasts in pregnancy, liver growth after resection
Pathological hyperplasia - occurs due to an abnormal stressor (adrenal gland growth due to production of ACTH by a pituitary adenoma)

Hyperplasia only happens in cells that divide (not the heart or neuron)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two types of hypertrophy? Give an example for each

A

Physiological hypertrophy - occurs due to a normal stressor (enlargement of skeletal muscle after exercise)
Pathological hypertrophy - occurs due to an abnormal stressor (increase in heart size due to aortic stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two types of atrophy? Give an example for each

A

Physiological atrophy - occurs due to a natural stressor (decrease in size of uterus post-pregnancy)
Pathological atrophy - occurs due to an abnormal stressor (usually due to a loss of stilumus to that organ - blood supply, innervation, decreased workload, aging)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the mechanism of metaplasia? Give an example

A

The epithelium normally present at a site cannot handle the new environment so it converts to a type of epithelium that can adapt (Barrett’s oesophagus - squamous to glandular)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some causes of cell injury?

A
  • Trauma
  • Thermal injury, hot or cold
  • Poisons
  • Infectious organisms
  • Ionising radiation
  • Drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the six mechanisms of cellular injury? Give examples for each

A

Mechanical disruption - trauma, osmotic pressure
Failure of membrane function integrity - damage to ion pumps, complement-mediated cytolysis, specific blockage of ion channels, alteration of membrane lipids
Membrane damage - free radicals
Deficiency of metabolites - oxygen, glucose, hormones
Blockage of metabolic pathways - interruption of protein synthesis, respiratory poisins
DNA damage or loss - ioinising radiation, chemotherapy, free radicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two ways in which cell damage can occur?

A

Reversibly and irreversibly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the four things that the effect of cellular injury on a tissue depend on?

A
  • the duration of injury
  • the nature of the injurious agent
  • the proportion and type of cells that are affected
  • the ability of tissues to regenerate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the definition of ischaemia and infarction?

A

Ischaemia is the pathological process resulting from a lack of oxygen due to impaired blood supply
Infarction is the specific process of necrosis resulting from lack of blood supply

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is reperfusion injury?

A

Under some conditions it is possible for the onset of cell death to be delayed until blood flow has been restored.
It may be due to the generation of reactive oxygen species, free radicals and damage to calcium pups.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In reperfusion injury, are cells damaged via apoptosis or necrosis

A

Cells damaged in this way probably go through apoptosis rather than necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a free radical?

A

Atoms or groups of atoms with an unpaired electron, as such they may enter into chemical bond formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some of the clinicopathological events involving free radicals?

A
  • toxicity of some poisons
  • oxygen toxicity
  • tissue damage in inflammation
  • intracellular killing of bacteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is necrosis and what causes it?

A

Death of tissues, causes include ichaemia, metabolic and truma. It is a pathological process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the six different types of necrosis? Give examples of each

A
  • Coagulative necrosis in most tissues, firm pale area with ghost outlines on microscopy (most common)
  • Colliquative necrosis is seen in the brain, the dead area is liquefied
  • Causeous necrosis is seen in TB, there is a pale yellow, semi-solid material
  • Gangrene is necrosis with putrefaction: it follows vascular occlusion or certain infections and is black
  • Fibrinoid necrosis is a microscopic feature in arterioles in malignant hypertension
  • Fat necrosis may follow trauma and cause a mass (often in the breast), or may follow pancreatitis visible as multiple white spots
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the different types of gangrene?

A
  • Wet - in the bowel (incarcarated hernia) or appendicitis
  • Dry - usually seen in the toes (gradual arterial or small vessel obstruction in diabetes)
  • Gas - result of infection by Clostridium perfringens
  • Synergistic - infection by a combination of organisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the two types of cell appearances following injury? Describe them

A
  • Hydropic change - cells when the cytoplasm becomes pale and swollen due to the accumulation of fluid (hypoxia or chemical poisoning) - often reversible
  • Fatty change - vacuolation of cells often due to the accumulation of lipid droplets as a result of a disturbance to ribosomal function and uncoupling of lipid from protein metabolism. (often in the liver) - moderate changes are reversible but severe fatty change is irreversible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the process of coagulative necrosis?

A

Following devitalisation, the cells retain their outline as their proteins coagulate and metabolic activity ceases.
Later, it may become soft as a result of digestion by the macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the morphology of caseous necrosis?

A

A pattern of necrosis in which the dead tissue lacks any structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the process of fibrinoid necrosis?

A

Arterioles are under such pressure that there is necrosis of the smooth muscle wall. This allows seepage of plasma into the media with consequent deposition of fibrin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How does trauma cause fat necrosis?

A

The release of intra-cellular fat elicits a brisk inflammatory response, the polymorphs and macrophages phagocytosing the fat, proceeding eventually to fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the process of fat necrosis in pancreatitis?

A

There is release of pancreatic lipase. As a result, fat cells have their stored fat split into fatty acids, which then combine with calcium to precipitate out as white soaps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is apoptosis?

A

Individual cell deletion in physiological growth control and in disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What does reduced apoptosis cause?

A

Cell accumulation (neoplasia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What does increased apoptosis cause?

A

Extensive cell loss (atrophy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are some of the roles of apoptosis?

A
  • Continuining control of organ size
  • Unwanted or defective cells undergo apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What factors control apoptosis?

A

Inhibitors include growth factors, cell matrix, sex steroids and some viral proteins
Inducers include growth factor withdrawal, loss of matrix attachment, glucocorticoids, some viruses, free radicals, ioinising radiation, DNA damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How do apoptosis inducers and inhibitors work?

A

They act via the bcl-2 protein family, inhibiting or activating the death pathway, resulting in activation of caspases
OR
Activation of plasma membrane receptor Fas (CD95) by its ligand bypasses bcl-2 to activate other caspases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the process of apoptosis?

A

Degradation of the cytoskeletal framework
Fragmentation of DNA and loss of mitochondrial function
Nucleus shrinks (pykonosis) and fragments (karyorrhexis)
Cell shrinks, retaining an intact plasma membrane
Alteration of this membrane rapidly induces phagocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What happens to dead cells not phagocytosed?

A

They break into smaller membrane-bound fragments called apoptotic bodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What gene checks the integrity of the genome before mitosis? What happens next?

A

p-53 gene
Defective cells are swtiched to apoptosis instead

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What diseases are associated with increased apoptosis?

A

AIDs (activate CD4, inducing apoptosis
Neurodegenerative disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What is the difference in induction of apoptosis vs necrosis?

A

Apoptosis - may be induced by physiological or pathological stimuli
Necrosis - invariably due to pathological injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is the difference in biochemical events of apoptosis vs necrosis?

A

Apoptosis - energy-dependent fragmentation of DNA by endogenous endonucleases - lysosomes intact
Necrosis - impairment or cessation of ion homeostasis - lysosomes leak lytic enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is the difference in extent of apoptosis vs necrosis?

A

Apoptosis - single cell
Necrosis - cell groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is the difference in cell membrane integrity of apoptosis vs necrosis?

A

Apoptosis - maintained

Necrosis - lost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is the difference in morphology of apoptosis vs necrosis?

A

Apoptosis - cell shrinkage and fragmentation to form apoptotic bodies with dense chromatin
Necrosis - cell swelling and lysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is the difference in inflammatory response of apoptosis vs necrosis?

A

Apoptosis - none
Necrosis - usual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is the difference in fate of dead cells of apoptosis vs necrosis?

A

Apoptosis - ingested (phagocytosed) by neighbouring cells
Necrosis - ingested (phagocytosed) by neutrophil polymorphs and macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is the definition of inflammation?

A

A response of vascularised tissues to infection and damaged tissues that brings cells and molecules of host defence from the circulation to the sites where they are needed, in order to eliminate the offending agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

In a broad sense

What are the key mediators of inflammation?

A

Phagocytic leukocytes, antibodies and complement proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What are some examples of key components of the innate immune system?

A

Natural killer cells, dendritic cells, and epithelial cells, as well as soluble factors such as the proteins of the complement system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What are the steps of the typical inflammatory reaction?

A
  • The offending agent, often in extrasvascular tissues, is recognised by host cells and molecules
  • Leukocytes and plasma proteins are recruited from the circulation to the site where the offending agents are located
  • The leukocytes and proteins are activated and work together to destroy and eliminate the offending substance
  • The reaction is controlled and terminated
  • The damaged tissue is repaired
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

How do blood vessels help in inflammation?

A
  • The blood vessels dilate to slow down blood flow, and by increasing their permeability, they enable certain selected proteins to enter the site of infection of tissue damage
  • The blood vessel epithelium characteristics change, such that circulating leukocytes first stop then enter the site of infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What do leukocytes do once they are recruited?

A

They are activated and acquire the ability to ingest and destroy microbes and dead cells, as well as foreign bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What are some of the harmful effects of inflammation?

A
  • Acute temporary things such as pain and functional impairment
  • There are many diseases in which the inflammatory reaction is misdirected (against self tissues in autoimmune diseases), occurs against normally harmless substances (allergies) or is inadequately controlled
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What cells are involved in these acute diseases:
1. ARDS
2. Asthma
3. Glomerulonephritis
4. Septic shock

A
  1. ARDS - neutrophils
  2. Asthma - IgE antibodies; eosinophils
  3. Glomerulonephritis - antibodies and complement, neutrophils, monocytes
  4. Septic shock - cytokines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What is the role of inflammatory mediators such as plasma proteins?

A

They initiate and amplify the inflammatory response and determine it’s pattern, severity, and clinical and pathological manifestations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Tell me about acute inflammation e.g. duration, mechanisms, and resolution

A
  • Typically develops within minutes or hours and is of short duration, lasting for several hours or a few days
  • Main characteristics are the exudation of fluid and plasma proteins (oedema), and the emmigration of leukocytes, particularly neutrophils,
  • When it reaches its desired goal, the reaction subsides, but if the response fails to clear the stimulus, the reaction can develop into chronic inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Tell me about chronic inflammation

A
  • It is of longer duration and is associated with more tissue destruction
  • Associated with the presence of lymphocytes and macrophages, the proliferation of blood vessels, and the deposition of connective tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What is the onset of acute vs chronic inflammation?

A

Acute - minutes to hours
Chronic - days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What are the cellular infiltrates in acute vs chronic inflammation?

A

Acute - neutrophils
Chronic - lymphocytes and macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

How are local and systemic signs present in acute vs chronic inflammation?

A

Acute - prominent
Chronic - less

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

How does the termination of inflammation occur?

A

It is terminated when the offending agent is eliminated
The reaction resolved because the mediators are broken down and dissipated, the leukocytes have a short life span in tissues
In addition, anti-inflammatory mechanisms are activated, serving to control the host and prevent it from causing excessive damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What are some examples of things that trigger inflammation?

A
  • Infections - bacterial, viral, fungal, parasitic
  • Tissue necrosis elicits inflammation regardless of the cause of cell death, which may include ischaema, trauma, physical and chemical injury
  • Foreign bodies - splinters, dirt, sutures - or endogenous molecules depositing in tissues e.g. urate in gout, cholesterol in atherosclerosis
  • Immune reactions - autoimmune diseases, allergies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

What are some cells and receptors that recognise microbes and damaged cells?

A
  • Cellular receptors for microbes in the plasma membrane (extracellular), the endosomes (ingested), and the cytosol (intracellular) - e.g. Toll-like receptors TLRs
  • Sensors of cell damage - all cells have cytosolic receptors that recognise a diverse set of molecules that are liberted of altered as a consequence of cell damage
  • Other cellular receptors involved in inflammation - many leukocytes express receptors for the Fc tails of antibodies and for complement proteins
  • Circulating proteins - the complement system reacts against microbes and produces inflammatory mediators, mannose-binding lectin recognises microbial sugars and promotes ingestion of the microbes and activation of the complement system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Where are TLRs expressed?
What do they do?

A

They are expressed on many cell types, including epithelial cells, dendritic cells, macrophages and other leukocytes
Engagement of these receptors triggers production of molecules involved in inflammation including adhesion molecules on endothelial cells, cytokines and other mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What are some examples of cytosolic sensors of cell damage?

A
  • Uric acid - a product of DNA breakdown
  • ATP - released from damaged mitochondria
  • Reduced intracellular K+ concentrations - reflecting loss of ions because of membrane injury
  • DNA in the cytoplasm because it should normally be in the nucleus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What do cytosolic sensors of cell damage do?

A
  • They activate a multiprotein cytosolic complex called inflammasome, which induces the production of IL-1
  • IL-1 recruits leukocytes and thus induces inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

What do the leukocyte receptors for the Fc tails do?

A

They recognise microbes coated with antibodies and complement (opsonisation) and promote ingestion and destruction of the microbes as well as triggering inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What are the three major components of acute inflammation?

A
  1. Dilation of small vessels, leading to an increased blood flow
  2. Increased permability of the microvasculature enabling plasma proteins and leukocytes to leave the circulation
  3. Emigration of the leukocytes from the microcirculation, their accumulation in the focus on injury, and their activation to eliminate the offending agent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What is an exudate vs a transudate?

A

Exudate is an extravascular fluid that has a high protein concentration and contains cellular debris. Its presence implies an ongoing inflammatory response
Transudate is a fluid with low protein content, little or no cellular material, and low specific gravity. It is essentially an ultrafiltrate of blood plasma that is produced as a result of imbalance between hydrostatic and osmotic pressure without an increase in vascular permability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

What is edema?

A

An excess of fluid in the interstital tissue or serous cavities, it can be either exudate or transudate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

What is pus?

A

A purulent inflammatory exudate rich in leukocytes (mostly neutrophils), the debris of dead cells, and in many cases, microbes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

What are the changes in vascular flow and caliber after injury?

A
  • Vasodilation is induced by the action of many mediators, notably histamine, on vascular smooth muscle. First the arterioles then capillaries, causing increased blood flow and erythema
  • Increased permeability of the microvasculature, with the outpouring of protein-rich fluid into extravascular tissues
  • These changes lead to engorgement of small vessels, which slowly moving red cells, a condition termed stasis (again causing erythema)
  • As stasis develops, blood leukocytes, principally neutrophils, accumulate along the vascular endothelium, simultaneously, endothelial cells are activated by inflammatory mediators and express increased levels of adhesion molecules, adhering to leukocytes, which then migrate through the vascular wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

What are the different mechanisms of increased vascular permability in short? (we’ll go into more detail after this)

A
  • Contraction of endothelial cells resulting in increased endothelial spaces is the most common mechanism of vascular leakage
  • Endothelial injury, resulting in endothelial cell necrosis and detachment
  • Increased transport of fluid and proteins called transcytosis, through the endothelial cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

What chemical mediators trigger endothelial cell contraction?

A

Histamine, bradykinin, leukotrienes, and other chemical mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

When does endothelial cell contraction happen and how long does it last for?

A

It is called the immediate transient response because it happens occurs rapidly after exposure to the mediator and is often short-lived (15 to 30 minutes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

What is delayed prolonged leakage?

A
  • In some forms of mild injury (e.g. sunburn), vascular leakage begins after a delay of 2-12 hours and lasts for several hours or even days
  • It may be caused by contraction of endothelial cells or mild endothelial damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

What is the mechanism behind endothelial injury causing increased vascular permeability?

A

Direct damage to the endothelium is encountered in severe injuries and is induced by the action of microbes and microbial toxins that target endothelial cells

Neutrophils that adhere to the endothelium during inflammation may also injure the endothelial cells and thus amplify the reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

What does leakage occur due to endothelial injury, necrosis and detatchment after injury?

A

In most instances, leakage starts immediately after injury and is sustained for several hours until the damaged vessels are thrombosed or repaired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

How do lymphatic vessels respond to inflammation?

A

In inflammation, lymphatic flow increases and helps drain oedema fluid. In addition to fluid, leukocytes and cell debris, as well as microbes, may find their way into the lymph.

Lymphatic vessels proliferate during inflammatory reactions to handle the increased load.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

What are the most important leukocytes in inflammation?

A

Neutrophils and macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

What is the function of leukoytes in the inflammatory response?

A
  • Ingest and destroy bacteria and other microbes, as well as necrotic tissue and foreign substances
  • Produce growth factors that aid in repair
  • When strongly activated, they may induce tissue damage and prolong inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

The journey of leukocytes from the vessel lumen to the tissue is a multi-step process that is mediated and controlled by what?

A

Adhesion molecules and cytokines called chemokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

What are the three phases of leukocyte migration?

A
  1. In the lumen: margination, rolling, and adhesion to the endothelium
  2. Migration across the endothelium and vessel wall
  3. Migration in the tissue toward a chemotactic stimulus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

How does margination occur?

A

In normal flowing venules, red cells are confined to a central axial column, displacing the leukocytes towards the wall of the vessel

Because of stasis (blood flow slowing) in early inflammation, haemodynamic conditions change, and more white cells assume a peripheral position along the enothelial surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

At what stage of the inflammatory process do neutrophils predominate?

A

6 - 24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

At what stage of the inflammatory process do monocytes predominate?

A

24 - 48 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

What are the mediators that trigger the following:
1. Leukocyte rolling on endothelium
2. Firm attachment to the endothelium

A
  1. Selectins (P-selectin (platelets), L-selectin (leukocytes), E-selectin (endothelium)) trigger leukocyte rolling
  2. Integrins trigger firm attachment to the endothelium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Which cytokines promote expression of selectins and integrins on endothelium?

A

TNF
IL-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Which cytokines increases the avidity of integrins for their ligands and promote directional migration of the leukocytes?

A

Chemokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

What is transmigration or diapedesis?

A

It is migration of the leukocytes through the endothelium.
It often happens mainly in the postcapillary venules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

After exiting the circulation, the leukocytes move in the tissues toward the site of injury. What is this process called?

A

Chemotaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

What are some endogenous chemoattractants? (things released in an injury that attract leukocytes in inflammation)

A
  • Cytokines, particularly those of the chemokine family e.g. IL-8
  • Components of the complement system (mainly C5a)
  • Arachidonic acid (AA) metabolites, mainly leukotriene B4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

What are the three steps of phagocytosis?

A
  1. Recognition and attachment of the particle to be ingested by the leukocyte
  2. Engulfment, with subsequent formation of a phagocytic vacuole
  3. Killing or degradation of the ingested molecule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

What phagocytic receptors bind and ingest molecules?

A
  • Mannose receptors - a lectin that binds to terminal mannose and fucose (which are only on microbes) therefore recognises microbes and not host cells
  • Scavenger receptors - bind to LDLs
  • Receptors for various opsonins - main ones are IgG antibodies, C3b breakdown product and certain lectins (mannose-binding lectins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

How does engulfment take place in phagocytosis?

A
  • After a particle is bound to the phagocyte receptors, extensions of the cytoplasm (psuedopods) flow around it
  • The plasma membrane pinches off to form a vesicle (phagosome) that engulfs the particle
  • The phagosome fuses with a lysosome granule, resulting in release of the granules contents into the phagosome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

What molecules are used to perform intracellular destruction of microbes and debris once in the phagosome and how?

A
  • Reactive oxygen series are produced by the oxidisation of NADPH by NADPH oxidase - it accompanies phagocytosis - produced by lysosome - may be released extracellularly, causing tissue damage
  • Reactive nitrogen series
  • Lysosomal enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

What are neutrophil extracellular traps?

A

Extracellular fibrillar networks that provide a high concentration of antimicrobial substances at sites of infection and prevent the spread of the microbes by trapping them in the fibrils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

What are mediators of inflammation?

A

Substances that initiate and regulate inflammatory reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

What are the most important mediators of acute inflammation?

A

Vasoactive amines
Lipid products (prostaglandins and leukotrienes)
Cytokines (including chemokines)
Products of complement activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

How are inflammatory mediators usually created?

A

They are either secreted by cells or generated by plasma proteins.
Cell-derived mediators are usually sequestered by intracellular granules and can be rapidly secreted by granule exocytosis (e.g. histamine in mast cell granules) or are synthesised de novo (e.g. prostagladins, leukotrienes, cytokines) in response to a stimulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

What are the main cells that create inflammatory mediators?

A

The major cell types that produce mediators of inflammation are the sentinels that detect invaders and damage in tissues, such as macrophages, dendritic cells, and mast cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

How long do inflammatory mediators last for?

A

They are usually short-lived.

They quickly decay or are inactivated by enzymes, or they are otherwise scavenged or inhibited.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Can one inflammatory mediator stimulate another one?

A

Yes!

For instance, products of complement activation can stimulate the release of histamine. the cytokine TNF acts on endothelial cells to stimulate the production of another cytokine IL-1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Where is histamine created and what does it do?

A

It is created in mast cells, basophils and platelets.
It causes vasodilation, increased vascular permeability and endothelial activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Where are prostaglandins created and what do they do?

A

It is created in mast cells, macrophages, endothelial cells and leukocytes
It causes vasodilation, pain and fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

Where are leukotrienes created and what do they do?

A

They are created in mast cells and leukocytes.
They cause increased vascular permability, chemotaxis, leukocyte adhesion, and activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Where are cytokines (TNF, IL-1 and IL-6) created and what do they do?

A

They are created in macrophages, endothelial cells and mast cells.
Locally, they cause endothelial activation (expression of adhesion molecules).
Systemically, they cause fever, metabolic abnormalities, hypotension (shock)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Where is complement created and what does it do?

A

It is in the plasma, created by the liver.
It causes leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

Where are kinins created and what do they do?

A

They are found in the plasma, created in the liver.
They cause increase vascular permeability, smooth muscle contraction, vasodilation and pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

How does histamine increase vascular permeability?

A

It binds to H1 receptors on microvascular endothelial cells, creating interendothelial gaps in venules and causing endothelial contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

What things stimulate the release of histamine?

A
  1. physical injury, such as trauma, cold or heat
  2. binding of antibodies to mast cells (immediate hypersensitivity reactions)
  3. products of complement called anaphylatoxins (C3a and C5a)
  4. Neuropeptides (substance P) and cytokines (IL-1 and IL-8) may also trigger histamine release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

What are some examples of arachidonic acid metabolites?

A

The lipid mediators prostaglandins and leukotrienes are produced from arachidonic acid (AA) present in membrane phospholipids, and stimulate vascular and cellular reactions in acute inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

Arachidonic acid (AA) is usually found esterified in the membrane phospholipids. How is it released?

A

Through the action of cellular phospholipases (mainly phospholipase A2).
An increase in cytoplasmic Ca2+ and activation of various kinases in response to external stimuli, activates phospholipase A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

What is created when AA is released from the membrane phospholipids?

A

From the AA, two major enzymes: cyclooxygenases and lipoxygenases synthesise many AA-derived inflammatory mediators - called eicosanoids
Cyclooxygenases create prostaglandins
Lipooxygenases create leukotrienes and lipoxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

How are prostaglandins generated?

A

By the actions of cyclooxygenase 1 and 2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

What is the difference between COX-1 and COX-2?

A

COX-1 is produced in response to an inflammatory stimuli and is also constitutively expressed in most tissues, where it may serve a homeostatic function
COX-2 is induced by inflammatory stimuli and thus generates prostaglandins, but it is low or absent in normal tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

What is the function of prostacyclin?

A

It is a vasodilator and a potent inhibitor of platelet aggregation, and also markedly potentiates the permeability-increasing and chemotactic effects of other mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

What are the most important cytokines in inflammation? What do they do?

A

TNF & IL-1 serve critical roles in leukocyte recruitment by promoting adhesion of leukocytes to endothelium and their migration through vessels.
* They increase expression of adhesion molecules (E- and P- selectin)
* They increase the production of other cytokines, growth factors and eicosanoids
* They produce fever and can cause sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

What are chemokines and what is their role?

A

A family of small proteins that act as chemoattractants for specific types of leukocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

What are the main morphological features of acute inflammation?

A

Dilation of small bloods vessels, accumulation of leukocytes and fluid in the extravascular tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

What are the different morphological types of acute inflammation?

A
  • Serous inflammation is marked by exudation of cell-poor fluid into spaces created by cell injury or into body cavities lined by the peritoneum, pleura or pericardium
  • Fibrinous inflammation is where a fibrinous exudate develops when the vascular leaks are large or there is a local procoagulant stimulus
  • Purulent (suppurative) inflammation is characterised by the production of pus, an exudate containing neutrophils, the liquefied debris of necrotic cells and edema fluid
  • Ulcers are a local defect, or excavation, of the surface of an organ or tissue that is produced by the sloughing of inflamed necrotic tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

What is (or isn’t) in the fluid of serous inflammation?

A

Typically, the fluid is not infected by destructive organisms and does not contain large numbers of leukocytes.
The fluid may be derived from plasma or from the secretions of mesothial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

What is the mechanism of fibrinous inflammation?

A

With greater increase in vascular permeability, large molecules such as fibrinogen pass out of the blood, and fibrin is formed and deposited in the extracellular space.
A fibrous exudate is characteristic of inflammation of the body cavities, such as the meninges, pleura and pericardium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

How does fibrinous inflammation present histologically?

A

Fibrin appears as an eosinophilic meshwork of threads, or sometimes as an amorphuos coagulum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

How does fibrinous inflammation resolve?

A

Fibrinous exudates may be dissolved by fibrinolysis and cleared by macrophages.

If the fibrin is not removed, over time it may stimulate the growth of fibroblasts and blood vessels and thus lead to scarring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

What are abscesses?

A

They are localised collections of purulent inflammatory tissue caused by a suppuration buried in a tissue, an organ or a confined space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

What components make up an abscess?

A

Abscesses have a central region that appears as a mass of nectrotic leukocytes and tissue cells. There is usually a zone of preserved neutrophils around this necrotic focus, and outside this region, there may be vascular dilation and parenchymal and fibroblastic proliferation, indicating chronic inflammation and repair.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

How does an ulcer develop?

A

During the acute stage, there is intense polymorphonuclear infiltration and vascular dilation in the margins of the defect.
With chronicity, the margins and the base of the ucler develop fibroblastic proliferation, scarring and the accumulation of lymphocytes, macrophages and plasma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

What are the outcomes of acute inflammation?

A
  • Complete resolution - the injury is short-lived, there is little tissue destruction and the damaged parenchymal cells can regenerate
  • Healing by connective tissue replacement (scarring or fibrosis) - there is substantial tissue destruction, abundant fibrin exudation that can’t be cleared, connective tissue grows into the area of damage, converting it into a mass of fibrous tissue, a process called organisation
  • Chronic inflammation occurs when the acute inflammatory response cannot be resolved, either due to the microbe or an inadequate immune response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

What is chronic inflammation?

A

A response of prolonged duration (weeks to months) in which inflammation, tissue injury and attempts of repair co-exist, in varying combinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

What are the causes of chronic inflammation?

A
  • Persistent infections by infections that are difficult to eradicate (e.g.mycobacteria, funghi, parasites) - these may be a delayed hypersensitivity reaction or granulomatous reactions
  • Hypersensitivity diseases such as autoimmune diseases or allergic diseases
  • Prolonged exposure to potentially toxic agents, either endogenous or exogenous for example silicosis (exogenous) or atherosclerosis (endogenous)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

What are the morphological characteristics of chronic inflammation?

A
  • Infiltration with mononuclear cells, which include macrophages, lymphocytes and plasma cells
  • Tissue destruction, induced by the persistent offending agent, or by the inflammatory cells
  • Attempts at healing by connective tissue replacement of damaged tissue, accomplished by angiogenesis and fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

What is the most dominant cell in chronic inflammation and what does it do?

A

Macrophages contribute to the reaction by secreting cytokines and growth factors that act on various cells, by destryoing foreign invaders and tissues, and by activating other cells, notably T lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

What are the stages in the life cycle of a macrophage?

A
  • They are tissue cells derived from haematopoietic stem cells in the bone marrow and from progenitors in the embryonic yolk sac and fetal liver during early development. They circulate as monocytes
  • Monocytes enter the blood, migrate into various tissues and differentiate into macrophages
  • The life span of a monocyte in 1 day, whereas a tissue macrophage can last for several months or years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

What are the names of macrophages in the following organs:
1. Liver
2. Spleen and lymph nodes
3. Central nervous system
4. Lungs

What do they form together?

A
  1. Liver - Kuppfer cells
  2. Spleen and lymph nodes - Sinus histiocytes
  3. CNS - microglial cells
  4. Lungs - alveolar macrophages

Together they form the mononuclear phagocyte system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

There are two major pathways of macrophage activation. What are they?

A
  • Classical macrophage activation may be induced by microbial products such as endotoxins, which engage TLRs and other cells by T cell-drived signals (cytokine IFN-gamma). Classically activate macrophages (M1) produce NO and ROS and upregulate lysosomal enzymes. These things help them kill ingested organisms, trigger inflammation via cytokines.
  • Alternate macrophage activation is induced by cytokines other than IFN-gamma (IL-4 and IL-13), produced by T lymphocytes and other cells. The function of alternately activated macrophages (M2) is tissue repair. They secrete GF that stimulates angiogenesis, activate fibroblasts and stimulate collagen synthesis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

What are the main functions of macrophages in chronic inflammation?

A
  • Ingest and eliminate microbes and dead tissue
  • Initiate the process of tissue repair
  • Secrete mediators of inflammation, such as cytokines (TNF, IL-1, chemokines) and eicosanoids
  • Display antigens to T-lymphocytes and respond to signals from T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

What are the roles of lymphocytes in chronic inflammation?

A

Microbes and other environmental antigens activate T and B lymphocytes, which amplify and propogate chronic inflammation.
Lymphocytes may be the dominant population in the chronic inflammation seen in autoimmune and other hypersensitivity diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

There are three subsets of CD4+ T cells that secrete different cytokines and ellicit different types of inflammation. Tell me them…

A
  1. TH1 cells produce the cytokine IFN-gamma, which activates macrophages via the classical pathway
  2. TH2 cells secrete IL-4, IL-5 and IL-13, which recruit and activate eosinophils and are reponsible for the alternative pathway of macrophage activation.
  3. TH17 cells secrete IL-17 and other cytokines, which induce the secretion of chemokines, reponsible for the recruitment of neutrophils (and monocytes) to the reaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

Lymphocytes and macrophages interact in a bidirectional way, and these interactions play an important role in propogating chronic inflammation. Tell me about them…

A
  • Macrophages display antigens to T cells, express membrane molecules (called costimulators), and produce cytokines (IL-12) that stimulate T cell responses.
  • Activated T cells produce cytokines (IFN-gamma), which recruit and activate macrophages, promoting more antigen presentation and cytokine secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

What is a tertiary lymphoid organ? What is the term used for it’s formation?

A

In some chronic inflammatory reactions, the accumulated lymphocytes, antigen-presenting cells, and plasma cells cluster together to form lymphoid tissues resembling - this is a tertiary lymphoid organ.

It’s formation is called lymphoid organogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

Apart from lymphocytes and macrophages, what other cells are involved in chronic inflammation?

A
  • Eosinophils are abundant in immune reactions mediated by IgE and parasitic infections. Their recruitment is similar to neutrophils, via the chemokine eotaxin. They contain major basic protein, which is toxic to parasites but also mammalian epithelial cells
  • Mast cells are present in chronic inflammatory reactions, and because they secrete a plethora of cytokines, they may promote inflammatory reactions in different situations.
  • Although neutrophils are characteristic of acute inflammation, many forms of chronic inflammation still show large numbers of neutrophils
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

What is granulomatous inflammation?

A

A form of chronic inflammation characterised by collections of activated macrophages, often with T lymphocytes, and sometimes associated with central necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

There are two types of granulomatous inflammation, which differ in pathogenesis. What are they and what is their pathogeneses?

A
  • Foreign body granulomas are incited by relatively inert foreign bodies, in the abscense of T cell-mediated immune responses. Typically occur around talc (IVDU) or sutures, things large enough to not be phagocytosed. Epitheliod cells and giant cells are opposed to the foreign body surface.
  • Immune granulomas are caused by agents capable of inducing a persistent T-cell mediated immune response. The agent is often difficult to erradicate. In such responses, macrophages keep activatign T cells and T cells keep activating macrophages until giant cells epitheliod cells form.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

What are epithelioid and giant cells?

A
  • The activated macrophages may develop abundant cytoplasm and begin to resemble epithelial cells, these are called epithelioid cells
  • Some activated macrophages may fuse, forming multinucleate giant cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

What are the two types of reaction that could occur in repair of damaged tissue?

A
  • Regeneration by proliferation of residual (uninjured) cells and maturation of tissue stem cells
  • The deposition of scar tissue to form a scar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

How does regeneration occur in tissue repair?

A

Some tissues are able to replace the damaged components and essentially return to a normal state - this is called regeneration
It occurs by proliferation of cells that survive the injury and retain the capacity to proliferate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

In what organs does regeneration often occur in tissue repair?

A

The rapidly dividing epithelia of the skin and intestines, and in some parenchymal organs, notably the liver.
In other cases, tissue stem cells may contribute to the restoration of the damaged tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

When would scar tissue form in tissue healing?

A

If the injured tissues are incapable of complete restitution, or if the supporting structures of the tissue are severely damaged, repair occurs by the laying down of connective (fibrous) tissue.
Although the fibrous scar is not normal, it provides enough structural stability that the injured tissue can continue to function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
145
Q

What is fibrosis? and how it this linked with organisation?

A

The term fibrosis is often used to describe the extensive depostion of collagen that occurs in the lungs, liver, kidney and other organs as a consequence of chronic inflammation or in the myocardium after extensive ischaemic necrosis.
If fibrosis occurs in a tissue space occupied by an inflammatory exudate, it is called an organisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
146
Q

The regeneration of injured cells and tissues involves cell proliferation. What is the driven by and dependent on?

A

It is driven by growth factors and is critically dependent on the integrity of the extracellular matrix, and by the development of mature cells from the stem cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
147
Q

Several cell types proliferate during tissue repair. What are they and why do they proliferate?

A
  • Remnants of the injured tissue - which attempt to restore normal structure
  • Vascular endothelial cells - to create new vessels that provide the nutrients required for tissue repair
  • Fibroblasts - the source of the fibrous tissue that forms the scar to fill defects that cannot be corrected by regeneration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
148
Q

The ability of tissues to repair themselves is determined, in part, by their intrinsic proliferative capacity. Based on this, tissues are divided into three groups. What are the groups and tell me about them?

Not examples yet, that will be next …

A
  • Labile (continuously dividing) tissues - cells of these tissues are constantly being lost and replaced by maturation from tissue stem cells and by proliferation of mature cells. They can readily regenerate after injury, as long as the stem cells aren’t damaged
  • Stable tissues - cells of these tissues are quiescent (in the G0 stage of the cell cycle) and have only minimal proliferative activity in their normal state. However, they are capable of dividing in response to injury but have a limited capacity for regeneration
  • Permanent tissues - The cells of these tissues are considered to be terminally differentiated and nonproliferative in post-natal life. Repair is normally dominated by scar formation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
149
Q

Give me some examples of labile, stable and permanent tissues…

A
  • Labile - haematopoeitic cells in the bone marrow, stratified squamous epithelium of the skin, oral cavity, vagina, and cervix ; the cuboidal epithelia of the ducts draining exocrine organs (salivary glands, pancreas, biliary tract); columnar epithelium of GI tract, uterus, fallopian tubes and the transitional epithelium of the urinary tract
  • Stable - the parenchyma of most solid tissues, such as liver, kidney and pancreas. They also include endothelial cells, fibroblasts, smooth muscle cells.
  • Permanent - cardiac myocytes and neurons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
150
Q

Where and by what cells are growth factors released that drive tissue repair?

A
  • They are typically produced by cells near the site of damage.
  • The most important sources are macrophages activated by the tissue injury, but epithlial cells and stromal cells also produce some of them.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
151
Q

How do growth factors drive tissue repair?

A
  • Several growth factors bind to ECM proteins and are displayed at high concentrations
  • All growth factors activate signaling pathways that ultimately induce the production of proteins that are involved in driving cells through the cell cycle and other proteins that release blocks on the cell cycle.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
152
Q

In addition to growth factors, what else can stimulate cell proliferation in tissue repair?

A

Cells use integrins to bind to ECM proteins, and signals from the integrins can stimulate cell proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
153
Q

What are the most important stem cells for regeneration after injury? Where are they and what do they do?

A

Tissue stem cells live in specialised niches, and it is believed that injury triggers signals in these niches that activate quiescent stem cells to proliferate and differentiate into mature cells that repopulate the injured tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
154
Q

How is the loss of blood cells corrected and what triggers this?

A

Loss of blood cells is corrected by the proliferation of haematopoietic stem cells in the bone marrow and other tissues, driven by growth factors called colony-stimulating factors, which are produced as the response to the reduced number of blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
155
Q

What are the steps in scar formation that follow tissue injury and the inflammation response?

A
  1. Angiogenesis to supply nutrients and oxygen needed to support the repair process. Newly formed vessels are leaky because of incomplete interendothelial junctions and because VEGF, the growth factor that drives angiogenesis, increases vasular permeability
  2. Formulation of granulation tissue - migration and proliferation of fibroblasts and the deposition of loose connective tissue, together with the vessels and interspersed leukocytes, form granulation tissue. It progressively invades the site of injury
  3. Remodelling of the connective tissue - maturation and reorganising of the connective tissue produces the stable fibrous scar. The amount of connective tissue increases in the granulation tissue, eventually resulting in a scar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
156
Q

What is the histological appearance of granulation tissue?

A

Proliferation of fibroblasts and new thin-walled delicate capillaries (angiogenesis) in a loose extracellular matrix, often with admixed inflammatory cells, especially macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
157
Q

How soon after injury do the steps of tissue repair take place?

A
  • Repair begins within 24 hours of injury by the emmigration of fibroblasts and the induction of fibroblast and endothelial cell proliferation.
  • By 3-5 days, the specialised granulation tissue that is characteristic of healing is apparent.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
158
Q

What is angiogenesis and when does it happen?

A

Angiogenesis is the process of new blood vessel development from existing vessels
It is critical:
* in healing at sites of injury
* in the development of collateral circulations at sites of ischaemia
* in allowing tumours to increase in size beyond the constraints of their original blood supply

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
159
Q

What are the steps of angiogenesis?

A
  1. Vasodilation in response to NO and increased permeability induced by VEGF
  2. Seperation of pericytes from the abluminal surface and breakdown of the basement membrane to allow formation of a vessel sprout
  3. Migration of endothelial cells towards the site of tissue injury
  4. Proliferation of endothelial cells just behind the leading front (‘tip’) of migrating cells
  5. Remodelling into capillary tubes
  6. Recruitment of periendothelial cells (pericytes for small vessels, smooth muscle for large) to form the mature vessel
  7. Suppression of endothelial proliferation and migration and deposition of the basement membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
160
Q

The process of angiogenesis involves several signalling pathways, cell-cell interactions, ECM proteins and tissue enzymes.
What growth factors are required (name 5) and what do they do?

A
  • Vascular endothelial growth factors (VEGF), mainly VEGF-A, stimulates both migration and proliferation of endothelial cells, initiating the process of capillary sprouting. It promotes vasodilation by stimulating the production of NO and contributes to the formation of the vascular lumen
  • Fibroblast growth factors, mainly FGF-2, stimulates the proliferation of endothelial cells. It also promotes the migration of macrophages and fibroblasts to the area, and stimulates epithelial cell migration to cover epidermal wounds
  • Angiopoietins 1 and 2 (Ang 1 & 2) are growth factors that play a role in angiogenesis and the structural maturation of new vessels. Ang1 interacts with an endothelial tyrosine kinase receptor called Tie1
  • PGDF recruits smooth muscle cells
  • TGF-beta suppresses endothelial cell proliferation and migration, and enhances the production of ECM proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
161
Q

What is Notch signalling?

A

Through ‘cross-talking’ with VEGF, the Notch signalling pathway regulates the sprouting and branching of new vessels and thus ensures that the new vessels that are formed have the proper spacing to effectively supply the healing tissue with blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
162
Q

The process of angiogenesis involves several signalling pathways, cell-cell interactions, ECM proteins and tissue enzymes.
What is the function of ECM proteins?

A

ECM proteins participate in the process of vessel sprouting, largely with interactions with integrin receptors in endothelial cells and providing the scaffold for vessel growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
163
Q

The process of angiogenesis involves several signalling pathways, cell-cell interactions, ECM proteins and tissue enzymes.
What is the function of the tissue enzymes?

A

Enzymes in the ECM, notably the matrix metalloproteinases (MMPs), degrade the ECM to permit remodelling and extension of the vascular tube

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
164
Q

What are the two steps in the laying down of connective tissue in tissue repair?

A
  1. Migration and proliferation of fibroblasts to the site of injury
  2. The deposition of ECM proteins produced by these cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
165
Q

The process of laying down connective tissue is orchestrated from what? and where are these produced?

A

The proceses are orchestrated by locally produced cytokines and growth factors, including PDGF, FGF-2 and TGF-beta.

The major sources for these are inflammatory cells, particularly macrophages activated by the alternative pathway (M2). Mast cells and lymphocytes can also release them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
166
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
167
Q

What is the most important cytokine for the synthesis and deposition of the connective tissue proteins?

A

Transforming growth factor - beta
TGF-beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
168
Q

Where is TGF-beta produced and what does it do?

A
  • It is produced by most of the granulation tissue, including alternatively activated macrophages.
  • It stimulates fibroblast migration and proliferation, increased synthesis of collagen and fibronectin, and decreased degradation of the ECM due to inhibition of metalloproteinases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
169
Q

What factors regulate TGF-beta production?

A

The levels in tissues are primary regulated not by the transcription of the gene but by the posttranscriptional activation of latent TGF-beta, the rate of secretion of the active molecule, and factors in the ECM (notably integrins), that enhance or diminish TGF-beta activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
170
Q

What are the processes in which TGF-beta is involved in?

A
  • Scar formation after injury
  • Development in fibrosis in the lung, liver and kidney that follow chronic inflammation
  • It serves as an anti-inflammatory cytokine that limits and terminates the inflammatory response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
171
Q

How does TGF-beta limit and terminate the inflammatory response?

A

It inhibits leukocyte production and the activity of other leukocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
172
Q

How do fibroblasts change as healing progresses and what is the outcome of this?

A

As healing progresses, the number of proliferating fibroblasts and new vessels decreases; however, the fibroblasts progressively assume a more synthetic phenotype, and hence there is an increased deposition of ECM.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
173
Q

When does collagen synthesis by fibroblasts begin after injury and how long does it last for?

A

It begins early in wound healing (3-5 days) and continues for several weeks, depending on the size of the wound.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
174
Q

What is a scar tissue composed of?

A

Largely inactive, spindle-shaped fibroblasts, dense collagen, fragments of elastic tissue and other ECM components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
175
Q

What happens to the scar as it matures?

A

There is progressive vascular regression, which eventually transforms the highly vascularised granulation tissue into a pale, largely asvascular scar.
Some of the fibroblasts also acquire features of smooth muscle cells, including the presence of actin filaments, and are called myofibroblasts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
176
Q

How do myofibrils change a scar over time?

A

The contribute to the contraction of a scar over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
177
Q

What affects the outcome of the repair process?

A

It is influenced by a balance between the synthesis and degradation of the ECM proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
178
Q

What family degrades the ECM proteins in scar formation?

A

The degradation of collagens and other ECM components is accomplished by a family of matrix metalloproteinases (MMPs), so called because they are dependent on metal ions (zinc) for their activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
179
Q

What are some examples of some matrix metalloproteinases (MMPs)?

A
  • Interstitial collagenases which cleave fibrillar collagen (MMP-1, -2 and -3)
  • Gelatinases which degrade amorphous collagen and firbonectin (MMP-2 and -9)
  • Stromelysins which degrade a variety of ECM constituents, including proteoglycans, laminin, fibronectin and amorphous collagen (MMP -3, -10 and -11)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
180
Q

What cells produce MMPs and what regulates them?

A
  • MMPs are produced by a variety of cell types (fibroblasts, macrophages, neutrophils, synovial cells, and some endotheliali cells)
  • Their synthesis and secretion is regulated by growth factors, cytokines and other agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
181
Q

MMPs have to be tightly controlled. What processes control this?

A
  • They are produced as inactive precursors (zymogens) that must first be activated by proteases (e.g.plasmin) likely to be present only at the site of injury
  • In addition, activated collagenases can be rapidly inhibited by specific tissue inhibitors of metalloproteinases (TIMPs), produced by most mesenchymal cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
182
Q

What are the factors that affect tissue repair?

A
  • Infection prolongs inflammation
  • Diabetes prolongs wound healing
  • Nutritional status particularly protein deficiency and vitamin C deficiency
  • Glucocorticoids (steroids) inhibit TGF-beta production and diminish fibrosis
  • Mechanical factors such as increased local pressure or torsion
  • Poor perfusion due to either atherosclerosis and diabetes or to obstructed venous damage
  • Foreign bodies
  • The type and extent of tissue injury - the type of cells, as explained earlier (you know this gurl)
  • The location of the injury depends on the type of acute inflammation that happens and some of those repair better than others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
183
Q

What is healing by first intention vs second intention?

A
  • First intention is when the injury only involves the epithelial layer, the principal mechanism of repair is epithelial regeneration
  • Second intention is when cell of tissue loss is more extensive, such as in large wounds, abscesses, ulceration and ischaemic necrosis in parenchymal organs, the repair process involves a combination of regeneration and scarring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
184
Q

What are the steps of first intention healing?

A
  1. Inflammation
  2. Proliferation of epithelial and other cells
  3. Maturation of the connective tissue scar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
185
Q

What happens immediately during healing of first intention?

A
  • Wounding causes the rapid activation of coagulation pathways, which results in the formation of a blood clot on the wound surface.
  • In addition to trapped red cells, the clot contains fibrin, fibronectin, and complement proteins.
  • The clot serves to stop bleeding and act as a scaffold for migrating cells, which are attracted by growth factors, cytokines and chemokines.
  • Release of VEGF leads to increased vascular permeability and oedema.
  • As dehydration occurs at the external surface of the clot, a scab covering the wound is formed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
186
Q

What happens within 24 hours of healing with first intention?

A
  • Neutrophils are seen at the incision margin, migrating towards the fibrin clot. They release proteolytic enzymes that begin to clear the debris.
  • Basal cells at the cut edge of the epidermis begin to show increased mitotic activity.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
187
Q

What happens between 24-48 hours of healing with first intention?

A
  • Epithelial cells from both edges have begun to migrate and proliferate along the dermis, depositing basement membrane components as they progress.
  • The cells meet in the midline beneath the surface scab, yielding a thin but continuous epithelial layer that closes the wound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
188
Q

What happens by day 3 of healing with first intention?

A
  • Neutrophils have been largely replaced by macrophages, and granulation tissue progressively invades the incision space.
  • As you know, macrophages clear extracellular debris, fibrin and other foreign material, promoting angiogenesis and ECM deposition.
  • Collagen fibres are now evident at the incision margins.
  • Epithelial cells continue to proliferate, forming a covering approaching the thickness of the epidermis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
189
Q

What happens by day 5 of healing with first intention?

A
  • Neovascularisation reaches its peak as granulation tissue fills the incisional space. These new vessels are leaky, allowing the passage of plasma proteins and fluid into the extravascular space. Thus, new granulation tissue is often oedematous.
  • Migration of fibroblasts to the site on injury is driven by chemokines, TNF, PDGF, TGF-beta and FGF. Their subsequent proliferation is triggered by multiple growths factors, including PDGF, EGF, TGF-beta and FGF, and the cytokines IL-1 and TNF.
  • The fibroblasts produce ECM proteins, and collagen fibrils become more abundant and begin to bridge the incision.
  • The epidermis recovers it’s normal thickness as differentiation of surface cells yields a mature epiderminal architechture with surface keratinisation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
190
Q

What happens during the second week of healing with first intention?

A
  • There is continued collagen accumulation and fibroblast proliferation.
  • The leukocyte infiltrate, oedema, and increased vascularity are substantially diminished.
  • The process of ‘blanching’ begings, accomplished by increasing collagen deposition within the incisional scar and the regression of the vascular channels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
191
Q

What happens by the end of the first month of healing with first intention?

A
  • The scar comprises a cellular connective tissue largely devoid from inflammatory cells and covered by an essentially normally epidermis
  • However, the dermal appendages destroyed in the line of incision are permanently destroyed.
  • The tensile strength of the wound increases with time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
192
Q

How does secondary intention differ from primary intention?

A
  • The fibrin clot is larger, there is more exudate and necrotic debris, therefore the inflammatory response is larger and may cause inflammation-mediated injury
  • Much larger amounts of granulation tissue, which generally results in a greater mass of scar tissue
  • At first, a provisional matrix containing fibrin, plasma fibronectin, and type 3 collagen is formed, but in about 2 weeks this is replaced by a matrix composed primarily by type 1 collagen
  • Wound contraction generally plays a larger role in secondary intention by myofibrils. Within 6 weeks, large skin defects may be reduced by 5-10% of their original size
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
193
Q

What are the phases of cell cycle?

A
  • G1 - presynthetic growth
  • S - DNA synthesis
  • G2 - premitotic growth
  • M - mitotic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
194
Q

What are quiescent cells? What phase of the cycle are they in?

A

Cells that are not actively cycling. They are said to be in the G0 phase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
195
Q

Where can cells enter G1 from?

A

Either from G0 or after completing a round of mitosis, as for continuously replicating cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
196
Q

What regulates the cell cycle?

A

It is regulated by activators and inhibitors.

  • Cell cycle progression is driven by proteins called cyclins and cyclin-associated enzymes called cyclic-dependant kinases (CDKs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
197
Q

How are cyclins and cyclic-dependant kinases linked?

A
  • CDKs acquire the ability to phosphorylate protein substrates by forming complexes with the relevant cyclins.
  • Transiently increased synthesis of a particular cyclin leads to increased kinase activity of the appropriate CDK binding partner.
  • As the CDK completes its round of phosphorylation, the associated cyclin is degraded and the CDK activity abades.
  • Thus, as cyclin levels rise and fall, the activity of associates CDKs likewise wax and wane.
  • The different CDKs happen sequentially, like a relay race
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
198
Q

Where are the cell cycle checkpoints and what do they check for?

A
  • The G1-S checkpoint monitors the integrity of the DNA before irreversibly commiting cellular resources to DNA replication.
  • The G2-M restriction point ensures that there has been accurate gene replication before the cell actually divides.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
199
Q

What happens if the checkpoints in the cell cycle detect an error in DNA replication?

A
  • When cells do have DNA irregularities, checkpoint activation delays cell cycle progression and triggers DNA repair mechanisms
  • If the genetic derangement is too severe to be repaired, the cells will undergo apoptosis.
  • Alternatively, they may enter a non-replicative state called senescence - primarily throught the p53-dependant mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
200
Q

What enzyme ensures the checkpoints in the cell cycle do their job? How does it do that?

A

It is the job of the CDK inhibitors: they accomplish this by modulating the CDK-cyclin complex activity.

Some examples are p21, p27, and p57

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
201
Q

What is the Warburg effect? Why is it important?

A
  • It is the effect to ensure that there are enough resources to perform DNA replication
  • It involves increased cellular uptake of glucose and glutamine, increased glycolysis, and (counter-intuitively) decreased oxidate phosphorylation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
202
Q

What are stem cells?

A

During development, stem cells give rise to all the various differentiated tissues.
In the adult organism, stem cells replace damaged cells and maintain tissue populations as individual cells within them undergo replicative senescence due to attirition of telemeres.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
203
Q

What are two important characteristics of stem cells?

A
  • Self-renewal, which permits stem cells to maintain their numbers
  • Asymmetric division, in which one daughter cell enters a differentiation pathway and gives rise to mature cells, while the other remains undifferentiated and retains its self-renewal capacity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
204
Q

What are the two varieties of stem cells?

A
  • Embryonic stem cells are the most undifferentiated. They are present in the inner cell mass of the blastocyst, have virtually limitless cell renewal capacity, and can give rise to every cell in the body. They are totipotent.
  • Tissue stem cells are found in intimate association with differential cells a given tissue. They are normally protected within specialised tissue microenvironments called stem cell niches. They have a limited repertoire of differentiated cells they can generate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
205
Q

Where are mesenchymal stem cells found and what can they differentiate to?

A

Mesenchymal stem cells are found in bone marrow.
They can differentiate into a variety of stromal cells including chondrocytes (cartilage), osteocytes, adipocytes, and myocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
206
Q

What is a bone fracture?

A

A fracture is defined as the loss of bone integrity due to mechanical injury and/or diminished bone strength

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
207
Q

How can you describe fractures?

A
  • Simple - the overlying skin is intact
  • Compound - the bone communicates with the skin surface
  • Comminuted - the bone is fragmented
  • Displaced - the ends of the bone at the fracture site are not aligned
  • Stress - a slowly developing fracture that follows a period of increased physical activity in which the bone is subjected to repetitive loads
  • “Greenstick” - extending only partially through the bone, common in infants, where the bone is soft
  • Pathological - involving bone weakened by an underlying disease process, such as tumour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
208
Q

What happens in the bone immediately after a fracture?

A
  • Rupture of the blood vessels results in a haematoma, which fills the fracture gap and surround the area of bone injury.
  • The clotted blood provides a fibrin mesh, sealing off the fracture site and at the same time creates a framework for the influx of inflammatory cells and ingrowth of fibroblasts and new capillaries.
  • Simultaneously, degranulated platelets and migrating inflammatory cells release PDGF, TGF-beta, FGF and other factors, which activate osteoprogenitor cells in the periosteum, medullary cavity, and surrounding soft tissues and stimulate osteoclastic and osteoblastic activity.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
209
Q

What happens in the bone by the end of the first week after a fracture?

A
  • Organisation of the haematoma, matrix production in adjacent tissues, and remodeling of the fractured ends of the bone
  • This fusiform and predominantly uncalcified tissue - called soft tissue callus - provides some anchorage between the ends of the fractured bones but not structural rigidity for weight bearing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
210
Q

What happens in the bone by two weeks after a fracture?

A
  • The soft tissue callus is transformed into a bony callus.
  • The activated osteoprogenitor cells deposit subperiosteal trabeculae of woven bone that are orientated perpendicular to the cortical axis and within the medullary cortex.
  • In some cases, the activated mesenchymal cells also form chondrocytes that make fibrocartilage and hyaline cartilage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
211
Q

When does the bony cartilage after a bone fracture reach it’s maximal girth?

A

At the end of the second or third week. It helps stabilise the fracture site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
212
Q

What happens to the newly formed cartilage after a bone fracture?

A

The newly formed cartilage along the fracture line undergoes endochondral ossification, forming a contigunous network of bone with newly deposited bone trabeculae in the medulla and beneath the periosteum.

In this fashion, the fracture ends are bridged, and as it mineralises, the stiffness and strength of the callus increases to the point that controlled weight bearing is tolerated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
213
Q

How does the bony callus disappear in healed bone?

A

As the callus matures and is subject to weight-bearing forces, the callus portions that are not physically stressed are resorbed.
In this manner, the callus is reduced in size and the shape and the outline of the fractured bone are re-established as lamellar bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
214
Q

The sequence of events in the healing of a fracture can be easily impeded or blocked. Give some examples of what by…

A
  • Inadequate immobilisation - causes nonunion
  • Infection
  • Malnutrition and skeletal dysplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
215
Q

What is pathological calcification?

A

The abnormal tissue deposition of calcium salts, together with smaller amounts of iron, magnesium and other mineral salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
216
Q

What are the two types of calcification?

A
  • Dystrophic calcification occurs despite normal serum levels of calcium and in the absence of derangements of calcium metabolism
  • Metastatic calcification - the deposition of calcium in otherwise normal tissues, almost always results from hypercalcaemia secondary to some disturbance in calcium metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
217
Q

In what conditions would dystrophic calcification take place?

A

It is encountered in areas of necrosis, whether they are of coagulative, caseous or liquefactive type, and in foci of enzymatic necrosis of fat.
Commonly happens in atherosclerosis and heart valves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
218
Q

How does dystrophic calcification present macroscopically and histologically?

A
  • Macroscopically, calcium salts appear as fine, white granules or clumps, often felt as gritty deposits
  • Histologically, they have a basophilic, amorphous, granular, sometimes clumped appearance. You can see psammoma bodies, which are mineral deposits around necrotic cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
219
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
220
Q

Are dystrophic and metastatic calcifications causes of organ dysfunction?

A
  • Dystrophic calcification is often a cause of organ dysfunction, such as in calcific valvular disease
  • Metastatic calcification if not often a cause of organ dysfunction, but on occasion massive involvement of the lungs produces some respiratory compromise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
221
Q

What are some common causes of transudates?

A

Heart failure
Liver failure
Kidney failure
Severe nutritional deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
222
Q

What are some causes of increased hydrostatic pressure?

A

Increases in hydrostatic pressure are mainly caused by disorders that impair venous return. For example:
Congestive heart failure
Constrictive pericarditis
Ascites
Venous obstruction or compression (thrombosis, external pressures e.g. mass, lower extremity inactivity)
It is also sometimes caused by arteriolar dilation. For example in heat or neurohumoral dysregulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
223
Q

What causes reduced plasma osmotic pressure?

A

Under normal circumstances albumin accounts for almost half of the total plasma protein; it follows that conditions leading to inadequate synthesis or increased loss of albumin from the circulation commonly cause reduced plasma oncotic pressure.
* Reduced synthesis occurs mainly in severe liver disease and protein malnutrition
* Increased loss occurs in nephrotic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
224
Q

How does sodium and water retention occur in oedema?

A

Increased salt retention (with obligate retention of water) causes both increased hydrostatic pressure and diminshes osmotic pressure (due to dilution).
Salt retention occurs whenever renal function is compromised, such as in primary kidney diseases and in cardiovascular diseases that cause hypoperfusion, resulting in the activation of the renin-angiotension-aldosterone axis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
225
Q

How does lymphatic obstruction cause lymph-oedema?

A

Trauma, fibrosis, invasive tumours, and infection agents can all disrupt lymphatic vessels and impair the clearance of interstitial fluid, resulting in lymphoedema in the affected part of the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
226
Q

What are the different places you can get oedema?

A

Subcutaneous oedema
Pulmonary oedema
Pulmonary effusions
Peritoneal effusions (ascites)
Brain oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
227
Q

How is oedema recognised microscopically?

A

It is appreciated as clearing and separation of the extracellular matrix and subtle cell swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
228
Q

What is hyperemia vs congestion?

A

Hyperemia and congestion both stem from increased blood volumes within tissues.
Hyperemia is an active process in which arteriolar dilation (inflammation or exercising muscles) leads to increased blood flow. Affected tissues turn red (erythema) because of increased delivery of oxygenated blood
Congestion is a passive process resulting from reduced outflow of blood from a tissue. It can be systemic (heart failure) or localised (isolated venous obstruction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
229
Q

What does chronic congestion lead to and why?

A

As a result of increased hydrostatic pressures, congestion commonly leads to edema.
The associated chronic hypoxia may lead to ischaemic tissue injury and scarring.
Capillary rupture can also produce small haemorrhagic foci; subsequent catabolism of extravasated red cells can leave clusters of haemosiderin-laden macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
230
Q

Microscopically, what will you see in acute pulmonary congestion vs chronic pulmonary congestion?

A
  • Acute pulmonary congestion exhibits engorged alveolar capillaries, alveolar septal emboli, and focal intraalveolar haemorrhage
  • In chronic pulmonary congestion (often caused by congested heart failure) the septa are thickened and fibrotic, and the alveoli often contain numerous haemosiderin-laden macrophages called heart failure cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
231
Q

Microscopically, what will you see in acute hepatic congestion vs chronic hepatic congestion?

A
  • In acute hepatic congestion, the central vein and sinusoids are distended. Because the centrilobular area is distal end of the hepatic blood supply, centrilobular hepatocytes may undergo ischaemic necrosis with the periportal hepatocytes may only develop fatty change (better oxygenated)
  • In chronic passive hepatic congestion, the centrilobular regions are grossly red-brown and slightly depressed and are accentuated against the surrounding zones of uncongested tan liver (nutmeg liver).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
232
Q

What is haemostasis?

A

A precisely organised process involving platelets, clotting factors, and endothelium that occurs at the site of the vascular injury and culminates in the formation of a blood clot, which serves to prevent or limit the extent of bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
233
Q

What two groups are abnormal haemostasis divided into?

A
  • Haemorrhagic disorders - characterised by excessive bleeding, haemostatic mechanisms are either blunted or insufficient to prevent abnormal blood loss.
  • Thrombotic disorders - blood clots (thrombi) form within intact blood vessels or within the chambers of the heart.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
234
Q

Are thrombotic and haemorrhagic disorders always separate entities?

A

No, sometimes in generalised activation of clotting paradoxically produces bleeding due to the consumption of coagulation factors, as in DIC.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
235
Q

What are the four steps in haemostasis?

A

1) Arteriolar vasoconstriction
2) Primary haemostasis - the formation of the platelet plug
3) Secondary haemostasis - deposition of the fibrin
4) Clot stabilisation and resorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
236
Q

What happens in arteriolar vasoconstriction during haemostasis?

A
  • It occurs immediately and markedly reduced blood flow to the injured area.
  • It is mediated by reflex neurogenic mechanisms and augmented by the local secretion of factors such as endothelin, a potent endothelium-derived vasoconstrictor.
  • This effect is transient and bleeding would continue if it wasn’t for the next steps
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
237
Q

What happens in primary haemostasis - formation of the platelet plug?

A
  • Disruption of the endothelium exposes subendothelium vWF and collagen, which promote platelet adherence and activation.
  • Activation of platelets results in a dramatic shape change (from small rounded discs to flat plates with spiky protrusions that markedly increase surface area), as well as the release of secretory granules (ADP, TxA2)
  • Within minutes, the secreted products recruit additional platelets, which undergo aggregation to form a primary haemostatic plug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
238
Q

What happens in secondary haemostasis - deposition of fibrin?

A
  • Tissue factor is exposed at the site of injury. Tissue factor is a membrane-bound procoagulant glycoprotein that is normally expressed by subendothelial cells in the vessel wall, such as smooth muscle cells or fibroblasts.
  • Tissue factor binds and activates factor VII, setting in motion a cascade of reactions that generates thrombin.
  • Thrombin cleaves circulating fibrinogen into insoluble fibrin, creating a fibrin mesh-work, and is also a potent activator of platelets, leading to additional platelet aggregation at the site of injury.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
239
Q

What happens during clot stabilisation and resorption during haemostasis?

A
  • Polymerised fibrin and platelet aggregates undergo contraction to form a solid, permanent plug that prevents further haemorrhage.
  • At this stage, counteregulatory mechanisms (e.g. tissue plasminogen factor t-PA) are set into motion that limit clotting to the side of injury and eventually lead to clot resorption and tissue repair.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
240
Q

What are platelets?

A

Disc-shaped anucleate cell fragments that are shed from megakaryocytes in the bone marrow into the bloodstream.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
241
Q

What do platelets need to function?

A

Their function depends on several glycoprotein receptors, a contractile cytoskeleton, and two types of cytoplasmic granules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
242
Q

What cytoplasmic granules do platelets rely on to function?

A
  • α-granules have the adhesion molecule P-selectin on their membranes and contain proteins involved in coagulation, such as fibrinogen, coagulation factor V, and vWF, as well as protein factors that may be involved in wound healing, such as fibronectin, platelet factor 4 (a heperin-binding chemokine), platelet-derived growth factor (PDGF), and transforming growth factor-β.
  • Dense (or δ) granules contain ADP and ATP, ionised calcium, serotonin, and adrenaline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
243
Q

After a traumatic vascular injury, platelets encounter consistuents of the subendothelial connective tissue, such as vWF and collagen. On contact with these proteins, platelets undergo a sequence of reactions the culminate the formation of a platelet plug. What are they?

A
  1. Platelet adhesion
  2. Platelets rapidly change shape
  3. Secretion of granules content
  4. Platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
244
Q

How does platelet adhesion take place in plug formation?

A
  • Platelet adhesion is mediated largely by interactions with vWF, which acts as a bridge between the platelet surface receptor glycoprotein 1b (Gp1B) and exposed collagen.
  • Notably, the genetic deficiencies of vWF or Gp1B (Bernard-Soulier syndrome) result in bleeding disorders.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
245
Q

What happens when the platelets change shape in plug formation?

A
  • The platelets change shape following adhesion, being converted from smooth discs to ‘sea urchins’ with greatly increased surface area.
  • This change is accompanied by alterations in glycoprotein IIb/IIIa that increase it’s affinity for fibrinogen, and by the translocation of the negatively charged phospholipids (particularly phosphatidylserine) to the platelet surface.
  • These phospholipids bind calcium and serve as nucleation sites for the assembly of coagulation factor complexes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
246
Q

What is platelet activation in the plug formation? What triggers it?

A

Secretion of the granule contents occurs along with the changes in shape; these two events together are known as activation.

  • Platelet activation is triggered by a number of factors, including the coagulation factor thrombin and ADP.
  • Thrombin activates platelets through a special type of G-protein coupled receptor, protease-activated receptor (PAR), which is switched on by a proteolytic cleavage by thrombin.
  • ADP is a component of dense body granules; thus, platelet activation and ADP release begets additional rounds of platelet activation, a phenomenon known as recruitment.
  • Activated platelets also produce the prostaglandin thromboxane A2 (TxA2), a potent inducer of platelet aggregation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
247
Q

What happens during platelet aggregation?

A
  • Platelet aggregation follows their activation.
  • The conformational change in glycoprotein 2b/3a that occurs with platelet activation allows a binding of fibrinogen, a large bivalent plasma polypeptide that forms bridges between adjacent platelets, leading to their aggregation
  • The inital wave of aggregation is reversible, but concurrent activation of thrombin stabilises the platelet plug by causing further platelet activation and aggregation, and by promoting irreversible platelet contraction
  • Platelet contraction is dependent of the cytoskeleton and consolidates the aggregated platelets.
  • In parallel, thrombin also converts fibrinogen into insoluble fibrin, cementing platelets in place and creating the definitely secondary hemostatic plug.
  • Entrapped red cells and leukocytes are also found in haemostatic plugs, in part due to adherence of leukocytes to P-selectin expressed on activated platelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
248
Q

What is the coagulation cascade?

A

It is a series of amplifying enzymatic reactions that leads to the deposition of an insoluble fibrin clot.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
249
Q

What does each step in the coagulation cascade have in common? Where do they happen?

A

Each reaction step involves an enzyme (an activated coagulation factor), a substrate (an inactive proenzyme form of a coagulaton factor), and a cofactor (a reaction accelerator).
These components are assembled on a negatively charged phospholipid surface, provided by activated platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
250
Q

Which ion and vitamin are important in the coagulation cascade?

A
  • Calcium ions - assembly of reaction complexes depend on calcium, which binds to γ-carboxylated glutamic acid residues that are present in factors
  • The enzymatic reactions that produce γ-carboxylated glutamic acid use Vitamin K as a cofounder and are antagonised by many drugs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
251
Q

What are the two pathways in the coagulation cascade? What do we use to assess them?

A

Extrinsic and Intrinsic Pathways
* The prothrombin time (PT) assay assess the function of the proteins in the extrinsic pathway (factors VII, X, V, II and fibrinogen). In brief, tissue factor, phospholipids, and calcium are added to plasma and the time for a fibrin clot to form is recorded
* The partial thromboplastin time (PTT) assay screens the function of the proteins in the intrinsic pathway (factors XII, XI, IX, VIII, X, V, II, and fibrinogen). In this assay, clotting of plasma is initiated by addition of negative-charged particles (e.g. ground glass) that activate factor XII (Hageman factor) together with the phospholipids and calcium, and the time to fibrin clot formation is recorded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
252
Q

What do the deficiencys in the different clottin factors lead to? What does this show?

A
  • Deficiencies in factors V, VII, VIII, IX and X are associated with moderate to severe bleeding disorders
  • Prothrombin deficiency is incompatible with life
  • Factor XI deficiency is only associated with mild bleeding
  • Individuals with factor XII deficiency do not bleed and are in fact susceptible to thrombosis

This shows that the process in vivo and in the lab are different!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
253
Q

Which is the most important coagulation factor?

A

Thrombin, because its various enzymatic activities control divers aspects of haemostasis and link clotting to inflammation and repair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
254
Q

What are thrombin’s most important roles?

A
  • Conversion of fibrinogen into crosslinked fibres - Thrombin directly converts soluble fibrinogen into fibrin monomers that polymerise into an insoluble clot, and also amplifies the coagulation process, not only by activating factor XI, but also by activating factors V and VIII.
  • Stabilises the secondary haemostatic plug by activating factor XIII, which covalently cross-links fibrin.
  • Platelet activation - thrombin in a potent inducer of platelet activation, and aggregation through its ability to activate PARs, therefore linking platelet function to coagulation
  • Pro-inflammatory effects - PARs are also expressed on inflammatory cells, endothelium, and other cell types, and activation of these receptors by thrombin is believed to mediate proinflammatory effects that contribute to tissue repair and angiogenesis
  • Anticoagulant effects - upon encountering normal endothelium, thrombin changes from a procoagulant to an anticoagulant. This reversal in function prevents clotting from extending beyond the site of vascular injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
255
Q

Once initiated, coagulation must be restricted to the site of vascular injury. What are the factors that limit coagulation?

A
  • Simple dilution - blood flowing past the site of injury washes out activated coagulation factors, which are rapidly removed by the liver
  • The requirement for negatively charged phospholipids - which are mainly provided by platelets that have been activated by contact with the subendothelial matrix at sites of vascular injury.
  • Factors that are expressed by intact endothelium adjacent to the injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
256
Q

Activation of the coagulation cascade also sets into motion the fibrinolytic cascade that limits the size of the clot and contributes to it’s later dissolution. Tell me about this process…

A
  • Fibrinolysis is largely accomplished through the enzymatic activity of plasmin, which breaks down fibrin and interferes with its polymerisation.
  • There is an elevated level of breakdown products of fibrinogen (often called fibrin split products) e.g. d-dimer.
  • Plasmin is generated by enzymatic catabolism of the inactive circulating precursor plasminogen, either by a factor XII-derived pathway or by plasminogen activators e.g. tPA.
  • Once activated, plasmin is tightly controlled by counterregulatory factors such as α2-plasmin inhibitor, a plasma protein that binds and rapidly inhibits plasmin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
257
Q

Normal endothelial cells express a multitude of factors that inhibit the procoagulant activities of platelets and coagulation factors and that augment fibrinolysis. What are the different antithrombotic properties of endothelium?

A
  • Platelet inhibitory effects - Intact epithelium acts as a barrier that shields platelets from subendothelial vWF and collagen. It also releases NO, prostacyclin (PGI2), and ADP which inhibit platelet activation and aggregation. They also bind and alter the activity of thrombin, which is a potent activators of platelets.
  • Anticoagulant effects - Intact epithelium shields coagulation factors from tissue factor. It also expresses multiple factors that actively oppose coagulation, such as thrombomodulin, endothelial protein C receptor, heparin-like molecules, and tissue factor pathway inhibitor.
  • Fibrinolytic effects - normal endothelial cells synthesise t-PA, a key component of the fibrinolytic pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
258
Q

How do thrombomodulin and endothelial protein C receptor have anticoagulant effects?

A

They bind thrombin and protein C, respectively, in a complex on the endothelial cell surface. When bound in this complex, thrombin loses it’s ability to activate coagulation factors and platelets, and instead cleaves and activated protein C, a vitamin K-dependent protease that requires a cofactor, protein S. Activated protein C/protein S complex is a potent inhibitor of coagulation factors Va and VIIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
259
Q

How do Heparin-like molecules have anticoagulant properties?

A

Heparin-like molecules on the surface of endothelium bind and activate anti-thrombin III, which then inhibits thrombin and factors IXa, Xa, XIa, and XIIa.
The clinical utility of heparin and related drugs is based on their ability to stimulate antithrombin III activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
260
Q

How does tissue factor pathway inhibitor have anticoagulant properties?

A

TFPI, like Protein C, requires Protein S as a cofactor, and binds and inhibits tissue factor/factor VIIa complexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
261
Q

What are the very broad causes of haemorrhagic disorders?

A
  • Primary or secondary defects in vessel walls e.g. aortic dissection or arterial ruptures
  • Platelet disorders
  • Coagulation factor disorders e.g. haemophilia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
262
Q

How do defects of primary haemostasis present? Give an example

A
  • Platelet defects or von Willebrand disease
  • Often present with small bleeds in skin or mucosal membranes, which take the form of petechiae or purpura
  • The capillaries of the mucosa and skin are more prone to rupture following minor trauma and under normal circumstances platelets seal these defects virtually immediately.
  • Mucosal bleeding associated with disorders of primary haemostasis may present with epistaxis, GI bleeding, or menorrhagia. A fatal complication is intracerebral haemorrhage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
263
Q

What are petechiae, purpura and ecchymoses?

A
  • Petechiae - minute 1-2mm haemorrhages
  • Purpura - slightly larger (>3mm) haemorrhages
  • Ecchymoses - haemorrhages of 1-2 cm in size
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
264
Q

How do defects of secondary haemostasis present? Give an example

A
  • Coagulation factor defects e.g. haemophilia
  • Often present with bleeding into soft tissue (muscles) and joints
  • Haemarthrosis after minor trauma is particularly characteristic of haemophilia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
265
Q

What does the clinical significance of haemorrhage depend on?

A
  • Volume of the bleed
  • Rate at which it occurs
  • Location
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
266
Q

What percentage of blood loss may lead to haemorrhagic shock?

A

Over 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
267
Q

What are the primary abnormalities that lead to thrombosis? (Virchow’s triad)

A
  • Endothelial injury
  • Stasis or turbulent blood flow
  • Hypercoagulability of the blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
268
Q

Where in the body is endothelial injury the most common cause of thrombosis and why?

A

Endothlial injury leading to platelet activation almost inevitably underlies thrombus formation in the heart and the arterial circulation, where the high rates of blood flow impede clot formation.
These clots are typically rich in platelets, which is why aspirin is good.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
269
Q

What is endothelial activation or dysfunction?

A

Severe endothelial injury may trigger thrombosis by exposing vWF and tissue factor. However, inflammation and other noxious stimuli also promote thrombosis by shifting the pattern of gene expression in endothelium to one that is ‘prothrombotic’. This is called endothelial activation or dysfunction.
It can be caused by physical injury, infection, abnormal blood flow, inflammatory mediators, metabolic abnormalities and toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
270
Q

What are the main endothelial changes that occur during endothelial activation?

A
  • Procoagulant changes - endothelial cells activated by cytokines downregulate the expression of thrombomodulin, which results is sustained action of thrombin, which stimulates platelets and augments inflammation through PARs expressed on platelets and inflammatory cells. Endothelial cells also downregulate the expression of other anticoagulants, such as protein C and tissue factor pathway inhibitor
  • Antifibrinolytic effects - activated endothelial cells secrete plasminogen activator inhibitors (PAIs), which limit fibrinolysis, and downregulate the expession of t-PA
The opposite of this diagram!!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
271
Q

What is laminar flow?

A

Normal blood flow is laminar such that the platelets (and other blood cellular elements) flow centrally in the vessel lumen, separated from endothelium by a slower moving layer of plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
272
Q

How do stasis and turbulent flow cause endothelial injury and thrombosis?

A
  • Promote endothelial activation, enhancing procoagulant activity and leukocyte adhesion, in part through flow-induced changes in the expression of adhesion molecules and pro-inflammatory factors
  • Disrupt laminar flow and bring platelets into contact with the endothelium
  • Prevent washout and dilution of activated clotting factors by fresh flowing blood and the inflow of clotting factor inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
273
Q

What are some of the causes of stasis and turbulent blood flow in vessels?

A
  • Ulcerated atherosclerotic plaques not only expose subendothelial vWF and tissue factor but also cause turbulence
  • Aortic and arterial dilatations (aneurysms) result in local stasis
  • Acute MIs are associated with areas of noncontractile myocardium and cardiac aneurysms, both are associated with stasis and flow abnormalities
  • Hyperviscosity such as in polycythaemia vera causes increased resistance to flow and stasis
  • Deformed red cells in sickle cell anaemia impede blood flow through small vessels, resulting in stasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
274
Q

What is hypercoagulability? What groups can it be split into

A

Also called thrombophilia, hypercoagulability can be loosely defined as any disorder of the blood that predisposes to thrombosis.
It can be divided into primary (genetic) and secondary (acquired) disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
275
Q

What are some primary causes of hypercoagulability?

A

Common
* Factor V mutation (Arg to Glu substitution in amino acid residue 506 leading to resistance to factor C; Factor V Leiden
* Prothrombin mutation (G20210A noncoding sequence variant leading to increased prothrombin levels)
* Increased levels of factors VIII, IX, XI or fibrinogen

Rare
* Antithrombin III deficiency
* Protein C deficiency
* Protein S deficiency

Very rare
* Fibrinolysis defects
* Homozygous homocystinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
276
Q

How do the following secondary causes of hypercoagulability cause it?
* oral contraceptive
* disseminated cancers
* old age

A
  • Oral contraceptive - increased hepatic synthesis of coagulation factors and reduced anticoagulant synthesis
  • Disseminated cancers - release of various pro-coagulants from tumours
  • Older age - reduced endothelial PGI2 production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
277
Q

What are some secondary causes of hypercoagulability?

A

High risk for thrombosis
* prolonged bed rest or immobilisation
* MI
* AF
* Tissue injury (fracture, burn, surgery)
* Cancer
* Prosthetic cardiac valves
* DIC
* Heparin-induced thrombocytopaenia
* Antiphospholipid syndrome

Lower risk for thrombosis
* Cardiomyopathy
* Nephrotic syndrome
* Hyperestrogenic states (pregnancy, oral contraceptive)
* Sickle cell anaemia
* Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
278
Q

What is Heparin-Induced Thrombocytopaenic Syndrome?

A
  • HIT occurs following the administration of unfractionated heparin, which may induce the appearance of antibodies that recognise complexes of heparin and platelet factor 4 on the surface of platelets, as well as complexes of heparin-like molecules and platelet factor 4-like molecules on endothelial cells.
  • Binding of these antibodies to platelets results in their activation, aggregation and consumption. This produces a pro-thrombotic state.
  • It happens less in LMWH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
279
Q

How may antiphospholipid antibody syndrome present?

A
  • Recurrent thromboses
  • repeated miscarriages
  • cardiac valve vegetations
  • thrombocytopaenia
  • pulmonary hypertension from recurrent subclinical PEs
  • stroke
  • bowel infarction
  • renovascular hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
280
Q

What are the two types of antiphospholipid antibody syndrome?

A
  • Secondary antiphospholipid antibody syndrome is when it occurs with individual with a well-defined autoimmune disease, such as SLE
  • In primary antiphospholipid antibody syndrome, patients exhibit only the manifestations of a hypercoagulable state and lack evidence of other autoimmune disorders; occasionally it comes following drugs or an infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
281
Q

Which way to arterial and venous thrombi occur and which ways do they grow?

A
  • Arterial or cardiac thrombi usually begin at sites of turbulence and tend to grow retrograde
  • Venous thrombi often begin at sites of stasis and extend in the direction of blood flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
282
Q

What is a line of Zahn? Where does it happen and what does it mean?

A
  • Thrombi often have grossly and microscopically apparent laminations called lines of Zahn, which are pale platelet and fibrin deposits alternating with darker red cell-rich layers
  • They signify that a thrombus formed in flowing blood; they can therefore distinguish post-mortem to ante-mortem clots
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
283
Q

What are mural thrombi?

A

Thrombi that form in heart chambers or in the aortic lumen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
284
Q

What is different in the content or arterial vs venous clots?

A

Arterial thrombi often consist of a friable meshwork of platelets, fibrin, red cells, and degenerating leukocytes
Venous thrombi contain more enmeshed red cells and relatively few platelets - they are therefore known as red or stasis thrombi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
285
Q

If a patient survive the initial thrombus, in the ensuing days to weeks, thrombi can have one of four processes happen. What are they?

A
  • Propagation - thrombi accumulate additional platelets and fibrin
  • Embolisation - thrombi dislodge and travel to other sites in the vasculature
  • Dissolution - the result of fibrinolysis, which can lead to shrinkage and total disappearance of the recent thrombi - only happens in the first few hours
  • Organisation and recanalisation - older thrombi become organised by the ingrowth of endothelial cells, smooth muscle cells and fibroblasts. Capillary channels eventually form that reestablish the continuity of the original lumen, albiet to a variable degree. Eventually, with remodeling and contraction of the mesenchymal elements, only a fibrous lump may remain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
286
Q

What veins do superficial and deep venous thrombosis affect?

A

Superficial - in the saphenous veins - rarely embolise but same symptoms as DVT
Deep - in the popliteal, femoral or iliac veins - often embolise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
287
Q

What happens in DIC?

A

Widespread formation of thrombi in the microcirculation. These microvascular thrombi can cause diffuse circulatory insufficiency and organ dysfunction, particularly of the brain, lungs, heart and kidneys.
The runaway thrombosis ‘uses up’ platelets and coagulation factors and often activates fibrinolytic mechanisms . Thus, symptoms initially related to thrombosis can evolve into a bleeding catastrophe, such as haemorrhagic stroke or hypovolaemic shock.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
288
Q

What is an embolism?

A

An embolus is a detached intravascular solid, liquid, or gaseous mass that is carried by the blood from it’s point of origin to a distant site, where it often causes tissue dysfunction or infarction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
289
Q

What is the most common thromboembolic disease?

A

Pulmonary emboli from the DVT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
290
Q

Where do pulmonary emboli travel?

A

Fragmented thrombi from DVTs are carried through progressively larger veins and the right side of the heart before slamming into the pulmonary arterial vasculature.
Depending on the size of the embolus, it can occlude the main pulmonary artery, straddle the pulmonary artery bifurcation (staddle embolus), or pass out into the smaller branching arteries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
291
Q

Once you have one PE, what happens to your risk?

A

It increases significantly.
Frequently there are multiple emboli, occuring either sequentially or simultaneously as a shower of small emboli from a single large mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
292
Q

What is a paradoxical embolism?

A

Rarely, a venous embolus passes through an interatrial or interventricular defect and gains access to the systemic arterial circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
293
Q

At what percentage occlusion does a PE cause sudden death or Cor Pulmonale?

A

When emboli obstruct 60% or more of the pulmonary circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
294
Q

Why does embolic obstruction of medium-sized pulmonary arteries with subsequent vascular rupture not often cause an infarct? Why is this different in small end-arteriolar pulmonary branches

A

Because the lung is supplied by both the pulmonary arteries and the bronchial arteries, and an intact bronchial circulation is usually sufficient to perfuse the attached area.
This is not the case in small end-arteriolar pulmonary branches, so they often produce haemorrhage or infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
295
Q

Where do most systemic thromboembolisms come from?

A

80% arise from intracardiac mural thrombi, two thirds of which are associated with left ventricular wall infarcts and one quarter with left atrial dilatation and fibrillation.

The remainder originates from aortic aneurysms, atherosclerotic plaques, valvular vegetations, or venous thrombi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
296
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
297
Q

Where do systemic thromboembolisms often end up?

A

75% in the lower extremities
10% in the brain
May also involve the intestines, kidneys, spleen, and upper extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
298
Q

How do fat and marrow emboli occur?

A

Microscopic fat globules - sometimes associated with marrow- can by found in the pulmonary vasculature after fractures of long bones, soft tissue trauma and burns
Presumably these injuries rupture vascular sinusoids in the marrow or small venules, allowing marrow and adipose tissue to herniate into the vascular space and travel to the lung.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
299
Q

Do fat embolisms often give symptoms?

A

Fat embolism occurs in 90% of invidiuals with severe skeletal injuries, but less than 10% have any clinical findings.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
300
Q

What is fat embolism syndrome?

A

The term applied to the minority of patients who become symptomatic.
Characterised by pulmonary insufficiency, neurologic symptoms, anaemia and thrombocytopaenia, and is fatal in about 5 to 15% of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
301
Q

What are the symptoms of fat embolism syndrome?

A

Typically, 1 to 3 days after injury, there is a sudden onset of tachypnoea, dyspnoea, and tachycardia; irritability and restlessness can progress into delirium or come

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
302
Q

Why does thrombocytopaenia occur in fat embolism syndrome?

A

It is attributed to platelet adhesion to fat globules and subsequent aggregation or splenic sequestration; anaemia can result from similar red cell aggregation and/or haemolysis.
A diffuse petechial rash is related to rapid onset of thrombocytopaenia and can be a useful diagnostic feature.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
303
Q

What is the pathogenesis of fat embolism syndrome?

A
  • Fat microemboli and associated red cell and platelet aggregates can occlude the pulmonary and cerebral microvasculature.
  • Release of fatty acids from the fat globules exacerbated the situation by causing local toxic injury to endothelium, and platelet activation and granulocyte recruitment (with free radical, protease, and eicosanoid release) complete the vascular assault.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
304
Q

What is an air embolism?

A

Gas bubbles within the circulation can coalesce to form frothy masses that obstruct vascular flow and cause distal ischaemic injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
305
Q

What volume of air is required to have an effect on the pulmonary circulation?

A

Generally more than 100cc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
306
Q

What is decompression sickness? Why does it happen?

A

It occurs when an individual experiences sudden decrease in atmospheric pressure.
When air is breathed at high pressure, increased amounts of gas (particularly nitrogen) are dissolved in the blood and tissues. If the diver then ascends too rapidly, the nitrogen comes out of the solution in the tissues and blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
307
Q

What happens if you get an air embolus in your lungs?

A

Gas bubbles in the vasculature cause oedema, haemorrhage and focal atelectasis or emphysema, leading to a form of respiratory distress called the chokes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
308
Q

What happens in caisson disease? Who does it happen to?

A

Persistence of gas emboli in the skeletal system causes multiple foci of ischaemic necrosis; common in the femoral head, tibia and humeri
Happens in chronic decompression sickness, like workers in pressurised vehicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
309
Q

What is an amniotic fluid embolis? What is it’s mortality?

A

It is the infusion of amniotic fluid or fetal tissue into the maternal circulation via a tear in the placental membranes or rupture of uterine veins.
It accounts for roughly 10% of maternal deaths in the US, the mortality rate is up to 80% and 85% of survivors are left with permanent neurological damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
310
Q

What are the symptoms of an amniotic fluid embolus?

A

The onset is characterised by sudden severe dyspnoea, cyanosis and shock, followed by neurological impairment ranging from headache to seizures.
If the patient survives the initial crisis, pulmonary oedema typically develops, frequently accompanied by DIC.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
311
Q

How does an amniotic fluid embolus vary from a PE?

A

Much of the morbidity and mortality of an amniotic fluid embolism may stem from the biochemical activation of coagulation factors and components of the innate immune system by substances in the amniotic fluid, rather than the mechanical obstruction of a PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
312
Q

What is an infarct?

A

An infarct is an area of ischaemic necrosis caused by occlusion or either the arterial supply or venous drainage.
Arterial thrombosis or arterial embolism underlies the vast majority of infarctions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
313
Q

How can infarcts be classified? Tell me about both groups

A
  • Red infarcts occur
    1) with venous occlusions (e.g. testicular torsion)
    2) in loose, spongy tissues (e.g. lung), where blood can collect in the infarcted zone
    3) in tissues with dual circulations (e.g. lung and intestine) that allow to blood to flow from an unobstructed parallel supply in a necrotic zone
    4) in tissues previously congested by sluggish venous outflow
    5) when flow is reestablished to a site of previous arterial occlusion and necrosis
  • White infarcts occur with arterial occlusions in solid organs with end-arterial circulation (e.g. heart, spleen and kidney), and where tissue density limits the seepage of blood from adjoining capillary beds into the necrotic area.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
314
Q

What shape are infarcts?

A

Infarcts tend to be wedge-shaped, with the occluded vessel at the apex and the periphery of the organ forming the base.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
315
Q

How does the morphology differ over the first few days and based on the location of infarcts?

A
  • When the base is a serousal surface, there may be an overlying fibrinous exudate resulting from an acute inflammatory response to mediators release from injured and necrotic cells
  • Fresh infarcts are poorly defined and slightly haemorrhagic, but over a few days their margins become better defined by a narrow rim of congestion attributable to inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
316
Q

Why are some infarcts red and some white?

A
  • Over time, infarcts resulting from arterial occlusion without a dual blood supply typically become progressively paler and more sharply defined - white infarcts
  • Extravasated red cells in haemorrhagic infarcts are phagocytosed by macrophages, which convert heme iron to haemosiderin, extensive haemorrhage can leave a firm, brown, haemosiderin-rich residuum.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
317
Q

What are septic infarctions?

A

They occur when infected cardiac valve vegetations embolise or when microbes seed necrotic tissue.
In these cases, the infarct is converted into an abscess, with a corresponding greater inflammatory response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
318
Q

What are the factors that influence development of an infarct?

A
  • Anatomy of the vascular supply - is there an alternative blood supply?
  • Rate of occlusion - slowly developing occlusions are less likely to cause infarction, because they provide time for collateral pathways of perfusion to form.
  • Tissue vulnerability to hypoxia - neurons undergo irreversible damage within 3-4 minutes, myocardial cells last 20-30 minutes, fibroblasts within myocardium can last hours
  • Hypoxaemia - the lower the oxygen, the more likely the infarct
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
319
Q

What is shock?

A

Shock is a state in which diminished cardiac output or reduced effective circulating blood volume impairs tissue perfusion and leads to cellular hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
320
Q

What are the three main types of shock? Why do they happen? What are the other types of shock?

A

1) Cardiogenic shock results from low cardiac output due to myocardial pump failure. This can be due to intrinsic myocardial damage (infarction), ventricular arrythmias, extrinsic compression (tamponade), or outflow obstruction (PE)
2) Hypovolaemic shock results from low cardiac output due to low blood volume, such as can occur with massive haemorrhage or fluid loss from severe burns
3) Shock associated with systemic inflammation may be triggered by microbial infections, burns, trauma or pancreatitis. The common pathogenic feature is a massive outpouring of inflammatory mediators from innate and adaptive immune cells that produce vasodilation, vascular leaking and venous blood pooling. These result in tissue hypoperfusion, cellular hypoxia and metabolic derangements
4) Less commonly, shock can be neurogenic or anaphylactic, where acute vasodilation leads to hypotension and tissue hypoperfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
321
Q

What are most common triggers for septic shock?

A

Gram-positive bacterial infections, followed by gram-negative bacterial infections and then funghi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
322
Q

In broad terms, what are the factors believed to play a major role in the pathophysiology of septic shock?

A
  • Inflammatory and counter-inflammatory responses
  • Endothelial activation and injury
  • Induction of a procoagulant state
  • Metabolic abnormalities
  • Organ dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
323
Q

What inflammatory responses have a play in the pathophysiology of septic shock?

A
  • Microbial cell wall consituents engage receptors on innate immune cells.
  • Likely initiators of inflammation are signalling pathways that lie downsteam of TLRs (which recognise PAMPs), and G-protein coupled receptors that detect bacterial pathogens.
  • Upon activation, innate immune cells produce TNF,IL-1, IFN-γ, IL-12 and IL-18
  • ROS, platelet activating factor and prostaglandins are also elaborated
  • These effector molecules induce endothelial cell activation to upregulate adhesion molecule expression and further stimulate chemokines and cytokines production.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
324
Q

How is the complement cascade involved in the pathophysiology of septic shock?

A
  • The complement cascade is also activated by microbial components, directly and indirectly by the proteolytic activity of plasmin
  • This results in the production of anaphylotoxins (C3a, C5a), chemotactic fragments (C5a) and opsonins (C3b), all of which contribute to the pro-inflammatory state
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
325
Q

How does the hyperinflammatory state initiated by sepsis also activate counter-regulatory immunosuppressive mechanisms? What does this mean?

A
  • Septic patients may oscillate between hyperinflammatory and immunosuppressed states during their clinical course.
  • Proposed mechanisms for the immune suppression include a shift from pro-inflammatory TH1 cells to anti-inflammatory TH2 cells, production of anti-inflammatory mediators (e.g. soluble TNF receptor, IL-1 receptor antagonist, and IL-10), lymphocyte apoptosis, the immunosuppressive act of apoptotic cells, and the induction of cellular energy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
326
Q

How does endothelial activation and injury contribute to the pathophysiology of septic shock?

A
  • It leads to widespread vascular leakage and tissue oedema, which have deleterious effects on both nutrient delivery and waste removal.
  • The oedema created impedes tissue perfusion
  • Activated endothelium also upregulates production of NO and other vasoactive inflammatory mediators (e.g. C3a, C5a, and PAF), which may contribute to vascular smooth muscle relaxation and systemic hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
327
Q

How does the induction of a procoagulant state contribute to the pathophysiology of septic shock?

A
  • Pro-inflammatory cytokines increase tissue factor production by monocytes and possibly endothelial cells as well, and decrease the production of endothelial anti-coagulant factors (e.g. TFPI, thrombomodulin and protein C)
  • They also dampen fibrinolysis by increasing plasminogen activator inhibitor 1 expression.
  • The vascular leak and vasodilation causes stasis.
  • All of these things together lead to systemic activation of thrombin and the deposition of fibrin-rich thrombi in small vessels throughout the body, often compromising tissue perfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
328
Q

How do metabolic abnormalities contribute to the pathophysiology of septic shock?

A
  • Septic patients exhibit insulin resistance and hyperglycaemia.
  • Cytokines such as TNF and IL-1, and stress hormones (glucagon, GH, and glucocorticoids) and catecholamines all drive gluconeogenesis.
  • Pro-inflammatory cytokines suppress insulin release whilst promoting insulin resistance in the liver and other tissues, likely by impairing the expression of GLUT-4.
  • Hyperglycaemia reduced neutrophil function - and causes increased endothelial cell adhesion molecule expression
  • Cellular hypoxia and diminished oxidative phosphorylation leads to increased lactate production and lactic acidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
329
Q

How does organ dysfuction contribute to the pathophysiology of septic shock?

A
  • Systemic hypotension, interstitial oedema and small vessel thrombosis all decrease the delivery of oxygen and nutrients to the tissue, which fail to properly utilise those nutrients that are delivered due to cellular hypoxia.
  • High levels of cytokines and secondary mediators diminish myocardial contractility and cardiac output, and increased vascular permeability and endothelial injury can lead to the acute respiratory distress syndrome.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
330
Q

What affects the outcomes and severity of septic shock?

A
  • The extent and virulence of the infection
  • the immune status of the host
  • the presence of other co-morbid conditions
  • the pattern and level of mediation production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
331
Q

What are the three general phases of hypovolaemic and cardiogenic shock?

A
  • An initial nonprogressive phase during which reflex compensatory mechanisms are activated and perfusion of vital organs is maintained
  • A progressive stage characterised by tissue hypoperfusion and onset of worsening circulatory and metabolic imbalances, including a lactic acidosis
  • An irreversible stage that sets in after the body has incurred cellular and tissue injury so severe that even if the haemodynamic defects are corrected, survival is not possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
332
Q

What are the neurohumeral mechanisms that occur in the early non-progressive stage of shock that help to maintain cardiac output and blood pressure?

A
  • Baroreceptor reflexes, catecholamine release, activation of the renin-angiotensin axis, ADH release, and generalised sympathetic stimulation.
  • The net effect is tachycardia, peripheral vasoconstriction, and renal conservation of fluid
  • Coronary and cerebral vessels are less sensitive to the sympathetic response and therefore maintain relatively normal caliber, blood flow and oxygen delivery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
333
Q

What happens during the progressive phase of shock?

A
  • There is widespread tissue hypoxia
  • In the setting of persistent oxygen deficit, intracellular aerobic respiration is replaced by anaerobic glycolysis with excessive production of lactic acid
  • The lactic acidosis lowers the tissue pH and blunts the vasomotor response, arterioles dilate, and blood begins to pool in the microcirculation
  • Peripheral pooling not only worsens the cardiac output, but also put the endothelial cells at risk of developing anoxic injury with subsequent DIC.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
334
Q

What happens during the irreversible stage of shock?

A
  • Widespread cell injury is reflected in lysosomal enzyme leakage, further aggrevating the shock state.
  • If ischaemic bowel allows intestinal flora into the circulation, bacterial septic shock may be superimposed
  • At this point, the patient may develop anuria as a result of acute tubular necrosis and acute renal failure
  • They may develop a coagulopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
335
Q

What are the morphological adrenal changes during shock?

A

There is cortical cell depletion. This does not reflect adrenal exhaustion but rather the conversion of the relatively inactive vacuolated cells to metabolically active cells that utilise stored lipids for the synthesis of steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
336
Q

Immunity is protection from infectious pathogens. The mechanisms of defense against microbes fall into two broad categories. What are they?

A
  • Innate immunity refers to the mechanisms that are ready to react to infections even before the occur, and that have evolved to specifically recognise and combat microbes
  • Adaptive immunity consists of mechanisms that are stimulated by microbes and are capable of recognising microbial and non-microbial substances.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
337
Q

When do innate immunity and adaptive immunity take place?

A
  • Innate immunity is the first line of defence. It is mediated by cells and molecules that recognise products of microbes and dead cells and induce rapid protective host reactions.
  • Adaptive immunity develops later, after exposure to microbes and other foreign substances, and is even more powerful that innate immunity in combating infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
338
Q

What are the stages of innate immunity?

A

Innate immunity is always present, ready to provide defense against microbes and to eliminate damaged cells.
The three stages are: recognition of microbes and damaged cells, activation of various mechanisms, and elimination of unwanted substances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
339
Q

What are the major components of innate immunity?

A

Epithelial barriers that block entry of microbes, phagocytic cells (mainly neutrophils and macrophages), dendritic cells, natural killer cells, and several plasma proteins, including the proteins of the complement system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
340
Q

What are the epithelial barriers in innate immunity?

A
  • Epithelia of the skin and GI and resp tracts provide mechanical barriers to the entry of microbes from the external environment
  • Epithalial cells also produce antimicrobial molecules, such as defensins, and lymphocytes located in the epithelia combat microbes at these sites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
341
Q

How do monocytes and neutrophils contribute towards innate immunity?

A

They are phagocytes in the blood that can rapidly be recruited to any site of infection; monocytes nter the tissues and mature to macrophages.
All tissues contain resident macrophages, which not only sense the presence of microbes and other offeding agents, but also ingest (phagocytose) these invaders and destroy them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
342
Q

How do dendritic cells contribute to innate immunity?

A
  • They are a specialised cell population present in epithelia, lymphoid organs and most tissues.
  • They capture protein antigens and display peptides for recognition by T lymphocytes.
  • They are endowed with a rich collection of receptors that sense microbes and cell damage and stimulate the secretion of cytokines, mediators that play critical roles in inflammation and anti-viral defense
  • Thus, dendritic cells are involved in the initiation of innate immune responses, but not destruction of microbes and other offending agents.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
343
Q

What are the roles of natural killer cells in innate immunity?

A

They provide early protection against many viruses and intracellular bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
344
Q

What are pathogen-associated molecular patterns (PAMPs)?

A

Cells that participate in innate immunity are capable of recognising certain microbial components that are shared among related microbes and are often essential for infectivity (and thus cannot be mutated). These are called PAMPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
345
Q

What are damage-associated molecular patterns?

A

Leukocytes recognise molecules released by injured and necrotic cells, which are called damage-associated molecular patterns (DAMPs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
346
Q

What and where are pattern recognition receptors?

A

The cellular receptors that recognise PAMPs and DAMPs are often called pattern recognition receptors. They are located in all the cellular compartments where microbes may be present: plasma membrane receptors detect extracelluls microbes, endosomal receptors detect ingested microbes, and cytosolic receptors detect microbes in the cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
347
Q

What are the different classes of pattern recognition receptors?

A
  • Toll-like receptors
  • NOD-like receptors
  • C-type lectin receptors
  • RIG-like receptors
  • G protein-coupled recetprs
  • Mannose receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
348
Q

Where are Toll-like Receptors (TLRs) and what do they do?

A

They are present in the plasma membrane and endosomal vesicles.
All these receptors signal by a common pathway that culminates in the activation of two sets of transcription factors:
1) NF-κB, which stimulates the synthesis and secretion of cytokines and the expression of adhesion molecules
2) Interferon regulatory factors (IRFs), which stimulate the production of antiviral cytokines, type I interferons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
349
Q

Where are NOD-like receptors (NLRs) and what do they recognise?

A

They are cytosolic receptors that recognise a wide variety of substances, including products of necrotic cells (uric acid and released ATP), ion disturbances (loss of K+), and some microbial products.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
350
Q

What is the inflammasome and how is it related to NLRs? What does it do?

A

Several of the NLRs signal via a cytosolic multiprotein complex - the inflammasome, which activates an enzyme (caspase-1) that cleaves a precursor form of IL-1 to generate the biologically active form.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
351
Q

Where are C-type lectin receptors (CLRs)? What do they do?

A
  • They are expressed on the plasma membrane of macrophages and dentritic cells.
  • They detect fungal glycans and ellicit inflammatory reactions to funghi.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
352
Q

Where are RIG-like receptors (RLRs)? What do they do?

A
  • They are located in the cytosol of most cell types
  • They detect nucliec acids of viruses that replicate in the cytoplasm of infected cells.
  • They stimulate the production of antiviral cytokines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
353
Q

Where are G protein-coupled receptors? What do they do?

A
  • They are on neutrophils, macrophages and most other types of leukocytes
  • They recognise short bacterial peptides containing N-formylmethionyl residues, which is produced by all bacteral proteins and few mammalian proteins, which enables neutrophils to detect bacterial proteins and stimulate chemotactic responses of the cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
354
Q

What do mannose receptors do?

A

They recognise microbial sugars and induce phagocytosis of the microbes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
355
Q

The innate immune system provides host defense by two main reactions. What are they?

A
  • Inflammation - cytokines and products of complement activation are produced during innate immune reactions and trigger the vascular and cellular components of inflammation. The recruited leukocytes destroy microbes and ingest and eliminate damaged cells
  • Antiviral defense - type I inferferons produced in response to viruses act on infected and uninfected cells and activate enzymes that degrade viral nucleic acids and inhibit viral replication.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
356
Q

How many different receptors does the innate immune system use compared to the adaptive immune system and why?

A

Innate immunity does not have memory or fine antigen specificity. It is estimated that innate immunity uses about 100 different receptors to recognise 1,000 molecular patterns.
In contrast, adaptive immunity uses two types of receptors (antibodies and T-cell receptors), each with millions or variations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
357
Q

What does the adaptive immune system consist of?

A

Lymphocytes and their products, inlduing antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
358
Q

There are two types of adaptive immunity. What are they and what are they mediated by?

A
  • Humoral immunity, which protects against extracellular microbes and their toxins, is mediated by B lymphocytes and their secreted products, antibodies (AKA immunoglobulins).
  • Cell-mediated immunity, which is responsible for defence against intracellular microbes, is mediated by T-lymphocytes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
359
Q

Where are lymphocytes and why are they there?

A

They are not fixed in particular tissues but constantly circulate among lymphoid and other tissues via the vlood and the lymphatic circulation.
This promotes immune surveillance by allowing lymphocytes to home to any site of infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
360
Q

What are the different types of lymphocytes (5) and what do they do?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
361
Q

What are naive lymphocytes?

A

Mature lymphocytes that have not encountered the antigen for which they are specific are said to be naive (immunologically inexperienced).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
362
Q

After lymphocytes are activated by recognition of antigens, they differentiate into what? What do these cells do?

A
  • Effector cells, which perform the function of eliminated microbes
  • Memory cells, which live in a state of heightened awareness and are able to react rapidly and strongly to combat the microbe in case it returns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
363
Q

What is clonal selection?

A

Lymphocytes specific for a large number of antigens exist before exposure to antigen, and when an antigen enters, it selectively activates the antigen-specific cells. This fundamental concept is called clonal selection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
364
Q

Antigen receptor diversity is generated by somatic recombination of the genes that encode the receptor proteins. How does this process happen?

A

All cells of the body contain antigen receptors genes in the germline configuration, in which the genes encoding these receptors consist of spatially separated segments that cannot be expressed as proteins. During lymphocyte maturation, these gene segments recombine in random sets and variations are introduced at the sites of recombination, forming many different geners that can be transcribed and translated into functional antigen receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
365
Q

What is the enzyme in developing lymphocytes that mediates recombination of the gene segments?

A

It is the product of RAG-1 and RAG-2 (recombination activating genes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
366
Q

What cells contain recombined antigen receptor genes? How does this influence tumour identification?

A

Germline receptor genes are present in all cells in the body, but only T and B cells contain recombined antigen receptor genes (T-cell receptors in T cells and immunoglobulin in B cells).
Hence the presence of recombined T-cell receptors or Ig genes, is a marker of T- or B-lineage cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
367
Q

There are three major populations of T cells, which serve distinct functions. What are they and what do they do?

A
  • Helper T lymphocytes stimulate B lymphocytes to make antibodies and activate other leukocytes (e.g. phagocytes) to destroy microbes
  • Cytotoxic T lymphocytes kill infected cells
  • Regulatory T lymphocytes limit immune responses and prevent reactions against self-antigens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
368
Q

Where do T cells develop and from what?

A

They develop in the thymus from precursors that arise from haematopoetic stem cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
369
Q

Where are mature T cells found and what percentage of lymphocytes do that constistute?

A

They are found in the blood, where they constitute 60-70% of lymphocytes, and in T-cell zones of peripheral lymphoid organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
370
Q

How do T cells recognise antigens and what is this thing made up of?

A

Each T cell recognises a specific cell-bound antigen by means of an antigen-specific TCR.
In approximately 95% of T cells, the TCR consists of a disulfide-linked heterodimer made up of an α and a β polypeptide chain, each having a variable (antigen-binding) region and a constant region.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
371
Q

The αβ TCR recognises peptide antigens that presented by what?

A

Major histocompatibility complex (MHC) molecules on the surfaces of antigen-presenting cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
372
Q

What is MHC restriction? What is its purpose?

A

By limiting the specificity of T cells for peptides displayed by cell surface MHC molecules, called MHC restriction, the immune system ensures that T cells see only cell-associated antigens (e.g. those derived from microbes in cells or from proteins ingested by cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
373
Q

What forms the TCR complex?

A

Each TCR is noncovelently linked to six polypeptide chains, which form the CD3 complex and the ζ chain dimer. The CD3 and ζ proteins are invarient (identical) in all T cells. They are involved in the transduction of signals into the T cell that are triggered by binding of antigen to the TCR. Together, with the TCR, these proteins form the TCR complexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
374
Q

In addition to CD3 and ζ proteins, T cells express several other proteins that assist the TCR complex in functional responses. These include CD4, CD8, CD28 and integrins. CD4 and CD8 are expressed on two mutually exclusive subsets of αβ T cells. What percentage are CD4 and what percentage are CD8. What do they do?

A
  • Approximately 60% of mature T cells are CD4+ and about 30% are CD8+.
  • Most CD4+ T cells function as cytokine-secreting helper cells that assist macrophages and B lymphocytes to combat infections.
  • Most CD8+cells function as cytotoxic (killer) T lymphocytes to destroy host cells harboring microbes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
375
Q

What MHC molecules do CD4+ and CD8+ bind to? What happens after that?

A
  • During antigen recognition, CD4 molecules bind to class II MCH molecules that are displaying antigen.
  • CD8 molecules bind to class I MHC molecules
  • The CD4 or CD8 coreceptor initiates signals that are necessary for activation of the T cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
376
Q

What cells are the only cells in the body capable of producing antibody molecules?

A

B lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
377
Q

Where are B lymphocytes produced and where are they found?

A

B lymphocytes develop from precursors in the bone marrow.
Mature B cells consistute 10% to 20% of the circulating peripheral lymphocyte population and are also present in peripheral lymphoid tissues such as lymph nodes, spleen and mucose-associated lymphoid tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
378
Q

How do B cells recognise antigens? How do they bind to them?

A
  • B cells recognise antigen via the B-cell antigen receptor complex.
  • Membrane bound antibodies of the IgM and IgD isotypes, present on the surface of all mature, naive B cells, are the antigen-binding component of the B-cell receptor complex.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
379
Q

What happens in B cells after they have bound to an antigen?

A

After stimulation by antigen and other signals, B cells develop into plasma cells, vertiable protein factories for antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
380
Q

How many antibody molecules can plasma cells secrete per second?

A

A single plasma cell can secrete hundreds to thousands of antibody molecules per second.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
381
Q

What are plasmablasts?

A

Antibody-secreting cells also detected in human peripheral blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
382
Q

What does the B-cell antigen receptor complex consist of?

A

It contains a heterodimer of Igα (CD79a) and Igβ (CD79b), which are essential for signal transduction through the antigen receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
383
Q

Apart from CD79a and CD79b, what are some other molecules that B cells also express that are essential for their reponses and what do they do?

A
  • The type 2 complement receptor (CD2 or CD21), which recognises complement products generated during innate immune responses to microbes
  • CD40, which receives signals from helper T cells
  • CD21 is also used by the EBV as a receptor to enter and infect B cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
384
Q

What is the purpose of dendritic cells?

A

They are the most important antigen-presenting cells for initiating T-cell responses against protein antigens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
385
Q

Several features of dendritic cells account for their key role in antigen presentation. What are they?

A
  • They are located at the right place to capture antigens - under epithelia, the common site of entry of microbes and foreign antigens, and in the interstitia of all tissues, where antigens may be produced
  • They express many receptors for capturing and responsing to microbes (and other antigens), including TLRs and lectins
  • In response to microbes, dendritic cells are recruited to the T-cell zones of lymphoid organs, where they are ideally located to present antigens to T cells.
  • Dendritic cells express high levels of MHC and other molecules needed for presenting antigens to and activating T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
386
Q

What is a follicular dendritic cell? What do they do?

A

A second type of cell with dendritic morphologi present in the germinal centers of lypmhoid follicles in the spleen and lymph nodes and is called the follicular dendritic cell.

These cells bear Fc receptors for IgG and receptors for C3b and can trap antigen bound to antibodies or complement proteins. Such cells play a role in humoral immune responses by presenting antigens to B cells and selecting the B cells that have the highest affinity for the antigen, thus improving the quality of the antibody produced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
387
Q

What is the function of natural killer cells?

A

The function of NK cells is to destory irreversibly stressed and abnormal cells, such as virus-infected cells and tumour cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
388
Q

What is the morphology of natural killer cells?

A

They are somewhat larger than small lymphocytes, and they contain abundant azurophilic granules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
389
Q

What ability of natural killer cells makes then an early line of defense against viral infections and, perhaps, some tumours?

A

Natural killer cells are endowed with the ability to kill a variety of virus-infected cells and tumour cells, without prior exposure to or activation by these microbes or tumours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
390
Q

What are the two cell surface molecules on natural killer cells? What do they do?

A

Two cell surface molecules, CD16 and CD56, are commonly used to identify NK cells.
CD16 is an Fc receptor for IgG, and it confers on NK cells the ability to lyse IgG-coated target cells. This process is known as antibody-dependent cell-mediated cytotoxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
391
Q

How is the functional activity of NK cells regulated?

A
  • By a balance between signals from activating and inhibitory receptors.
  • There are many types of activating receptors, of which the NKG2D family is the best characterised - they recognise surface molecules that are induced by various kinds of stress, such as infections and DNA damage.
  • NK cell inhibitory receptors recognise self class I MHC molecules, which are expressed on all healthy cells. The inhibitory receptors prevent NK cells from killing normal cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
392
Q

How does viral infection or neoplastic transformation trigger natural killer cells?

A

It often enhances expression of ligands for activating receptors and at the same time reduces the expression of class I MHC molecules.
As a result, the balance is tilted towards activation, and the infected or tumour cell is killed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
393
Q

What cytokines are associated with natural killer cells?

Which ones do they secrete? Which ones stimulate proliferation and activate killing?

A
  • Natural killer cells secrete cytokines such as interferon-γ, which activates macrophages to destroy ingested microbes, and thus NK cells provide early defense against intracellular microbial infections.
  • The activity of NK cells is regulated by many cytokines, including the interleukins (IL-2, IL-15, and IL-12)
  • IL-2 and IL-15 stimulate proliferation of NK cells
  • IL-12 activated killing and secretion of IFN-γ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
394
Q

What are the peripheral lymphoid organs and what do they do?

A
  • Lymph nodes - antigen-presenting cells in the nodes are able to sample the antigens of microbes that may enter through epithelia into tissues and are carried in the lymph. Dendritic cells transport antigens of microbes from epithelia and tissues via lymph vessels to the nodes. Thus, the antigens become concentrated in lymph nodes
  • Spleen - Blood entering the spleen flows through a network of sinusoids. Bloodborne antigens are trapped by dendritic cells and macrophages in the spleen
  • The cutaneous and mucosal lymphoid systems are located under the epithelia of the skin and the GI and resp tracts, respectively. Pharyngeal tonsils and Peyer’s patches of the intestine are two anatomically defined mucosal lymphoid tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
395
Q

Within the peripheral lymphoid organs, T lymphocytes and B lymphocytes are segregated into different regions. What are they?

A
  • In lymph nodes the B cells are concentrated in discrete structures, called follicles, located around the periphery, or cortex, of each node. If the B cells in a follicle have recently responded to an antigen, this follicle may contain a central region called a germinal center.
  • The T lymphoctyes are concentrated in the paracortex, adjacent to the follicles.
  • The follicles contain the follicular dendritic cells, involved in B cell activation, and the paracortex contains the dendritic cells that present antigens to T lymphocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
396
Q

What is lymphocyte recirculation and why is it important?

A

Lymphocytes constantly recirculate between tissues and home to particular sites; naive lymphocytes traverse the peripher lympoid organs where immune responses are initiated and antigens are concentrated and effector T cells migrate to sites of infection and inflammation, to locate and eliminate microbes at any site of infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
397
Q

What is the purpose of MHC molecules?

A

To display peptide fragments of protein antigens for recognition by antigen-specific T cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
398
Q

What are human leukocyte antigens (HLA)?

A

In humans, the MHC molecules are called HLA because they were initially detected on leukocytes by the binding of antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
399
Q

On the basis of their structure, cellular distibution and function, MHC gene products are classified into two major classes. What are these classes and where are they found?

A
  • Class I MHC molecules are expressed on all nucleated cells and platelets. They are heterodimers made of a polymorphic α heavy chain linked convalently to a smaller non-polymorphic β2-microglobulin.
  • Class II MHC molecules are mainly expressed on cells that present ingested antigens and respond to T-cell help (macrophages, B lymphocytes, and dendritic cells).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
400
Q

What is the role of Class I and Class II MHC molecules?

A
  • Class I MHC molecules display peptides that are derived from proteins, such as viral and tumour antigens, that are located in the cytoplasm and usually produced in the cell, and class I-associated peptides are recognised by CD8+ T lymphocytes
  • Class II MHC molecules present antigens that are internalised into vesicles, and are typically derived from extracellular microbes and soluble proteins, class II-peptide complex is recognised by CD4+ T cells, which function as helper cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
401
Q

MHC molecules play several key roles in regulating T cell-mediated immune reponses. What are they?

A

1) Because diferent antigenic peptides bind to different MHC molecules, it follows that an individual mounts an immune response against a protein antigen only if they inherit the genes for those MHC molecules that can bind peptides derived from the antigen and present it to T cells
2) By segregating cytoplasmic and internalised antigens, MHC molecules ensure that the correct immune reponse is mounted against different microbes - cytotoxic lymphocyte mediated killing of cells harboring cytoplasmic microbes, and helper T cell-mediated antibody and macrophage activation to combat extracellular microbes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
402
Q

Cytokines contribute to different types of immune responses. How do they contribute to innate vs adaptive immune responses? Give examples for each type

A
  • In innate immune responses, cytokines are produced rapidly after encounter with microbes and other stimuli, and function to include infammaltion and inhibit virus replication - TNF, IL-1, IL-2, type 1 IFNs, IFN-γ, and chemokines, produced mainly by macrophages, dendritic cells and natural killer cells
  • In adaptive immune responses, cytokines are produced principally by CD4+ T lymphocytes activated by antigen and other signals, and function to promote lymphocyte proliferation and differentiation and to activate effector cells. - IL-2, IL-4, IL-5, IL-17, IFN-γ.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
403
Q

What cells secrete IL-2 and what does it do?

A

One of the earliest responses of CD4+ helper T cells is secretion of the cytokine IL-2 and expression of high-affinity receptors for IL-2. IL-2 is a growth factor that acts on these T lymphocytes and stimulates their proliferation, leading to an increase in the number of antigen-specific lymphocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
404
Q

Some of the activated CD4+ T cells differentiate into effector cells that secrete different sets of cytokine and perform different functions. What are these sets and their functions?

A
  • T helper 1 cells secrete the cytokine IFN-γ, which is a potent macrophage activator. The combination of CD40- ad IFN-γ mediated activation results in “classical” macrophage activation, leading to the induction of microbicidal substances in macrophages and the destruction of ingested microbes
  • T helper 2 cells produce IL-4, which stimulates B cells to differntiate into IgE-secreting plasma cells, and IL-5, which activates eosinophils. Eosinophils and mast cells bind to IgE-coated microbes such as helminthic parasites, and function to eliminate helminths. They also induce the ‘alternative’ activation pathway of macrophages
  • T helper 17 cells, which produce IL-17, recruit neutrophils and monocytes, which destroy some extracellular bacteria and funghi and are involved in some inflammatory diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
405
Q

What do activated CD8+ T lymphocytes differetiate into? What do they do?

A

They differentiate into cytotoxic T lymphocytes that kill cells harboring microbes in the cytoplasm. By destroying the infected cells, CTLs eliminate the reservoirs of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
406
Q

Antibody responses to most protein antigens require T cell help and are said to be T-dependent. In what way is this the case?

A
  • B cells ingest protein antigens into vesicles, degrade them, and display peptides bound to class II MHC molecules for recognition by helper T cells.
  • The helper T cells are activated and express CD40L and secrete cytokines, which work together to stimulate the B cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
407
Q

What antigens are T-independent? What happens here?

A

Many polysaccharide and lipid antigens cannot be recognised by T cells but have multiple identical antigenic determinants (epitopes) that are able to engage many antigen receptor molecules on each B cell and initate the process of B-cell activation; these responses are said to be T-independent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
408
Q

Each plasma cell is derived from an antigen-stimulated B cell and secretes antibodies that recognise the same antigen that initiated the reponse. What type of antibodies do different molecules stimulate the secretion of?

A
  • Polysaccarides and lipids stimulate secretion mainly of IgM antibody
  • Protein antigens, by virtue of CD40L- and cytokine-mediated helper T-cell actons, induce the production of antibodies of different classes, or isotypes (IgG, IgA, IgE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
409
Q

What is affinity maturation and isotype switching? Where do they occur and what stimulates them?

A
  • Isotype switching is induced by cytokines including IFN-γ and IL-4.
  • Helper T cells also stimulate the production of antibodies with high affinities for the antigen. This process, affinity maturation, improved the quality of the humoral immune response
  • They occur mainly in germinal centers, which are formed by proliferating B cells, especially in helper T cell-dependent response to protein antigens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
410
Q

What are follicular helper T cells? What do they do?

A

Some activated B cells migrate into follicles and form germinal centers, which are the major sites of isotype switching and affinity maturation. The helper T-cells that stimulate these process in B lymphocytes migrate to and reside in the germinal centers and are called follicular helper T cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
411
Q

The humoral immune response combates microbes in many ways. What are they?

A
  • Antibodies bind to microbes and prevent then from infecting cells, thus neutralising the microbes
  • IgG antibodies coat (opsonise) microbes and target them for phagocytosis as phagocytes express receptors for the Fc tails of IgG.
  • IgG and IgM activate the complement system by the classical pathway, and complement products promote phagocytosis and destruction of microbes
  • IgA is secreted from mucoseal epithelia and neutralises microbes inthe lumens of the respiratory and GI tracts
  • IgG is actively transported across the placenta and protects the newborn until the immune system becomes mature
  • IgE and eosinophils cooperate to kill parasites, mainly by release of eosinphil granules contents that are toxic to the worms.
  • TH2 cytokines stimulate the production of IgE and activeate eosinophils, and thus the response to helminths is orchestrated by TH2 cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
412
Q

There are several important general features of hypersensitivity disorders. What are they?

A
  • Hypersensitivity reactions can be eilicited by exogenous environmental antigens (microbial and non-microbial) or endogenous self antigens
  • Hypersensitivity usually results from an imbalance between the effector mechanisms of immune responses and the control mechanisms that serve to normally limit such responses
  • The development of hypersensitivity diseases is often associated with the inheritance of a particular susceptibility genes (HLA genes)
  • The mechanisms of tissue injury in hypersensitivity reactions are the same as the effector mechanisms of defense against infectious pathogens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
413
Q

What are the different types of hypersensitivity reactions?

A

1) Immediate hypersensitivity - caused by TH2 cells, IgE antibodies, and mast cells and other leukocytes. Mast cells release mediators that act on vessels and smooth msucle and proinflammatory cytokiens that recruit inflammatory cells
2) Antibody-mediated disorders - secreted IgG and IgM antibodies injure cells by promoting their phagocytosis or lysis and injure tissues by inducing inflammation
3) Immune complex-mediated disorders - IgG and IgM antibodies bind antigens usually in the circulation, and the antigen-antibody complexes deposit in tissues and induce inflammation. The leukocytes that are recruited produce tissue damage by release of lysosomal enzymes and generation of toxic free radicals
4) Cell-mediated immune disorders - sensitised T lymphocytes (Th1 and Th17 cells and CTLs) are the cause of the tissue injury. Th2 cells indue lesions that are part of immediate hypersensitivity reactions and are not considered a form of type IV hypersentivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
414
Q

How is an immediate or type 1 hypersensitivity reaction triggered?

A

It is a rapid immunological reaction occurring in a previously sensitised individual that is triggered by the binding of an antigen to IgE antibody on the surface of mast cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
415
Q

Local reactions are diverse and vary depending on the portal of entry of the allergen in type 1 hypersensitivity reaction?

A

Localised cutaneous rash or blisters (shin allergy, hives), nasal and conjunctival discharge (allergic rhinitis and conjunctivitis), hay fever, bronchial asthma, or allergic gastroenteritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
416
Q

Many local type 1 hypersensitivity reactions have two well-defined phases. What are they and what happens during them?

A

1) The immediate reaction is characterised by vasodilation, vascular leakage, and depending on the location, smooth muscle spasm or glandular secretions. These changes usually become evident within minutes after exposure to an allergen and tend to subside in a few hours.
2) A second, late-phase reaction sets in 2-24 hours later without additiona exposure to antigen and may last for several days. This late-phase reaction is characterised by infiltration of tissues with eosinophils, neutrophils, basophils, monocytes and CD4+ T cells, as well as tissue destruction, typically in the form of mucosal epithelial cell damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
417
Q

Most immediate hypersensitivity disorders are caused by excessive responses from what cells? What do they do?

A

Most are caused by excessive Th2 responses and these cells play a central role by stimulating IgE production and promoting inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
418
Q

The first step in the generation of Th2 cells is the presentation of the antigen (likely by dendritic cells) to naive CD4+ helper T cells. How do naive CD4+ helper cells respond to this?

A
  • In response to antigen and other stimuli (IL-4), the T cells differentiate into Th2 cells.
  • The newly minted Th2 cells produce a number of cytokines upon consequence encounter with the antigen (IL-4, IL-5, IL-13).
  • IL-4 acts on B cells to stimulate class swtiching to IgE and promotes the development of Th2 cells
  • IL-5 is involved in the development and activation of eosinophils.
  • IL-13 enhances IgE production and acts on epithelial cells to stimualte mucus secretion
  • In addition, Th2 cells produce chemokines that attract more Th2 cells, as well as other leukocytes to the reaction site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
419
Q

Where are mast cells? What do they contain?

A
  • They are bone marrow-derived cells that are widely distributed in the tissues, being abundant near blood vessels and nerves and in subepithelial tissues
  • Mast cells have cytoplasmic membrane-bound granules that contain a variety of biologically active mediators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
420
Q

How are mast cells activated in type 1 hypersensitivity reactions?

A
  • They are activated by the cross-linking of high-affinity IgE Fc receptors
  • They may also be triggered by complement components C5a and C3a (anaphylatoxins), both of which act by binding to receptors on the mast cell membrane.
  • Other mast cell secretagogues include some chemokines (e.g. IL-8), drugs such as codeine, morphine, adenosine, bee stings and physical stimuli (heat, cold, sunlight)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
421
Q

How are basophils and mast cells similar and what makes them different?

A

They are similar in many ways, including the presence of cell surface IgE Fc receptors as well as cytoplasmic granules.
In contrast to mast cells, however, basophuls are not normally present in tissues but rather circulate in the blood in extremely small numbers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
422
Q

Mast cells and basophils express a high-affinity receptor, called FcεRI. What is this specific for and what does this mean?

A

FcεRI is specific for Fc portion of IgE and therefore avidly binds IgE antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
423
Q

When are masts cells sensitised?

A

IgE-coated mast cells are said to eb sensitised, because they are sensitive to a subsequent encounter with the specific antigen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
424
Q

When a sensitised mast cell is exposed to the same antigen, what happens?

A

The cell is activated, leading eventually to the release of an arsenal of powerful mediators responsible for the clinical features of immediate hypersensitivity reactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
425
Q

What are the steps of mast cell activation?

A
  • The antigen binds to the IgE antibodies precious attached to the amst cells
  • Multivalent antigens bind to and cross-link adjacent IgE antibodies.
  • The underlying Fcε receptors are brought together, and this activates signal transudction pathways from the cytoplasmic portion of the receptors
  • These signals lead to the production of mediators that are responsible for the initial, sometimes explosive, symptoms of immediate hypersensitivity, and they also set into motion the events that lead to the late-phase reaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
426
Q

Mast cell activation leads to degranulation, with the discharge of preformed (primary) mediators that are stored in the granules, and de novo synthesis and release of secondary mediators, including lipid products and cytokines. Name some preformed mediators and what they do?

A
  • Vasoactive amines - most important is histamine, causing smooth muscle contraction, increased vascular permeabilityk and increased mucus secretion
  • Enzymes - contained in the granule matrix, include neutral proteases (chymase, tryptase) and several acid hydrolases. The enzymes cause tissue damage and lead to the generation of kinins and activated components of complement (C3a) by acting on their precursor proteins
  • Proteoglycans - these include heparin and chondroitin sulfate, they seve to packes and store the amines in the granules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
427
Q

Mast cell activation leads to degranulation, with the discharge of preformed (primary) mediators that are stored in the granules, and de novo synthesis and release of secondary mediators, including lipid products and cytokines. Name some lipid mediators and what they do?

A

The major lipid mediators are arachidonic acid-derived products. Reactions in the mast cell membranes lead to activation of phospholipase A2.
* Leukotrienes C4 and D4 are the most potent vasoactive and spasmogenic agents known, they are several thousant times more active than histamine in increaseing vascular permeability and causing bronchial smooth muscle contraction. Leukotriene B4 is highly chemotactic for neutrophils, eosinophils and monocyes
* Prostaglandin D2 is the most abundant mediator produced in mast cells by the COX pathway, it causes intense bronchospasm and increased mucus secretion
* Platelet-activating factor is a lipid mediated produced by some mast cell populations but is not derived from AA. It causes platelet aggregation, release of histmine, bronchospasm, increased vascular permeability, and vasodilation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
428
Q

Mast cell activation leads to degranulation, with the discharge of preformed (primary) mediators that are stored in the granules, and de novo synthesis and release of secondary mediators, including lipid products and cytokines. Name some cytokines and their roles.

A
  • TNF, IL-1 and chemokines, which promote leukocytes recruitment
  • IL-4, which amplified the Th2 response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
429
Q

On a morphological level, what happens during the late-phase reaction during type 1 hypersensitivity reactions?

A

In the late-phase reaction, leukocytes are recruited that amplify and sustain the inflammatory response without additional exposure to the tiggering antigen.
* Eosinophils are often an abundant leukocyte population in these reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
430
Q

How are eosinophils recruited to sites of immediate hypersensitivity?

A

By chemokines, such as eotaxin, and others that may be produced by epithelial cells, Th2 cells, and mast cells
The Th2 cytokine IL-5 is the most potent eosinophil-activating cytokine known.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
431
Q

Upon activation in late-phase immediate hypersensitivity reactions, what do eosinophils do?

A

They liberate proteolytic enzymes, as well as two unique proteins called major basic protein and eosinophil cationic protein, which damage tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
432
Q

An increase propensity to develop immediate hypersensitivity reactions is called atopy. What are the morphological changes that atopic individuals tend to have?

A

They tend to have higher serum IgE levels and more IL-4 producing Th2 cells than does the general population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
433
Q

Studies in patients with asthma reveal linkage to polymorphisms in several genes. What chromosome are these genes encoded, what are they and what do they do?

A
  • Some of these genes are located in the chromosome 5q31 region
  • These include genes encoding the cytokines IL-3, IL-4, IL-5, IL-9, IL-13 and GM-CSF.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
434
Q

What is nonatopic allergy?

A

It is estimated that 20-30% of immediate hypersensitivity reactions are triggered by non-antigenic stimuli, such as temperature extremes and exercsie, and do not invovle Th2 cells or IgE; such reactions are sometimes called nonatopic allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
435
Q

Give me an overview of what happens during antibody-mediated (type II) hypersensitivity reactions

A

Anibodies that react with antigens present on cell surfaces or in the extracellular matrix cause disease by destroying these cells, triggering inflammation, or interfering with normal functions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
436
Q

What are the three steps that occur during antibody mediated (type II hypersensitivity) reactions?

A

1) Opsonisation and phagocytosis
2) Complement and Fc receptor-mediated inflammation
3) Antibody-mediated cellular dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
437
Q

What happens during opsonisation and phagocytosis in antibody mediated (type 2) hypersensitivity reaction?

A
  • Cells opsonised by IgG antibodies are recognised by phagocyte Fc receptors.
  • When IgM or IgG antibodies are deposited on the surfaces of cells, they may activated the complement system and C3b and C4b are deposited on the surfaces of the cells and recognised by phagocytes that express receptors for these proteins.

The net result is phagocytsis of the opsonised cells and their destruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
438
Q

Clinically, in what situations does antibody-mediated cell destruction and phagocytosis occur?

A

1) Transfusion reactions, in which cells from an incompatible donor react with and are opsonised by preformed antibody in the host
2) Heamolytic disease of the newborn, in which there is an antigenic difference between the mother and the fetus, and IgG antierythrocyte antibodies from the mother cross the placenta and cause destruction of fetal red cells
3) Autoimmune haemolytic anaemia, agranulocytosis, and thrombocytopaenia, in which individuals produce antibodies to their own blood cells, which are then destroyed
4) Certain drug reactions, in which a drug acts as a “hapten”, by attaching to plasma membrane proteins of red cells and antibodies are produced against the drug protein complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
439
Q

What happens during the inflammation stage of antibody mediated (type II) hypersensitivity?

A
  • When antibodies deposit in fixed tissues, such as basement membranes and extracellular matrix, the resultant injury is due to inflammation.
  • The deposited antibodies activate complement, generating by-products, including chemotactic agents (C5a), which direct the migration of polymorphonuclear leukocytes and monocytes and anaphylatoxins (C3a and C5a), which increase vascular permeability
  • The leukocytes are activated by engagement of their C3b and Fc receptors.
  • This results in the production of other substances, that damage tissues, such as lysosomal enzymes, including proteases capable of digesting basement membrane, collagen, elastin, and cartilage, and ROS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
440
Q

Clinically, in what situations does antibody-mediated inflammation occur as the mechanism responsible for tissue injury?

A

In some forms of glomerulonephritis, vascular rejection in organ grafts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
441
Q

How does cellular dysfunction happen during antibody-mediated (type II) hypersensitivity reactions? Give examples

A

In some cases, antibodies directed against cell surface receptors impair or dysregulate function without causing cell injury or inflammation.
* In myasthenia gravis, antibodies reactive with acetylcholine receptors in the motor end plates of skeletal muscles block neuromuscular transmission and therefore cause muscle weakness
* In Graves disease, antibodies against the thyroid-stimulating hormone receptor on thyroid epithelial cells stimulate the cells, resulting in hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
442
Q

Give a general overview of what happens in immune complex-mediated (type III) hypersensitivity?

A

Antigen-antibody complexes produce tissue damage mainly by eliciting inflammation at the sites of deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
443
Q

How is the pathological reaction usually initiated in immune complex-mediated (type III) hypersensitivity?

A
  • It is usually initiated when antigen combines with antibody in the cirulation, creating immune complexes that typically deposit in vessel walls.
  • Less frequently, the complexes may be formed at sites where antigen has been “planted” previously (called in situ immune complexes).
  • The antigens that form immune complexes may be exogenous or endogenous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
444
Q

What organs do immune complex-mediated (type III) hypersensitivity reactions often take place in?

A

They tend to be systemic, but often preferentially involve the kidney (glomerulonephritis), joints (arthritis), and small blood vessels (vasculitis), all of which are common sites of immune complex deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
445
Q

The pathogenesis of systemic immune complex disease can be divided into three phases. What are they and what happens in each one?

A

1) Formation of immune complexes - the introduction of a protein antigen triggers an immune response that results in the formation of antibodies, typcically about a week after injection. These antibodies are secreted into the blood, where they react with the antigen still present and form antigen-antibody complexes
2) Deposition of immune complexes - the circulating antigen-antibody complexes are deposited in various tissues, often in the glomeruli and joints
3) Inflammation and tissue injury - once the complexes are deposited, they initiate an acute inflammatory reaction. The resultant inflammatory lesion is termed vasculitis if it occurs in blood vesels, glomerulonephritis if it occurs in renal glomeruli, arthritis if it occurs in the joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
446
Q

What are the symptoms of immune complex-mediated (type III) reactions? When do thy happen?

A

During the inflammation and tissue injury phae (approx 10 days after antigen administration), clinical features such as fever, urticaria, joint pains, lymph node enlargement and proteinuria appear.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
447
Q

What antibodies are involved in immune complex-mediated (type III) hypersensitivity?

A

Complement-fixing antibodies (IgG and IgM) and antibodies that bind to leukocyte Fc receptors (some subclasses of IgG) induce the pathological lesions of immune complex disorders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
448
Q

Give some examples of immune complex-mediated diseases

A

SLE
Post-strep glomerulonephritis
Polyarteritis nodosa
Reactive arthritis
Serum sickness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
449
Q

What is an Arthus reaction?

A

The Arthus reaction is localised area of tissue necrosis resulting from acute immune complex vasculitis, usually elicited in the skin.
These complexes precipitate in the vessel walls and cause fibrinoid necrosis, and superimposed thrombosis worsens the ischaemic injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
450
Q

Give a general overview of the process of T Cell-mediated (type IV) hypersensitivity?

A

The cell mediated type of hypersensitivity is caused by inflammation resulting from cytokines produced by CD4+ T cells and cell killing by CD8+ T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
451
Q

Give a general overview of what happens in CD4+ T cell-mediated hypersensitivity

A

In CD4+ T cell-mediated hypersensitivity reactions, cytokines produced by the T cells induce inflammation that may be chronic and destrucive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
452
Q

What is the prototype of T cell-mediated inflammation? What happens during this?
Give an example

A

Delayed-type hypersensitivity, a tissue reaction to antigens give to immune individuals. An antigen administered into the skin of a previously immunised individual results in a detectable cutaneous reaction within 24-48 hours

An example of this is the tuberculin reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
453
Q

The inflammatory reactions stimulated by CD4+ T cells can be divided into sequential stages. What are these?

A

1) Activation of CD4+ T cells - naive CD4+ T cells recognise peptides displayed by dendritic cells and secrete IL-2, which functions as an autocrine growth factor to stimulate proliferation of the antigen-responsive T cells. The T cells differentiate into either Th1 (due to IFN-γ) or Th17 (via IL-1, IL-6 or IL-12).
2) Responses of differentiated effector T cells - upon repeat exposure to an antigen, Th1 cells secrete IFN-γ, which activates macrophages and they do their thing; if the activation is sustained, continued inflammation and tissue injury result

This produces granulomatous inflammation, which you know from before

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
454
Q

Give some examples of T cell-mediated (type IV) diseases…

A

RA
MS
T1DM
TBD
Psoriasis
Contact sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
455
Q

What happens during CD8+ T Cell-mediated cytoxocity in T cell-mediated (type IV) hypersensitivity?

A

CD8+ CTLs kill antigen-expressing target cells. Tissue destruction by CTLs is important in T cell-mediated diseases, such as type 1 diabetes. The killing of infected cells leads to the elimination of the infection, but in some cases it is responsible for cell damage that accompanies the infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
456
Q

What is the principal mechanism of T cell-mediated killing of targets involves what?

A

Perforins and granzymes, preformed mediators contained in the lysosome-like granules of CTLs.
* CTLs that recognise the target cells secrete a complex consisting of perforin, granzymes, and other proteins which enters target cells by endocytosis.
* In the target cell cytoplasm, perforin facilitates the release of the granzymes from the complex. Granzymes are proteases that cleave and activate caspases, which induce apoptosis of teh target cells
* Activated CTLs also express Fas ligand, which can bind to Fas expressed on target cells and trigger apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
457
Q

What is the complement system?

A

It is a collection of soluble proteins and membrane receptors that function mainly in host defence against microbes and in pathological inflammatory reactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
458
Q

What does the complement system consist of?

A

More than 20 proteins, some of which are numbered C1 through C9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
459
Q

When does the complement system function?

A

In both innate and adative immunity for defense against microbial pathogens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
460
Q

Broadly, what are the effects of complement activation?

A

Severeal cleavage products of complement proteins are elaborated that cause increased vascular permeability, chemotaxis, and opsonisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
461
Q

Complement proteins are present in inactive forms in the plasma, what is the critical step in complement activation?

A

The proteolysis of the third (and most abundant) component, C3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
462
Q

Cleavage of C3 in the complement pathway can occur by one of three pathways. What are these pathways?

A
  • The classical pathway, which is triggered by fixation of C1 to antibody (IgM or IgG) that has combined with antigen
  • The alternative pathway, which can be triggered by microbial surface molecules (e.g. endotoxin or LPS), complex polysaccharides, cobra venom, and other substances, in the absence of antibody
  • The lectin pathway, in which plasma mannose-binding lectin binds to carbohydrates on microbes and directly activates C1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
463
Q

All three complement pathways converge lead to the same outcome. What is this and what happens next?

A
  • They all lead to the formation of an active enzyme called the C3 convertase, which splits C3 into two functionally distinct fragments, C3a and C3b.
  • C3a is released, and C3b becomes convalently attached to the cell or molecules where complement is being activated.
  • More C3b then binds to the previously generated fragments to form C5 convertase, which cleaves C5 to release C5a and leave C5b attached to the cell surface.
  • C5b binds the late components (C6-C9), culminating in the formation of the membrane attack complex (MAC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
464
Q

The complement system has three main functions. What are they and how do they occur?

A
  • Inflammation - C3a, C5a (anaphylatoxins) and, to a lesser extent, C4a stimulate histamine release from mast cells and thereby increase vascular permeability and cause vasodilation. C5a is also a chemotactic agent and activates the lipooxygenase pathway of AA, releasing leukotrienes.
  • Opsonisation and phagocytosis - C3b and iC3b (inactive), when fixed to a microbial cell wall, act as opsonins and promote phagocytosis
  • Cell lysis - the deposition of the MAC on cells makes these cells permaeblt ot water and ions and results in lysis of the cells. - this is particularly importnat in microbes with thin walls such as Neissaria bacteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
465
Q

The activation of complement is tightly controlled by cell-associated and circulatin regulatory proteins. What are these and what do they do?

A
  • C1 inhibitor (C1 INH) blocks the activation of C1
  • Decay accelerating factor (DAF) and CD59 are two proteins that are linked to plasma memrbanes by a glycophosphatidyl anchor. DAF presents formation of C3 convertases and CD59 inhibits formation of the MAC
466
Q

What are oncogenes and proto-oncogenes?

A

Proto-oncogenes - normal cellular genes whose products promote cell proliferation
Oncogenes - mutated or overexpressed versions of proto-oncogenes that function autonomously, having lost dependence on normal growth promoting signals

467
Q

How are oncogenes created?

A

By mutations in proto-oncogenes and encode proteins called oncoproteins that have the ability to promote cell growth in the absence of normal growth-producing signals

468
Q

What are the roles of proto-oncogenes?

A

They have multiple roles, but all participate at some level in signaling pathways that drive proliferation. Thus, pro-growth proto-oncogenes may encode growth factors, growth factor receptors, signal transducers, transcription factors or cell cycle components.

469
Q

When discussing tumours, what does differentiation and anaplasia mean?

A

Differentiation refers to the extent to which neoplastic parenchymal cells resemble the corresponding normal parenchymal cells, both morphologically and functionally
Lack of differentiation is called anaplasia

470
Q

Are benign or malignant cells well differentiated or not?

A
  • In general, benign tumours are well differentiated, mitoses are usually rare and of normal configuration.
  • Malignant neoplasms exhibit a wide range of parenchymal cell differentiation, most exhibit morphological alterations that betray their malignant nature.
471
Q

Malignant neoplasms that are composed of poorly differentiated cells are said to be anaplastic. This is often associated with many other morphological changes. What are these?

A
  • Pleomorphism - variety in size and shape, cells within the same tumour are not uniform
  • Abnormal nuclear morphology - the nuclei are often disproportionately large for the cell
  • Mitoses - many cells are in mitosis, reflecting the high proliferative activity of the parenchymal cells.
  • Loss of polarity - the orientation of anaplastic cells is markedly disturbed. Sheets or large amsses of tumour cells grow in an anarchic, disorganised fashion
  • Large central area of ischaemic necrosis
472
Q

What are the ranges of cells that occur with malignant pleomorphisms?

A

Cells within the same tumour are not uniform, they range from small cells with an undifferentiated appearance, to tumour giant cells many time larger than their neighbours.
Some tumor giant cells possess only a single huge polymorphic nucleus, whilst others may have two or more large hyperchromatic nuclei.

473
Q

What is abnormal about the nuclear morphology of malignant cells?

A

They have a nuclear-to-cytoplasm ratio that may approach 1:1 instead of the normal 1:4 or 1:6.
The nuclear shape is variable and often irregular, and the chromatin is often coarsely clumped and distributed along the nuclear membrane, or more darkly stained than normal (hyperchromatic)

474
Q

The better the differentiation of the transformed cell, the more completely it retains the functional capabilities of its normal counterpart. What does this mean for endocrine tumours?

A

Benign neoplasms and well-differentiated carcinomas of endocrine glands frequently secrete hormones characteristic of their origin. Increased levels of these hormones in the blood are used clinically to detect and follow such tumours.

475
Q

In some instances of highly anaplastic undifferentiated cells, new and unanticipated functions emerge. What does this mean? Give some examples

A

Some tumours express fetal proteins that are not produced by comparable cells in the adult, while others express proteins that are normally only found in other types of adult cells. e.g. bronchogenic carcinomas may produce corticotropin, PTH, insulin, glucagon and other hormones, giving rise to paraneoplastic syndromes

476
Q

What is dysplasia?

A

It is a term that literally means ‘disordered growth’. It is encountered principally in epithelia and is characterised by a constellation of changes that include the loss of uniformity of the individual cells as well as loss in their architectural orientation.

477
Q

Morphologically, what are some characteristics of dysplastic cells?

A

They may exhibit considerable pleomorphism and often contain large hyperchromatic nuclei with a high nuclear-to-cytoplasmic ratio.
In addition, mitotic figures are more abundant that in the normal tissue and rather than being confined to the basal layer may instead be seen at all levels, including surface cells.

478
Q

What is a carcinoma in situ?

A

When dysplastic changes are marked and involve the full thickness of the epithelium, but the lesion does not penetrate the basement membrane, it is considered a pre-invasive neoplasm and is referred to as carcinoma in situ

479
Q

What is an invasive tumour?

A

Once the tumor cells breach the basement membrane, the tumour is said to be invasive

480
Q

Does dysplasia always progress to cancer?

A

Dysplastic changes are often found adjacent to foci of invasive carcinoma, and in some situations, frequently antedates the appearance of cancer.
Some mutations associated with cancers may be present in even ‘mild’ dysplasia.
Therefore, although dysplasia may be a pre-cursor to malignant transformation, it does not always progress to cancer.

481
Q

How does the process of growth vary between malignant and benign tumours?

A
  • The growth of cancers is accompanied by progressive infiltration, invasion, and destruction of the surrounding tissue
  • Nearly all benign tumours grow and cohesive expansile masses that remain localised to their site of origin and lack the capacity to infiltrate, invade or metastasize to distant sites
482
Q

What is a capsule associated with benign tumours and what does it consist of?

A

Because benign tumours grow and expand slowly, they usually develop a rim of compressed fibrous tissue called a capsule that separates them from the host tissue.
This capsule consists largely of extracellular matrix deposited by stromal cells such as fibroblasts, which are activated by hypoxic damage resulting from the pressure of the expanding tumour

483
Q

How does the capsule of a benign tumour affect how it feels clinically?

A

Such encapsulation does not prevent tumour growth, but it creates a tissue plane that makes the tumour discrete, readily palpable, moveable (non-fixed), and easily excisable by surgical enucleation

484
Q

How do malignant tumors vary from benign tumours re: the capsule and demarcation from normal tissue?

A

Malignant tumours are, in general, poorly demarcated from the surrounding normal tissue, and a well-defined cleavage plane in lacking.
Slowly explanding malignant tumours, however, may develop an apparently enclosing fibrous capsule and may push along a broad fron into adjacent normal structures.

485
Q

Histologically, what would you see in ‘pseudoencapsulated’ malignant masses?

A

They almost always show rows of cells penetrating the margin and infiltrating the adjacent structures, a crablike pattern of growth that consitutes the popular image of cancer.

486
Q

Next to the development of metastases, invasiveness is the most reliable feature that differentiates cancers from benign tumours. How?

A

Most malignant tumours do not recognise normal anatomic boundaries and can be expected to penetrate the wall of the colon or uterus for example.

487
Q

Some cancers seem to evolve from a preinvasive stage - carcinoma in situ. Name some examples.

A

Carcinomas of the skin, breatst and uterine cervix

488
Q

What is metastasis?

A

Metastasis is defined by the spread of a tumour to sites that are physically discontinuours with the primary tumour, and unequivocally marks a tumour as malignant, as by definition noeplasms do not metastasise.

489
Q

In general, the likelihood of a primary tumour to metastasise is what?

A

It correlates with lack of differentiation, aggressive local invasion, rapid growth, and large size.

490
Q

What percentage of newly diagnosed solid tumours present with metastases?

A

30%

491
Q

Dissemination of cancers may occur through one of three pathways. What are these pathways?

A

1) Direct seeding of body cavities or surfaces
2) Lymphatic spread
3) Haematogenous spread

492
Q

Where does seeding of body cavity and surfaces take place?

A

Seeding of body cavities and surfaces may occur whenever a malignant neoplasm penetrated into a natural ‘open field’ lacking physical barriers.
Most often involved is the peritoneal cavity, but any other cavity - pleural, pericardial, subarachnoid, and joint spaces - may be affected.

493
Q

What is pseudomyxoma peritonei?

A

Sometimes mucus-secreting appendiceal carcinomas or ovarian carcinomas fill the peritoneal cavity with a gelatinous neoplastic mass referred to as pseudomyxoma peritonei

494
Q

What is the most common pathway for the initiall dissemination of carcinomas?

A

Lymphatic spread

495
Q

How do tumours spread through lymphatics?

A

Tumours do not contain functional lymphatics, but lymphatic vessels located at the tumor margins are apparently sufficien for the lymphatic spread of tumour cells

496
Q

What cancers often spread through seeding of body cavities?

A

It is particularly characteristic of carcinomas arising in the ovaries, which, not infrequently, spread to peritoneal surfaces, which become coated with a heavy cancerous glaze.

497
Q

What cancers often spread via lymphatic spread? and via which nodes?

A
  • Because carcinomas of the breast usually arise in the upper outer quadrants, they generally disseminate first to the axillary lymph nodes. Cancers of the inner quadrants drain to the nodes along the internal mammary arteries. Thus, the infraclavicular and supraclavicular nodes may become involved
  • Carcinomas of the lyng arising in the major respiratory passages metastasis first to the perihilar tracheobronchial and mediastinal nodes.
498
Q

What are skip metastases regarding lymph nodes? Why do they happen?

A

Local lymph nodes, however, may be bypassed - so called skip metastasis - because of venous-lymphatic anastomoses or because inflammation or radiation has obliterated lymphatic channels

499
Q

What is a sentinal lymph node?

A

A senitel lymph node is defined as ‘the first node in a regional lymphatic basin that receives lymph flow from the primary tumour’

500
Q

Does nodal enlargement in proximity to a cancer always equate with dissemination of the primary lesion?

A

Drainage of tumour cell debris or tumour antigens, or both, also induces reactive changes within nodes.
Thus, enlargement of nodes may be caused by the spread and growth of cancer cells or reactive hyperplasia

501
Q

Are arteries or veins more or less readily penetrated by haematogenous spread of metastases?

A

Arteries, with their thicker walls, are less readily penetrated than the veins.

502
Q

In what situation does arterial spread of metastases occur?

A

Arterial spread may occur, however when tumour cells pass through the pulmonary capillary beds or pulmonary arteriovenous shunts or when pulmonary metastases themselves give rise to additional tumour emboli.

503
Q

In what situation does venous invasion of metastases occur?

A

With venous invasion, the bloodborne cells follow the venous flow draining the site of the neoplasm, and the tumour cells often come to rest in the first capillary bed they encounter. Understandably, the liver and lungs ar the most frequently involved in such haematogenous dissemination.

504
Q

Certain cancers have a propensity for invasion of veins. What are they and where do they spread?

A
  • Renal cell carcinoma often invades the branches of the renal vein and then the renal vein itself, from where it may grow in a snakelike fashion up the inferior vena cava, sometimes reaching the right side of the heart
  • HCCs often penetrate portal and hepatic radicles to grow within them into the main venous channels.
505
Q

What are the different modes of activation in tumours that proto-oncogenes can do?

A

Overexpression
Amplification
Point mutation
Translocation

506
Q

Why is angiogenesis essentional in tumour growth?

A

Even if a solid tumour possesses all of the genetic aberrations that are required for malignant transofrmation, it cannot enlarge beyond 1 to 2mm in diameter unless it has the capacity to induce angiogenesis

507
Q

What happens due to neovascularisation?

A

Perfusion supplied needed nutrients and oxygen, and newly formed endothelial cells stimulate the growth of adjacent tumour cells by secreting growth factors, such as insulin-like growth factos (IGFs) and PDGF.

508
Q

Is tumour neovascularisation normal?

A

No, it is effective at delivering nutrients and removing wastes but it is not entirely normal; the vessels and leaky and dilated, and have a haphazard pattern of connection, features that can be appreciated on angiograms.

509
Q

What is an angiogenic switch?

A

Early in their development, most human tumours do not induce angiogenesis. Starved of nutrients, these tumours remain small or in situ, possible for years, until an angiogenic switch terminates the stage of vascular quiescence.

510
Q

What is the molecular basis of the angiogenic switch?

A

It involves increased production of angiogenic factors and/or loss of angiogenic inhibitors. These factors may be produced by the tumour cells themselves or by inflammatory cells or other stromal cells associated with the tumours.

511
Q

What are the two phases of the metastatic cascade?

A

1) invasion of the extracellular matrix
2) vascular dissemination, homing of tumour cells and colonisation

512
Q

Tumour cells must interact with the extracellular matrix at several stages in the metastatic cascade. What are they?

A
  • A carcinoma must first breach the underlying basement membrane, then traverse the interstitial connective tissue, and ultimately gain access to the circulation by penetrating the vascular basement membrane.
  • This process is repeated in revers when tumour cell emboli extravasate to a distant site.
513
Q

Invastion of the ECM initiates the metastatic cascade and is an active process that can be resolved into several steps. What are they?

A
  • “Loosening up” of tumour cell-tumour interactions
  • Degradation of ECM
  • Attachment to novel ECM components
  • Migration and invasion of tumour cells
514
Q

Dissociation of cancer cells from one another is often the result of alterations in intercellular adhesion molecules and is the first step in the process of invasion. How is the function of E-cadherins related to this?

A

Normal epithelial cells are tightly glued to each other and the ECM by a variety of adhesion molecules. E-cadherins mediate the homotypic adhesion of epithelial cells, serving to both hold the cells toegterh and to relay signals between the cells.
In several epithelial tumours, including adenocarcinomas of the colon, stomach and breast, E-cadherin function is lost.

515
Q

Degradation of the basement membrane and interstitial connective tissue is the second step in invasion. How does it occur?

A

Tumour cells may accomplish this by either secreting proteolytic enzymes themselves or by inducing stromal cells (e.g. fibroblasts and inflammatory cells) to elaborate proteases.

516
Q

Many different families of proteases have been implicated in tumour cell invasion. Name some and explain what they do?

A
  • Metalloproteinases (MMPs) regulate tumour invasion not only by remodeling insoluble components of the basement membrane and interstitial matrix but also by releasing ECM-sequestered growth factors.
  • Cathepsin D
  • Urokinase plasminogen activator
517
Q

The third step of tumour invasion involves changes in attachment of tumour cells to ECM proteins. How does this happen?

A
  • Loss of adhesion in normal cells leads to induction of apoptosis, but tumour cells are resistant to this form of cell death.
  • Additionally, the matrix itself is modified in ways that promote invasion and metastasis - e.g. cleavage of the basement membrane proteins collagen IV and laminin by MMP2 or MMP9 generates novel sites that bind to receptors on tumour cells and stimulate migration.
518
Q

What is measles?

A

Measles is an acute viral infection that affects multiple organs and causes a wide range of disease, from mild, self-limiting infections to severe systemic manifestations

519
Q

What type of virus is the measles virus?

A

It is a single-stranded RNA virus of the paramyxovirus family, which includes mumps, RSV, parainfluenze and human metapneumovirus.

520
Q

How many serotypes of the measles virus are there? How is it transmitted?

A

There is only one serotype of measles virus.
Measles virus is transmitted by respiratory droplets.

521
Q

What are three cell-surface receptors that have been identified for measles? Where are they and what do they bind to?

A
  • CD46 (a complement-regulartory protein that inactivates C3 convertases) is expressed on all nucleated cells
  • Signaling lypmhocytic activation molecule (SLAM, a molecule involved in T-cell activation) is expressed on cells of the immune system
  • Nectin 4 (adherens junction protein) is expressed on epithelial cells.

All of these receptors bind the viral haemgglutinin protein.

522
Q

How does the measles virus replicate?

A
  • It can replicate in a variety of cell types, including epithelial cells and leukocytes.
  • The virus initially multiplies within the respiratory tract and then spreads to local lymphoid tissues
  • Replication of the virus in lymphatic tissue is followed by viremia and systemic dissemination to many tissues, including the conjunctiva, skin, respiratory tract, urinary tract, small blood vessles, lymphatic system, and CNS
523
Q

How do children develop immunity to measles?

A
  • Most children develop T-cell-mediated immunity to measles virus that helps control the viral infection and produces the measle rash.
  • Antibody-mediated immunity to measles virus protects against reinfection.
524
Q

What does measles cause, that is responsible for much of measles-related morbidity and mortality? How does this happen?

A
  • It can cause transient but profound immunosuppression, resulting in secondary bacterial and viral infections, which are responsible for much of measles-related morbidity and mortality.
  • Alterations of both innate and adaptive immune responses occur following measles infection, including defects in dendritic cell and lymphocyte function.
525
Q

What are some rare late complications of measles?

A

Subacute sclerosing panencephalitis and measles inclusion body encephalitis (in immunocompromised individuals).

526
Q

What is the morphology of measles virus?

A
  • The blotchy, reddish brown rash of measles virus infection on the face, trunk and proximal extremities is produced by dilated skin vessels, oedema, and a mononuclear perivascular infiltrate.
  • Ulcerated mucosal lesions in the oral cavity near the opening of the Stensen ducts (the pathognomic Koplic spots) are marked by necrosis, neutrophilic exudate, and neovascularisation.
  • The lymphoid organs typically have marked follicular hyperplasia, large germinal centers, and randomly distributed multinucleate giant cells, called Warthin-Finkeldey cells, which have eosinophilic nuclear and cytoplasmic inclusion bodies, found in the lung and sputum
Koplic spots
527
Q

What is mumps?

A

Mumps is an acute systemic viral infection usually associated with pain and swelling of the salivary glands

528
Q

What type of virus is mumps?

A

Like measles, mumps is a member of paramyxovirus family.

529
Q

What are the two types of surface glycoproteins that the mumps virus has?

A
  • One with hemagglutinin and neuraminidase activities
  • The other with cell fusion and cytolytic activities
530
Q

How do mumps viruses replicate and effect cells?

A
  • They enter the upper respiratory tract through inhalation of respiratory droplets, spread to draining lymph nodes where they replicate in lymphocytes (preferentially in activated T cells), and then spread through the blood to the salivary and other glands
  • Mumps virus infects salivary gland ductal epithalial cells, resulting in desquamation of involved cells, oedema, and inflammation that leads to the classic salivary gland pain and swelling.
531
Q

Where can mumps spread to?

A

Mumps can spread to other sites, including the CNS, testis, ovary and pancreas.
Aseptic meningitis is the most common extrasalivary gland complication of mumps infection, occurring in up to 15% of cases.

532
Q

What can be used to get a definitive diagnosis of mumps?

A

Serology, viral culture, or PCR assays.

533
Q

What is the morphology of mumps parotitis?

A
  • Mumps parotitis is bilateral in 70% of cases
  • The affected glands are enlarged, have a doughy consistency, and are moist, glistening, and reddish-brown on cross-section.
  • On microscopic examination the gland interstitium is oedematous and diffusely infiltrated by macrophages, lymphocytes, and plasma cells, which compress acini and ducts.
  • Neutrophils and nectrotic debris may fill the duct lumen and cause focal damage to the lining epithelium
534
Q

What is the morphology of mumps orchitis?

A
  • In mumps orchitis testicular swelling may be marked, caused by oedema, mononuclear cell infiltration, and focal haemorrhages.
  • Because the testis is tightly contained within the tunica albuginea, parenchymal swelling may compromise the blood supply and cause areas of infarction.
  • The testicular damage can lead to scarring, atrophy, and, if severe, sterility.
535
Q

How does mumps affect the pancreas and the CNS?

A
  • Infection and damage of acinar cells in the pancreas may release digestive enzymes, causing parenchymal and fat necrosis and neutrophil-rich inflammation.
  • Mumps encephalitis causes perivenous demyelination and perivascular mononuclear cuffing.
536
Q

What is poliovirus infection?

A

Poliovirus causes an acute systemic viral infection, leading to a wide range of manifestations, from mild, slef-limited infections to paralysis of limb muscles and respiratory muscles.

537
Q

What type of virus is polio?

A

It is a spherical, unencapsulated ENA virus of the enterovirus genus.

538
Q

What type of vaccine is polio?

A
  • Salk formalin-fixed (killed) vaccine
  • Sabin oral, attenuated (live) vaccine
539
Q

How is poliovirus transmitted and how does it replicate?

A
  • Polio, like other enteroviruses, is transmitted by the fecal-oral route.
  • The virus infects human cells by binding to CD155, an epithelial adhesion molecule.
  • The virus is ingested and replicates in the mucosa of the pharynx and gut, including tonsils and Peyer patches in the ilerum.
  • It then spreads through lymphatics to lymph nodes and eventually the blood, producing transient viremia and fever.
  • Although most polio infections are symptomatic, in 1% of people it invades the CNS and replicates in motor neurons of the spinal cord (spinal poliomyelitis) or brain stem (bulbar poliomyelitis).
540
Q

What is Viral haemorrhagic fever?

A

It is a severe life-threatening multisystem syndrome in which there is vascular dysregulation and damage, leading to shock.

541
Q

What causes viral haemorrhagic fever?

A

It is caused by enveloped RNA viruses belonging to four different genera: Arenaviridae, Filoviridae, Bunyaviridae, and Flaviviridae.

542
Q

What are the symptoms of viral haemorrhagic fever?

A

It can produce a spectrum of illnesses, ranging from a mild acute disease, characterised by fever, headache, myalgia, rash, neutropaenia, and thrombocytopaenia to severe, life-threatening disease in which there is sudden haemodynamic deterioration and shock.

543
Q

How is viral haemorrhagic fever transmitted?

A
  • All the viruses pass through an animal or insect host during their life cycles and therefore their ranges are restricted to areas in which their hosts reside.
  • Humans are incidental hosts who are infected when they come into contact with infected hosts (typically rodents) or insect vectors (mosquitos adn ticks). Some viruses that cause haemorrhagic fever (Ebola) also can spread from person to person
544
Q

What is the pathogenesis of viral haemorrhagic fever?

A
  • The pathogenesis of the infection and its complications vary among the different viruses but there are some common features
  • Damage to blood vessels is often prominent. It may be caused by direct or indirect infection of and damage to endothelial cells, or infection of macrophages and dendritic cells leading to production of inflammatory cytokines.
  • There may be haemorrhagic manifestations, including petechiae, caused by a combinations of thrombocytopaenia or platelet dysfunction, endothelial injury, cytokine-induced DIC, and deficiency of clotting factors because of hepatic injury.
  • Necrosis of tissues secondary to the vascular lesions and haemorrages may be seen and varies from mild and focal to massive, but the attendant inflammatory response is usually minimal.
545
Q

What is a latent infection?

A

Latency is defined as the persistence of viral genomes in cells that do not produce infectious virus.

546
Q

What happens when a latent infection is reactivated?

A

Dissemination of the infection and tissue injury stem from reactivation of the latent virus.

547
Q

What are the viruses that most frequently establish latent infections in humans?

A

Herpesviruses

548
Q

What type of virus are herpesviruses?

A

They are large encapsulated viruses with double-stranded DNA genomes that encode approximately 70 proteins.

549
Q

What are the patterns of infection caused by herpesvirus?

A

Herpesviruses cause acute infection followed by latent infection in which the viruses persist in a noninfectious form with periodic reactivation and shedding of infectious virus.

550
Q

There are eight types of human herpesviruses, belonging to three subgroups that are defined by the type of cell most frequently infected and the site of latency. What are the groups, give some examples and what cells do they infect?

A
  • α-group viruses, including HSV-1, HSV-2 and VZV, which infect epithelial cells and produce latent infection in neurons
  • Lymphotropic β-group viruses, including CMV, human herpesvirus-6 (which causes exanthem subitum, also known as roseola infantum and sixth disease, a benign rash of infants), and human herpesvirus-7, which infect and produce latent infection in a variety of cell types
  • γ-group viruses EBV and KSHV/HHV-8, the cause of Kaposi sarcoma, which produce latent infection mainly in lymphoid cells.
551
Q

What are the similarities of HSV-1 and HSV-2?

A

HSV-1 and HSV-2 differ serologically but are closely related genetically and cause a similar set of primary and recurrent infections

552
Q

How do HSV-1 and HSV-2 replicate and infect?

A
  • Both viruses replicate in the skin and the mucous membranes at the site of entry of the virus (usually oropharynx or genitals), where they produce infectious virions and cause vesicular lesions of the epidermis.
  • The viruses spread to sensory neurons that innervate these primary sites of replication.
  • Viral nucleocapsids are transported along axons to the neuronal cell bodies, where the viruses establish latent infection
553
Q

In immunocompetent hosts, how long does it take for primary HSV infection to resolve?

A

A few weeks, although the virus remains latent in nerve cells

554
Q

What happens for the HSV during latency?

A
  • During latency the viral DNA remains within the nucleus of the neuron, and only latency-associated viral RNA transcripts (LATs) are synthesised.
  • No viral proteins appear to be produced during latency.
  • LATs may contribute to latency by conferring resistance to apoptosis, silencing lytic gene expression through heterochromatin formation, and serving as precursors for microRNAs that downregulate expression of critical HSV lytic genes.
555
Q

How does reactivation occur?

A
  • Reactivation of HSV-1 and HSV-2 may occur repeatedly with or without symptoms, and results in the spread of virus from the neurons to the skin or to mucous membranes.
  • Reactivation can occur in the presence of host immunity, because HSVs have developed ways to avoid immune recognition.
556
Q

What ways have HSV developed to avoid immune recognition?

A
  • HSVs can evade antiviral CTLs by inhibiting the MHC class I recognition pathway
  • They can elude humoral immune defenses by producing receptors for teh Fc domain of immunoglobulin and inhibitors of complement.
557
Q

HSV-1 is the major infectious cause of corneal blindness in the US. How does it cause it?

A
  • Corneal epithelial disease is thought to be due to direct viral damage, whilst corneal stromal disease appears to be immune-mediated.
558
Q

HSV-1 is the major cause of fatal sporadic encephalitis in the US. Where in the brain does it involve?

A

When the infection spreads to the brain, it usually involves the temporal lobes and orbital gyri of the frontal lobes.

559
Q

How does HSV-2 infection effect HIV transmission?

A

HSV-2 infection increases the risk of HIV transmission by four-fold and increases the risk of HIV acquisition by two-to-three-fold.

560
Q

What is the morphology of HSV-infected cells?

A

They contain large, pink to purple intranuclear inclusions (Cowdry type A) that consist of viral replication proteins and virions at various stage of assembly that push the host cell chromatin out to the edges of the nucleus. Due to cell fusion, HSVs also produc inclusion-bearing multinucleated syncytia.

561
Q

Where are HSV-1 and HSV-2 lesions?

A
  • They cause lesions ranging from self-limited cold sores and gingivostomatitis to life-threatening disseminated visceral infection and encephalitis.
  • Fever blisters or cold sores favor the facial skin around mucosal orifices (lips, nose), where their distribution is frequently bilateral and independent of skin dermatomes.
562
Q

What is gingivostomatitis? Is it HSV-1 or -2?

A
  • It is usually encountered in children, and is caused by HSV-1
  • It is a vesicular eruption extending from the tongue to the retropharynx and causing cervical lymphadenopathy.
563
Q

What is herpetic whitlow in HSV? Who does it happen to?

A

Swollen, erythematous HSV lesions of the fingers of palm (herpetic whitlow) occur in infants and, occasionally, in health care workers

564
Q

What are genital herpes? Is it caused by HSV-1 or -2?

A
  • It is more often caused by HSV-2 than by HSV-1.
  • It is characterised by vesicles on the genital mucous membranes as well as on the external genitalia that are rapidly converted into superficial ulcerations, rimmed by an inflammatory infiltrate
565
Q

How is HSV transmitted to neonates? Is it usually HSV-1 or HSV-2? How does it affect them?

A
  • Usually HSV-2 can be transmitted to neonates during passage through the birth canal of infected mothers.
  • Although HSV-2 infection in the neonate may be more mild, more commonly it is fulminating with generalised lymphadenopathy, splenomegaly and necrotic foci throughout the lungs, liver, adrenals and CNS
566
Q

Two forms of corneal lesions are caused by HSV. What are they? How do they present?

A

1) Herpes epithelial keratitis shows typical virus-induced cytolysis of the superficial epithelium
2) Herpes stromal keratitis is characterised by infiltrates of mononuclear cells around keratinocytes and endothelial cells, leading to neovascularisation, scarring, opacification of the cornea, and eventual blindness. Here the damage is caused by an immunologic reaction to the HSV infection, rather than the cytopathic effects of the virus itself

567
Q

What is Varicella-Zoster Virus?

A

Acute infection with VZV causes chickenpox and reactivation of latent VZV causes shingles.

568
Q

What is the pathological process of VZV?

A
  • Like, HSV, VZV infects mucous membranes, skin, and neurons and causes a self-limited primary infection in immunocompetent individuals.
  • Also like HSV, VZV evades immune responses and establishes a latent infection in sensory ganglia.
  • In contrast to HSV, VZV is transmitted by respiratory aerosols, disseminates haemtogenously, and causes widespread vesicular skin lesions
569
Q

Where is VZV infection seen? How is it reactivated?

A
  • Latent VZV infection is seen in neurons and/or satellite cells around neurons in the dorsal root ganglia.
  • Reactivation and clinical recurrences causing shingles are uncommon but may occur many years after the primary infection
570
Q

Where is localised recurrence of VZV most frequent and painful?

A

In dermatomes innervated by the trigeminal ganglia, where the virus is more likely to be latent.

571
Q

How is VZV infection diagnosed?

A

By viral culture, or detection of viral antigens in cells scraped from superficial lesions.

572
Q

How long after a respiratory infection does the chickenpox rash present? How does it present?

A
  • The chickenpox rash occurs approx 2 weeks after respiratory infection. Lesions appear in multiple waves centrifugally from the torso to the head and extremities.
  • Each lesion progresses rapidly from a macule to a vesicle, which resembles a dewdrop on a rose petal.
  • After a few days most chickenpox vesicles rupture, crust over, and heal by regeneration, leaving no scars. However, bacterial superinfection of vesicles that are ruptured by trauma may lead to destruction of the basal epidermal layer and residual scarring.
573
Q

How does chickenpox appear histologically?

A

Chickenppox lesions show intraepithelial vesicles with intranuclear inclusions in epithelial cells at the base of the vesicles.

574
Q

When does shingles occur?

A

When VZV that has long remained latent in dorsal root ganglia after a previous chickenpox infection is reactivated and infects sensory nerves that carry it to one or more dermatomes.

575
Q

What cells does VZV infect in shingles and how does it present?

A

The virus infects keratinocytes and causes vesciular lesions, which, unlike chickpox, are often associated with intense itching, burning, or sharp pain because of concomitant radiculoneuritis. This pain is especially severe when the trigeminal nerves are involved

576
Q
A
577
Q

What is Ramsay Hunt syndrome?

A

Rarely, the geniculate nucleus is involved in a shingles infection, causing facial paralysis (Ramsay Hunt syndrome).

578
Q

Histologically, what do the sensory ganglia appear like in shingles?

A

They contain a dense, predominantly mononuclear infiltrate, with herpetic intranuclear inclusions within neurons and their supporting cells.

579
Q

What is cytomegalovirus?

A

CMV, a β-group herpesvirus, can produce a variety of disease manifestations, depending on the age of the host, and, more importantly, on the host’s immune status.

580
Q

How does CMV infection start?

A

CMV latently infects monocytes and their bone marrow progenitors and can be reactivated when cellular immunity is depressed

581
Q

How does CMV vary due to the host’s immune system?

A

CMV cause an asymptomatic or mononucleosis-like infection in healthy individuals but devastating systemic infections in neonates and in immunocompromised people, in whom the virus may infect many different cell types and tissues.

582
Q

How do CMV-infected cells appear?

A

CMV-infected cells exhibit gigantism of both the entire cell and its nucleus, which typically contains a large inclusion surrounded by a clear halo “owl’s eye)

583
Q

Transmission of CMV can occur be several mechanisms, depending on the age group affected. What are these?

A
  • Transplacental transmission, from a newly acquired or primary infection in a mother who does not have protective antibodies (congenital CMV)
  • Neonatal transmission, through cervical or vaginal secretions at birth, or later throough breat milk from a mother who has an active infection (perinatal CMV)
  • Transmission through saliva during preschool years, especially in day care centers. Toddlers so infected readily transmit the virus to their parents
  • Tramission by the genital route is the dominant mode after about 15 years of age. Spread may also occur via respiratory secreation and the fecel-oral route.
  • Iatrogenic transmission, at any age through organ transplants or blood transfusions
584
Q

How does acute CMV infection affect the immune system?

A

It induces transient but severe immunosuppression. CMV can infect dendritic cells and impair antigen processing and the ability of dentritic cells to stimulate T lymphocuyes

585
Q

How does CMV evade the immune system?

A
  • By downmodulating MHC class I and II molecules and by producing homologues of TNF receptor, IL-10, and MHC class I molecules.
  • Interestingly, CMV can evade NK cells by producing ligands that block activating receptors and class I-like proteins that engage inhibitory receptors.
  • thus, CMV both hides from and actively suppresses immune responses.
586
Q

How do MCV infected cells appear?

A
  • They are strikingly enlarged, often to a diameter of 40μ, and show cellular and nuclear pleomorphism.
  • Prominent intranuclear basophilic inclusions spanning half the nuclear diameter are usually set off from the nuclear membrane by a clear halo.
  • Within the cytoplasm of infected cells, smaller basophilic inclusions can also be seen.
  • In the glandular organs, the parenchymal epithalial cells are infected; in the brain, the neurons; in the lungs, the alveolar macrophages and epithelial and endothelial cells; and in the kidneys, the tubular epithelial and glomerular endothelial cells.
  • Disseminated CMV causes focal necrosis with minimal inflammation in virtually any organ.
587
Q

How does congential CMV present?

A
  • Infection acquired in utero may take many forms.
  • Inapproximately 95% of cases it is asymptomatic.
  • However, sometimes when the virus is acquired from a mother with primary infection (who does not have protective antibodies), classic cytomegalic inclusion disease develops.
588
Q

How does cytomegalic inclusion disease present in utero? How is diagnosis of neonatal CMV made?

A
  • It resembles erythroblastosis fetalis.
  • Affected infants may suffer IUGR, and present with jaundice, hepatosplenomegaly, anaemia, bleeding due to thrombocytopaenia, and encephalitis.
  • In fatal cases, the brain is often smaller than normal (microcephaly) and may show foci of calcification
  • Diagnosis of neonatal CMV is made by viral culture or PCR amplification of viral DNA in urine or saliva
589
Q

What are the effects for an infant who had cytomegalic inclusion disease?

A
  • The infants who survive usually have permanent deficits, including intellectual disability, hearing loss, and other neurologic impairments.
  • The congenital infection is not always devastating, however, and may take the form of interstitial pneumonitis, hepatitis, or a haematologic disoder
  • Most infants with this milder form recover, although a few develop intelectual disability later
590
Q

How does perinatal infection of CMV usually present?

A
  • Infection acquired during passage through the birth canal or from breast milk is usually asymptomatic due to protective maternal anti-CMV antibodies, which are transmitted to the fetus across the placenta.
  • Despite the lack of symptoms, many of these infants continue to excrete CMV in their urine or saliva for months to years.
  • Subtle effects on hearing and intelligence later in life have been reported in some studies
  • Much less commonly, infected infant develop interstitial pneumonitis, failure to thrive, rash or hepatitis
591
Q

What is the most common clinical manifestation of CMV infection in immunocompetent hosts beyond the neonatal period?

A

In healthy young children and adults the disease is nearly always asymptomatic, 50-100% of adults have had previous exposure. If there are symptoms, most commonly they are an infectious mononucleosis-like illness, with fever, atypical lymphocytosis, lymphadenopathy and hepatitis, marked by hepatomegaly and abnormal liver function tests.

592
Q

What organs does CMV primarily affect in immunosuppressed patients? What happens in these organs

A
  • The lungs (pneumonitis) and GI (colitis)
  • In the pulmonary infection an interstitial mononuclear infiltrate with foci of necrosis develops, accompanied by the typical enlarged cells with inclusions. The pneumonitis can progress to full-blown ARDS.
  • Intestinal necrosis and ulceration can develop and be extensive, leading to the formation of pseudomembranes and debilitating diarrhoea.
593
Q

What are transforming viral infections? Name some

A
  • Some viruses can transform infected cells into benign or malignant tumour cells.
  • Oncogenic viruses can stimulate cell growth and survival by a variety of mechanisms.
  • Examples include EBV, HPV, HBV.
594
Q

What does EBV cause?

A

EBV causes infectious mononucleosis, a benign, self-limited lymphoproliferative disorder, and is associated with the pahtogenesis of several human tumours, most commonly certain lymphomas and nasopharyngeal carcinomas.

595
Q

What are the symptoms of infectious mononucleiosis?

A

It is characterised by fever, sore throat, generalised lymphadenopathy, splenomegaly, and the appearace in the blood of atypical activated T lymphocytes (mononucleiosis cells).
Some people develop hepatitis, meningoencephalitis, and pneumonitis.

596
Q

In what age group does EBV usually occur?

A

Infectious mononucleiosis occurs principally in late adolescents or young adults among upper socioeconomic classes in developed nations.
In the rest of the wold, primary infection with EBV occurs in childhood and is usually asymptomatic.

597
Q

How is EBV transmitted?

A

By close human contact, frequently through the saliva during kissing.

598
Q

How does EBV infect the body?

A
  • EBV infects B cells and possibly epithelial cells of the oropharynx.
  • An EBV envelope glycoprotein binds CD21 (CR2), the receptor for C3d component of complement, which is present on B cells.
  • In a minority of B cells, infection is lytic, leading to viral replication and eventual cell lysis accompanied by release of virions, which may infect other B cells.
  • In most B cells however, EBV establishes latent infection, during which the virus persists as an extrachromosomal episome.
599
Q

A small number of EBV-encoded proteins are believed to be particularly important in the establishment of latency. What are they and what do they do?

A
  • Epstein-Barr nucleur antigen 1 (EBNA1) binds the EBV genome to host cell chromosomes during mitosis, thereby ensuring that viral episomes are partitioned evenly to daughter cells when infected cells divide
  • Latent membrane protein 1(LMP1) drives B-cell activation and proliferation. LMP1 does so by mimicking a constitutively active form of CD40, a B cell surface receptor. Like activating CD40, LMP1 binds to TNF receptor-assocated factors, adaptor molecules that trigger downstream events that activate NF-κB and the JAK/STAT signaling pathway. In addition, LMP1 prevents apoptosis by activating Bcl-2.
  • EBNA2 also promotes B-cell activation and replication. It turns on the transcription of several host cell genes, inclduing genes that encode proteins that drive cell cycle antry, such as cyclin D.
  • EBV produces a homologue of IL-10 (vIL-10), which inhibits its amcrophages and dendritic cells and suppresses anti-viral T cell responses.
600
Q

What happens as a result of the actions of the EBV proteins?

A
  • B cells that are latently infected with EBV are activated and begin to proliferate and to disseminate.
  • This uncontrolled, expanding polyclonal population of EBV-infected B cells secretes antibodies with many specificities, inclduing antibodies that recognise sheep or horse red cells.
  • These so-called heterophile antibodies are detected in diagnostic tests for mononucleosis.
601
Q

Where in the body is EBV shed?

A
  • In the saliva.
  • It is not known whether the source of the virus is B cells, oropharyngeal epithelial cells, or both
602
Q

The symptoms of infectious mononucleosis appear uopn initiation of the host immune response. What happens during this response on a cellular level?

A
  • Cellular immunity mediated by EBV-specific CD8+ cytotoxic T cells and CD16+ NK cells is the most important component of this response.
  • The reactive proliferation of T cells is largely centered in lymphoid tissues, which accounts for the lymphadenopathy and splenomegaly.
  • Early in the course of the infection, IgM antibodies are formed against viral capsid antigens; later IgG antibodies are formed that persist for life.
603
Q

How does the response to EBV vary from healthy to immunosupressed people?

A
  • In healthy people, the fully developed humoral and cellular responses to EBV act as brakes on viral shedding, resulting in the elimination of B cells expressing the full complement of EBV latency-associated genes.
  • In hosts with acquired defects in cellular immunity, reactivation of EBV can lead to B-cell proliferation, which can progress through a multistep process to EBV-associated B-cell lymphomas.
604
Q

EBV contributes to the development of which lymphoma? How?

A

It contributes to the development of some cases of Burkitt lymphoma, in which a chromosomal translocation (most commonly an 8:14 translocation) involving the MYC oncogene is the critical ongongenic event.

605
Q

What are the morphological changes in EBV?

A
  • The peripheral blood shows absolute lymphocytosis. Many of these are large, atypical lymphocytes, characterised by an abundant cytoplasm containing multiple clear vacuolations, an oval, indented, or folded nucleus, and scattered cytoplasmic azurophilic granules.
  • The lymph nodes, histologically, have expansion of paracortical areas due to activation of T cells (immunoblasts). A minor population of EBV-infected B cells can also be detected in the paracortex.
  • EBV-infected B cells resembling Reed-Sternberg cells may be found.
606
Q

What are the physical and histological changes in the spleen in EBV?

A
  • The spleen in enlarged in most cases. It is usually soft and fleshy, which a hyperemic cut surface
  • The histological changes are an expansion of white pulp follicles and red pulp sinusoids due to the presence of numerous activated T cells.
  • These spleen are especially vulnerable to rupture, possibly in part because the rapid increase in size produces a tense, fragile splenic capsule.
607
Q

What are the physical and histological changes to the liver in EBV?

A
  • Heptamegaly is at most moderate.
  • On histological examination, atypical lymphocytes are seen in the portal areas and sinusoids, and scattered, isolated cells or foci of parenchymal necrosis may be present.
608
Q

What are the clinical features of EBV?

A
  • In young children is classically presents with fever, sore throat, lymphadenitis, and other features mentioned earlier.
  • However, malaise, fatigue and lymphadenopathy are the common presentation in young adults with infectious mononucleiosis and can raise the specter of leukaemia or lymphoma
  • EBV can also prsent as a fever of unknown origin without significant lymphadenopathy or other localised findings, hepatitis resembling one of the hepatotropic viral syndromes, or a febrile rash resembling rubella.
609
Q

What does the diagnosis of infectious mononucleiosis involve?

A

The diagnosis depends on:
1) lymphocytosis with the characteristic atypical lymphocytes in the peripheral blood
2) a positive heterophile antibody reaction (Monospot test)
3) a rising titer of specific antibodies for EBV antigens (viral capsid antigens, ealry antigens, or Epstein-Barr nuclear angiten)

610
Q

In most patients, infectious mononucleosis resolves within 4-6 weeks, but sometimes the fatigue lasts longer. One of more complications ocassionally supervene. What are these?

A
  • Most common is marked hepatic dysfunction with jaundice, elevated hepatic enzyme levels, disturbed appetite, and rarely, even liver failure
  • Other complications involve the nervous system, kidneys, bone marrow, lungs, eyes, heart and spleen.
  • Splenic rupture can occur even with minor trauma, leading to haemorrhage that may be fatal.
611
Q

What are the common conditions caused by staphylococcal aureus?

A
  • Skin lesions (boils, carbuncles, impetigo, and scalded-skin syndrome)
  • Abscesses
  • Sepsis
  • Osteomyelitis
  • Pneumonia
  • Endocarditis
  • Food poisoning
  • Toxic shock syndrome
612
Q

What type of bacteria are staph aureus?

A
  • Pyogenic, gram-positive cocci that form clusters resembling bunches of grapes
613
Q

What type of infections does staph. epidermidis cause?

A

Opportunistic infections in:
* catheterised patients
* patients with prosthetic cardiac valves
* drug addicts

614
Q

What is the pathogenesis of staph aureus infections?

A
  • It produces a mulitude of virulence factors, which include surface proteins involved in adherence and evasion of the host immune response, secreted by enzymes that degrade host structures, secreted toxins that damage host cells, and proteins that cause antibiotics resistance.
  • S. aureus expresses surface receptors for fibrinogen (called clumping factor), fibronectin, and vitronectin and use these molecules to find to host endothelial cells
615
Q

How do staphylococci infecting prosthetic valves and catheters do that?

A

They have a polysaccharide capsule that allows them to attach to artificial materials and resist host cell phagocytosis.

616
Q

Staphylococco have their surface protein A. What does this do?

A

It binds the Fc portion of immunoglobulins, allowing the organism to escape antibody-mediated killing.

617
Q

S. aureus produces multiple membrane-damaging (haemolytic) toxins. What are they and what do they do?

A
  • α-toxin, a protein that intercalates into the plasma membrane of host cells, forming pores that allow toxic levels of calcium to leak into cells
  • β-toxin, a sphingomyelinase
  • δ-toxin, which is a detergent-like peptide.
  • Staphylococcal γ-toxin and leukocidin lyse red cells and phagocytes, respectively
618
Q

How do the exfoliative A and B toxins produced by S.aureus work?

A
  • They are serine proteases that cleave the desmosomal protein desmoglein 1, which holds epidermal cells tightly together.
  • This causes keratinocytes to detach from one another and from the underlying basement membrane, resulting in a loss of barrier function that often leads to secondary skin infections
  • Exfoliation may occur locally at the site of infection (bullous impetigo) or may result in widespread loss of superficial epidermis (staphycoccal scalded-skin syndrome).
619
Q

Superantigens produced by S.aureus may cause what?

A

Food poisoning and toxic shock syndrome.

620
Q

What is the pathophysiology of toxic shock syndrome?

A
  • It is often caused by hyperabsorbent tampons, which become colonised with S.aureus during use. It can also be caused by strep. pyogenes.
  • The most common sites are the vagina and infected surgical sites.
  • Bacterial superantigens cause polyclonal T cell proliferation by binding to conserved portions of MHC molecules and to relatively conserved portions of T-cell receptor β chains.
  • In this manner, superantigens may stimulate up to 20% of T lymphocytes, leading to release of TNF and IL-1 in such large amounts that they trigger the inflmmatory response.
621
Q

What are the clinical features of toxic shock syndrome?

A
  • It is characterised by hypotension, renal failure, coagulopathy, liver disease, respiratory distress, a generalised erythematous rash, and soft tissue necrosis at the site of infection.
  • If not treated promptly, it can be fatal.
  • Superantigens produced by S.aureus also cause vomiting, presumably by affecting the CNS or enteric nervous system
622
Q

What is the morphology of S.aureus infection?

A

Where the lesion is located in the skin, lungs, bones or heart valves, S.aureus causes pyogenic inflammation that is distinctive for its local destruction of host tissue.

623
Q

Where do staphylococcal skin infections begin?

A

Excluding impetigo, which is restricted to the superficial epidermis, staphylococcal skin infections are centered around the hair follicles where they begin

624
Q

What is a furuncle or boil in association with S.aureus? Where and how do they happen?

A
  • A focal suppurative inflammation of the skin and subcutaneous tissue.
  • They may be soliatry or multiple or recur in successive crops.
  • Furuncles are most frequent is moist, hairy areas, such as the face, axillae, groin, legs and submammary folds.
  • Beginning in a single hair follicle, a boil develops into a growing and deepening abscess that eventually ‘comes to a head’ by thinning and rupturing the overlying skin.
625
Q

What is a carbuncle associated with S.aureus? Where and how do they happen?

A
  • A carbuncle is a deeper suppurative infection that spreads laterally beneath the deep subcutaneous fascia and then burrow superficially to erupt in multiple adjacent skin sinuses
  • Carbuncles typically appear beneath the skin of the upper back and posterior neck, where fascial planes favor their spread
626
Q

What is hidradenitis?

A

It is a chronic suppurative infection of apocrine glands, most often in the axilla. Caused by S.aureus

627
Q

What is the morphology of S.aureus lung infections? What normally causes them

A
  • They have a polymorphonuclear infiltrate similar to that of S.pneumoniae infections, but cause much more tissue destruction.
  • They usually arise from a haematogenous source, such as an infected thrombus, or in the setting of a predisposing condition such as infleunza.
628
Q

What is staphylococcal scalded-skin syndrome? Who does it happen in and how does it happen?

A
  • It occurs most frequently in children with S.aureus infection of the nasopharynx or skin.
  • There is a sunburn-like rash that spreads over the entire body and evolves into fragile bullae that lead to partial or total skin loss.
  • The desquamation of the epidermis in staphylococcal scalded-skin syndrome occurs at the level of the granulosa layer, distinguishing it from the toxic epidermal necrolysis, or Lyell disease, which is secondary to drug hypersensitivity and causes desquamation at the level of the epidermal-dermal junction.
629
Q

What are some species that cause respiratory diseases and what diseases do the often cause?

A
  • Streptococcus pyogenes - pharyngitis
  • Corynebacterium diphtheria - diphtheria
  • Bordatella pertussis - pertussis
  • Streptococcus pnuemonia - lobar pneumonia
  • Mycobacterium tuberculosis - TB
  • Legionella pneumophila - Legionnaire disease
630
Q

What are some species that cause gastrointestinal diseases and what diseases do the often cause?

A
  • Helicobacter pylori - peptic ulcers
  • Vibrio cholerae, enterotoxigenic E.coli - non-inflammatory gastroenteritis
  • Shigella, Salmonella, Campylobacter, enterohaemorrhagic E.coli - Inflammatory gastroenteritis
  • Salmonella typhi - enteric (typhoid) fever
  • Clostridium difficile - pseudomembranous colitis
631
Q

What are some species that cause nervous system diseases and what diseases do the often cause?

A
  • Neisseria meningitidis, Streptococcus pneumonia, Haemophilus influenza, Listeria monocytogenes - acute meningitis
  • Clostridium tetani, Clostridium botulinum - paralytic intoxications, tetanus and botulism
632
Q

What are some species that cause urogenital diseases and what diseases do the often cause?

A
  • Escherichia coli, Pseudomonas aeruginosa, Entercoccus species - UTIs
  • Neisseria gonorrhoeae - gonorrhea
  • Chlamydia trachomatis - chlamydia
  • Treponema pallidum - syphilis
633
Q

What are some species that cause skin and adjacent soft tissue diseases and what diseases do the often cause?

A
  • Staphylococcus aureus - abscess, cellulitis
  • Streptococcus pyogenes - impetigo, erysipela, necrotising fasciitis
  • Clostridium perfringens - gas gangrene
  • Bacillus anthracis - cutaneous anthrax
  • Pseudomonas aeruginosa - burn infections
  • Mycobacterium leprae - leprosy
634
Q

What are some species that cause disseminated infections and what diseases do the often cause?

A
  • Yersinia pestis - plague
  • Borrelia burgdorferi - lyme disease
635
Q

What are some species that cause disseminated neonatal infection and what diseases do the often cause?

A
  • Streptococcus agalactiae, Listeria monocytogenes - neonatal bacteraemia, meningitis
  • Treponema pallidum - congenital syphilis
636
Q

What infections do Streptococci cause?

A
  • Suppurative infections of the skin, oropharynx, lungs and heart valves
  • Postinfectious syndromes, including rheumatic fever, immune complex glomerulonephritis, and erythema nodosum.
637
Q

What type of bacteria are Streptococci?

A

They are gram-positive cocci that grow in pairs or chains.

638
Q

β-haemolytic streptococci are typed according to their surface carbohydrate (Lancefield) antigens. What are the different types of β-haemolytic streptococci and what do they cause?

A
  • Strep. pyogenes (group A) causes pharyngitis, scarlet fever, erysipelas, impetigo, rheumatic fever, toxic shock syndrome, and glomerulonephritis.
  • Strep. agalactiae (group B) colonises the female genital tract and causes sepsis and meningitis in neonates and chorioamnionitis in pregnancy.
639
Q

What is the most important α-haemolytic stretococcus? What does it cause?

A

Strep. pneumoniae is a common cause of CAP in older adults and meningitis in children and adults.

640
Q
A
641
Q

What does Strep. mutans cause?

A

Dental caries

642
Q

What type of bacteria are enterococci? What do they cause

A
  • Enterococci are gram-positive cocci that grow in chains.
  • They are often resistant to commonly used antibiotics
  • They are a significant cause of endocarditis and urinary tract infections.
643
Q

What is the pathogenesis of Strep. pyogenes?

A
  • Expresses M protein, a surface protein that prevents bacteria from being phagocytosed
  • Expresses a complement 5a peptidase that degrades degrades this chemotactic peptide
  • It secretes a phage-encoded pyrogenic exotoxin that causes fever and rash in scarlet fever
644
Q

What do S.pyogenes, S.agalactiae, and S.pneumoniae all have that allows them to resist phagocytosis?

A

They have capsules that resist phagocytosis

645
Q

How is post-streptococcal acute rheumatic fever cause?

A

By antistreptococcal M protein antibodies and T cells that cross-react with cardiac proteins

646
Q

Although the antiphagocytic capsule is the most important virulence factor of S.pneumoniae, what other virulence factor does it produce?

A

Pneumolysin, a toxin that inserts into host cell membranes and lyses cells, greatly increasing tissue damage

647
Q

How does S.mutans produce caries?

A

By metabolising sucrose to lactic acid (which causes demineralisation of tooth enamel) and by secreting high-molecular-weight glucans that promote aggregation of bacteria and plaque formation.

648
Q

Enterococci are low-virulence bacteria, although they do have an antiphagocytic capsule and produce enzymes that injur host cells, what is the primary cause of the emergence of enterococci?

A

Their resistance to antibiotics

649
Q

What is the morphology of streptococcal infections?

A

They are characterised by diffuse interstitial neutrophilic infiltrates with minimal destruction of host tissues.

650
Q

What causes Erysipelas? How does it present both clincically and histologically?

A
  • It is caused by exotoxins from superficial infection with S.pyogenes
  • Characterised by rapidly spreading erythematous cutaneous swelling that may begin on the face, or less frequently, on the body or an extremity. The rash has a sharp, well-demarcated, serpiginous border and may form a ‘butterfly’ distribution on the face.
  • Histologically, there is a diffuse, oedematous, neutrophilic inflammatory reaction in the dermis and epidermis extending into the subcutaneous tissues. Microabscesses may be formed, but tissue necrosis is usually minor.
651
Q

What are the symptoms of streptococcal pharyngitis?

A
  • Oedema, epiglottic swelling, and punctate abscesses of the tonsillar crypts, sometimes accompanied by cervical lymphadenopathy.
  • Swelling associated with severe pharyngeal infection may encroach on the airways, especially if there is peritonsillar or retropharyngeal abscess formation.
652
Q

What bacteria causes scarlet fever? How does it present?

A
  • Associated with pharyngitis cause by S.pyogenes.
  • Most common between the ages of 3 and 15 years
  • Manifested y a punctate erythematous rash that is most prominent over the trunk and inner aspects of the arms and legs.
  • The face is also involved, but usually a small area about the mouth remains relatively unaffected, producing circumoral pallor.
  • They skin usually becomes hyperkeratotic and scaly during defervescence.
653
Q

What is the bacteria that causes Diphtheria? How is it spread?

A

It is caused by Corynebacterium diphtheriae, a slender gram-positive rod with clubbed ends that spreads from person to person in respiratory droplets or skin exudate.

654
Q

What symptoms does diphtheria infection cause?

A
  • Respiratory diphtheria causes pharyngeal, or less often, nasal or laryngeal infection.
  • There is toxin-mediated formation of a gray pharyngeal membrane, and damage to the heart, nerves, and other organs.
  • Cutaneous diphtheria causes chronic ulcers with a dirty gray membrane, but does not cause systemic damage.
655
Q

What is the pathogenesis of diphtheria?

A
  • C. diphtheriae produces a phage-encoded A-B toxin that blocks host cell protein synthesis.
  • The A fragment does this by catalysing the covalent transfer of ADP–ribose to elongation factor-2 (EF-2).
  • This inhibits EF-2 function, which is required for the translation of mRNA into protein.
  • A single molecule of diphtheria toxin can kill a cell by ADP-ribosylating, and thereby inactivating, more than a million EF-2 molecules.
656
Q

How does immunisation with diphtheria toxoid work?

A

Immunisation with diphtheria toxoid (formalin-fixed toxin) stimualtes production of toxin-neutralising antibodies that protect people from the lethal effects of the toxin

657
Q

What is the morphology of C.diphtheriae?

A
  • Inhaled C.diphtheriae carried in respiratory droplets proliferate at the side of attachment on the mucosa of the nasopharynx, oropharynx, larynx, or trachea. The bacteria also form satellite lesions in the oesophagus or lower airways.
  • Release of exotoxin causes necrosis of the epithelium, accompanied by an outpouring of a dense fibrinosuppurative exudate. The coagulaton of this exudate on the ulcerated necrotic surface created a tough, dirty gray to black, superficial membrane, sometimes called pseudo-membrane because it is not formed by viable tissue.
  • There is an intense neutrophilic infiltration with marked vascular congestion, interstitial edema and fribin exudation.
  • When the membrane sloughs off its inflamed and vascularised bed, bleeding and asphyxiation may occur.
  • With control of the infection, the membrane is coughed up or removed by enzymatic digestion, and the inflammatory reaction subsides.
658
Q

Although the bacterial invasion of diphtheriae remains localised, what happens with entry of exotoxin into the blood adn its systemic distribution?

A

There may be a fatty change in the myocardium with isolated myofiber necrosis, polyneuritis with degeneration of the myelin sheaths and axis cylinders, and (less commonly) fatty change and focal necroses of parenchymal cells in the liver, kidneys and adrenals.

659
Q

What type of bacteria causes cholera?

A

Vibrio cholerae are comma-shaped, gram-negative bacteria, that cause cholera, a disease that has been endemic in the Ganges Valley of India and Bangladesh for almost all of recorded history

660
Q

There is a marked seasonal variation in the incidence of cholera in most climates. Why?

A

Due to radpi growth of Vibrio bacteria at warm temperatures.

661
Q

Where do people get cholera from?

A

While the bacteria can be present in food, the infection is primarily transmitted by contaminated drinking water.
Thus, cholera can become rampant in areas devastated by natural or man-made disasters, such as earthquakes or war, that threaten sewage systems and drinking water supplied.

662
Q

What is the pathogenesis of cholera?

A
  • Cholera toxin is composed of five B subunits and a single A subunit.
  • The B subunit binds GM1 ganglioside on the surface of intestinal epithelial cells, and is carried by endocytosis to the endoplasmic reticulum, a process called retrograde transport.
  • Here, the A subunit is reduced by protein disulfide isomerase, and a fragment of the A subunit is unfolded and released.
  • This peptide fragment is transported into the cytosol using host cell machinery that moves misfolded proteins from the endoplasmic reticulum to the cytosol. The A subnit refolds to void degradation.
  • The refolded A subunit peptide then interacts with cytosolic ADP ribosylation factors (ARFs) to ribosylate and activate the stimulatory G protein Gsα, which stimulates adenylate cyclase and the resulting cAMP opens the cystic fibrosis transmembrane conductance regulator, CFTR, which releases chloride ions into the lumen.
  • Chloride and sodium absoprtion are also inhibited by cAMP.
  • The resulting accumulation accumulation of chloride, bicarbonate, and sodium within the lumen creates an osmotic driving force that draws water into the lumen and causes massive diarrhoea
663
Q

What are the clinical features of cholera?

A
  • Most individuals exposed are asymptomatic or develop only mild diarrhoea.
  • In those with severe disease there is an abrupt onset of watery diarrhoea and vomiting following an incubation period of 1 to 5 days.
  • The voluminous stools resemble rice water and are sometimes described as having a fishy odor.
  • The rate of diarrhoea may reach 1L per hour, leading to dehydration, hypotension, muscular cramping, anuria, shock, LOC and death.
664
Q

What is the most common bacterial enteric pathogen in developed countries? What do you get it from?

A

Campylobacteri jejuni is an important cause of traveler’s diarrhoea
* Most infections are associated with ingestion of improperly cooked chicken, but outbreaks can also be caused by unpasteurised mild or contaminated water

665
Q

The pathogenesis of Campylobacter infection remains poorly defined, but what are the four major properties that contribute to virulence?

A
  • Motility - flagella allow campylobacter to be motile
  • Adherence - the motility facilitates adherence and colonisation, which are necessary for mucosal invasion.
  • Cytotoxins that cause epithelial damage and a cholera toxin-like enterotoxin are also released by some C.jejuni isolates.
666
Q

With Campylobacter infection, when does dysentry and enteric fever occur?

A
  • Dysentry, i.e. blood diarrhoea, is generally associated with invasion and only occurs with a small minority of Campylobacter strains.
  • Enteric fever occurs when bacteria proliferate within the lamina propria and mesenteric lymph nodes.
667
Q

What are some extra-intestinal complications of Campylobacter?

A
  • Campylobacter infection can result in reactive arthritis, primarily in patients with HLA-B27.
  • Erythema nodosum and Guillain-Barre syndome.
668
Q

What is the morphology of Campylobacter and how is it diagnosed?

A
  • Diagnosis is primarily by stool culture, since biopsy findings are nonspecific, and reveal acute self-limited colitis with features ocmmon to many forms of infectious colitis.
  • Mucosal and intraepithelial neutrophil infiltrates are prominent, particularly within the superficial mucosa; cryptitis (neutrophil infiltration of the crypts) and crypt abscesses may also be present.
  • Importantly, crypt architecture is preserved, although this can be difficult to assess in cases with severe mucosal damage
669
Q

What are the clinical features and inbucation period of campylobacter?

A
  • Incubation period is up to 8 days
  • Watery diarrhoea, either acute of following an influenza-like prodrome, is the primary symptom, but dysentery develops in 15% of adults and more than 50% of children.
  • Patients may shed bacteria for 1 month or more after clinical resolution.
670
Q

What type of bacteria are shigella?

A

Shigella are gram-negative unencapsulated, nonmotile, facultative anaerobes that belong to teh enterobacteriaceae family and are closely related to enteroinvasive E.coli.

671
Q

How is shigella transmitted? What populations are most affected?

A
  • By the faecal-oral route or via contaminated water and food.
  • In the US and Europe, children in daycare, migrant workers, travelers, and those in nursing homes are more commonly affected.
672
Q

What is the pathogenesis of Shigella?

A
  • Shigella are resistant to the harsh acidic environment of the stomach, thereby explaining teh extremely low infective dose
  • Once in the intestine, organisms are taken up by M, or microfold cells. There are epithelial cells, which are specialised for sampling and presentation of luminal antigens.
  • Shigella proliferate intracellularly, escape into the lamina propria, and are phagocytosed by macrophages, in which they induce apoptosis.
  • The ensuing inflammatory response damages surface epithelia and allows shigella within the intestinal lumen to gain access to the basolateral membranes of colonic epithelial cells, which is the preferred domain for invasion.
  • All Shigella species carry virulence plasmids, some of which encode a type III secretion system capable of directly injecting bacterial proteins into the host cytoplasm.
  • Shigella. dysenteriae serotype 1 also release the Shiga toxin Stx, which inhibits eukaryotic protein synthesis, resulting in host cell damage and death.
673
Q

Where in the colon are Shigella infections most prominent and why?

A

In the left colon, but the ileum may also be involved, perhaps reflecting the abundance of M cells in the dome epithelium over the Peyer patches.

674
Q

What is the histology of Shigella?

A

The mucose is haemorrhagic and ulcerated, and pseudomembranes may be present
* The histology of early cases is similar to other acute self-limiting colitides, such as Campylobacter, but because of the tropism for M cells, apthous-appearing ulcers similar to those seen in Crohn disease may occur

675
Q

What are the clinical features of Shigella, including the incubation period?

A
  • After an incubation period of up to 1 week, Shigella causes self-limiting disease characterised by about 1 week fo diarrhoea, fever and abdominal pain
  • The initially watery diarrhoea progresses to a dysenteric phase in approx 50% of patients, and constitutional symptoms can persist for as long as 1 month.
  • The subacute presentation that develops in a minority of patients is characterised by several weeks of waxing and waning diarrhoea that can mimic new-onset ulcerative colitis.
676
Q

What are the extra-intestinal complications of shigella?

A
  • They are uncommon and include a triad of sterilr reactive arthritis, urethritis and conjunctivitis that preferentially affects HLA-B27 positive men between 20 and 40 years of age.
  • Haemolytic-uraemic syndrome, may also occur after infection with serotype 1 infection that secretes Shiga toxin.
  • Toxic megacolon and intestinal obstruction are uncommon complications
677
Q

How do antibiotics affect Shigella and Campylobacter?

A
  • No effect in Campylobacter
  • Shortens the clinical course and reduces the duration of organism shedding in stools in Shigella
678
Q

What type of bacteria is Salmonella? How are they divided

A

Salmonella, which are classified within then Entero-bacteriaceae family of gram-negative bacilli, are divided into Salmonella typhi, the causative agent of typhoid fever and the nontyphoid Salmonella, of which S.enteritidis is the most common.

679
Q

What causes Salmonella?

A

Ingestion of contaminated food, particularly raw or udnercooked meat, poutlry, eggs, and milk.
Centralised food processing can lead to large outbreaks

680
Q

Can you get a vaccine for Salmonella?

A

Yes, and so can farm animals e.g. egg-laying hens

681
Q

What increases your risk of Salmonella?

A

Very few viable Salmonella are necessary to cause infection, and the absence of gastric acid, in individuals with atrophic gastritis or those on acid-suppressive therapy, further reduces the required inoculum.

682
Q

What is the pathogenesis of Salmonella?

A
  • Salmonella possess virulence genes that encode a type III secretion system capable of transferring bacterial proteins into M cells and enterocytes.
  • The transferred proteins activate host Rho GTPases, thereby triggering actin rearrangement and bacterial endocytosis which, in turn, allows bacterial growth within endosomes.
  • In addition, flagellin, the core protein of bacterial flagellae, activates TLR5 on host cells and icnreases the local inflammatory response.
  • Similarly, bacterial lipopolysaccharide activates TLR4, although some Salmonella strains express a virulence factor that prevents TLR4 activation.
  • Salmonella also secrete a molecule that induces epithelial cell release of the eicosanoid hepoxilin A3, thereby drawing neutrophils into the intestinal lumen and potentiaing mucosal damage
683
Q

What are the clinical features on Salmonella?

A
  • They are clinically indistinguishable from other enteric pathogens, and symptoms range from loose stools to cholera-like profuse diarrhoea to dysentery.
  • Fever often resolves within 2 days, but diarrhoea can persist for a week and organisms can be shed in the stool for several weeks after resolution.
684
Q

Are antibiotics recommended in Salmonella?

A

Antibiotics therapy is not recommended in uncomplicated cases because it can prolong the carrier state or even cause relapse and does not typically shorten the duration of diarrhoea.
Most salmonella infections are self-limited, but deaths do occur.

685
Q

What bacteria causes typhoid fever?

A
  • It is caused by Salmonella enterica and its two subtypes, typhi and paratyphi.
  • The majority of cases in endemic countries are due to S.typhi, while infection by S.paratyphi is more common among travelers, perhaps because travelers tend to be vaccinated against S.typhi.
686
Q

What countries are associated with typhoid?

A

India, Mexico, the Philippins, Pakistan, El Salvador, and Haiti.

687
Q

How is S.typhi and S.paratyphi transmitted?

A

Humans are the sole reservoir for S.typhi and S. paratyphi and transmission occurs from person to person or via food or contaminated water.

688
Q

What is the pathogenesis of S.typhi?

A
  • S.typhi are able to survive in gastric acid and, once in the small intestine, they are taken up by and invade M cells.
  • Bacteria are then engulfed by mononuclear cells in the underlying lymphoid tissue.
  • Unlike S.enteritidis, S.typhi can then disseminate via lymphatic and blood vessels.
  • This causes reactive hyperplasia of phagocytes and lymphoid tissues throughout the body.
689
Q

What is the morphology of typhoid fever?

A
  • Infection causes Peyer patches in the terminal ileum to enlarge into sharp, delineated, plateau-like elevations up to 8cm in diameter.
  • Draining mesenteric lymph noces are also enlarged.
  • Neutrophils accumulate within the superficial lamina propria, and macrophages containing bacteria, red cells, and nuclear debris mix with lymphocytes and plasma cells in the lamina propria.
  • Mucosal damage creates oval ulcers, oriented along the axis of the ileum, that may perforate.
  • The draining lymph nodes also harbor organisms and are enlarged due to phagocyte accumulation
690
Q

How does typhoid affect the liver and spleen morphologically?

A
  • The spleen is enlarged and soft, with uniformly pale red pulp, obliterated follicular markings, and prominent phagocyte hyperplasia.
  • The liver shows small, randomly scattered foci of parenchmal necrosis in which hepatocytes are replaced by macrophage aggregates, called typhoid nodules; such nodules may also develop in the bone marrow and lymph nodes.
691
Q

What are the clinical features of typhoid?

A
  • Patients experience anorexia, abdominal pain, bloating, nausea, vomiting, and blood diarrhoea followed by a short asymptomatic phase that gives way to bacteraemia and fever with flu-like symptoms.
  • Patients have sustained high fevers and abdominal tenderness, that may mimic appendicitis
  • Rose spots, small erythematous maculopapular lesions, are seen on the chest and abdomen.
  • Symptoms abate after several weeks, although relapse can occur
692
Q

Do antibiotics help with typhoid?

A
  • Blood cultures are positive in more than 90% of affected individuals during the febrile phase.
  • Antibiotic treatment can prevent further disease progression.
  • In patients who do not receive antibiotics, the initial febrile phase continues for up to 2 weeks.
693
Q

What is AIDS?

A

Acquired immunodeficiency syndrome is a disease causes by the retrovirus human immunodeficiency virus (HIV) and characterised by profound immunosuppression that leads to opportunistic infections, secondary neoplasms, and neurologic manifestations.

694
Q

Epidemiological studies in the US have identified five groups of adults at high risk for developing AIDS. What are they?

A
  • Homosexual or bisexual men constitute the largest group, accounting for more than 50% of the reported cases.
  • IVDUs with no previous history of homosexuality are the next largest group, representing about 20% of infected indiviuals
  • Haemophiliacs, especially those who receive large amounts of factor VIII or factor IX concentrated before 1985
  • Recepients of blood and blood components who are not haemophiliacs but who received transufusions of HIV-infected whole blood or components account for 1% of patients
  • Heterosexual contacts of members of other high-risk groups (chiefly IVDUs), globally heterosexual transmission is most common mode by which HIV is spread - mainly female partners of male IVDUs.
695
Q

The transmission of HIV occus under conditions that facilitate exchange of blood or bodily fluids containing the virus or virus-infected cells. What are the three major routes and tell me a bit about them?

A
  • Sexual transmission is clearly the dominant mode of infection worldwide, accounting for >75% of cases. Viral tramission occurs in two ways 1) direct inoculation into the blood vessels breached by trauma and 2) infection of dendritic cells or CD4+ cells within the mucosa.
  • Parenteral transmission occurs by sharing of needles and syringes with HIV-containing blood.
  • Mother-to-infant transmission is the major cause of paediatric AIDS. It can occur by three routes: 1) in utero by transplacental spread. 2) during delivery through an infected birth canal, and 3) after birth by ingestion of breast milk. Transmission during birth and in the immediate period after is the most common.
696
Q

How do STIs affect HIV transmission? Why?

A

Sexual transmission of HIV is enhanced by coexisting STDs, especially those associated with genital ulceration - syphillips, herpes. Other STDs are also co-factors for transmission, perhaps because in these genital inflammatory states there is a greater concentration of the virus and virus-containing cells in genital fluids, as a result of increased numbers of inflammatory cells in the semen

697
Q

Transmission of HIV by transfusion of blood of blood products has been virtually eliminated by three public health measures. What are they?

A

1) Screening of donated blood and plasma for antibody to HIV
2) Stringent purity criteria for factor VIII and factor IX preperations
3) Screening of donors on the basis of history

698
Q

What type of virus is HIV?

A

A non-transforming human retrovirus belonging to the lentivirus family.

699
Q

What is the structure of HIV?

A
  • The HIV-1 virion is spherical and contains an electron-dense, cone-shaped core surrounded by a lipid envelope derived from the host cell membrane
  • The virus core contains 1) the major capsid protein 24; 2) nucleocapsid protein p7/p9; 3) two copies of viral genomic RNA; and 4) the three viral enzymes (protease, reverse transcriptase, and integrase).
  • The viral core is surrounded by a matrix protein called p17, which lies underneath the virion envelope.
  • Studding the viral envelope are two viral glycoproteins, gp120 and gp41, which are critical for HIV infection of cells.
700
Q

What does the HIV-1 RNA genoma contain?

A
  • The gag, pol and env genes, which are typical of retroviruses.
  • The products of the gag and pol genes are large precursor proteins that are cleaved by the viral protease to yield the mature proteins.
  • HIV contains several other accessory genes, including tat, rev, vif, nef, vpr and vpu, which regulate the synthesis and assembly of infectious viral particles and the pathogenicity of the virus
701
Q

Two genetically different but related forms of HIV have been isolated from patients with AIDS. What are these and where are they most common?

A
  • HIV-1 is the most common type associated with AIDS in the US, Europe and Central Africa
  • HIV-2 causes a similar disease principalle in West Africa and India
702
Q

HIV-1 can be divided into three subgroups. What are they? Tell me more about the most common one

A
  • Group M (major) viruses are the most common worldwide, and they are further divided into several subtypes designated A through K. Subtype B is the most common in Western Europe and the US.
  • Group O (outlier)
  • Group N (neither M nor O)
703
Q

What is the broad pathogenesis of HIV and AIDs?

A
  • The two major targets of HIV infection are the immune system and the CNS.
  • Profound immune deficiency results chiefly from infection and subsequent loss of CD4+ T cells as well as the impairment in the function of surviving helper T cells. Macrophages and dendritic cells are also targets of HIV infection.
  • HIV enters thebody through mucosal tissues and blood and first infects T cells as well as dendritic cells and macrophages
  • The infection becomes established in lymphoid tissues, where the virus may remain latent for long periods.
  • Active viral replication is associated with more infection of cells and profression to AIDS.
704
Q

What does the life cycle of HIV consist of?

A

Infection of cells, integration of the provirus into the host cell genome, activation of viral replication, and production and release of infectious virus.

705
Q

How does the infection of cells by HIV occur?

A
  • HIV infects cells by using the CD4 molecule as a receptor and various chemokine receptors as corectpors.
  • The initial step of infection is the binding of gp120 envelope glycoprotein to CD4 molecules, which leads to a conformation change that results in the formation of a new recognition site on gp120 for the coreceptors CCR5 and CXCR4.
  • The conformational changes in gp41 result in the exposure of a hydrophobic region called the fusion peptide at the tip of gp41.
  • This peptide inserts into the cells membrane of the target cells, leading to fusion of the virus with the host cell.
  • After fusion, the virus core containing the HIV genome enters the cytoplasm of the cell
706
Q

How do chemokines effect HIV infection of cells in culture?

A

They sterically hinder it by occupying their receptors, and therefore, the level of chemokines in the tissues may influence the efficiency of viral infection in vivo

707
Q

Once HIV is internalised into the cells, the RNA genome of the virus undergoes reverse trascription, leading to the synthesis of double-stranded complementary DNA (cDNA; proviral DNA). What are the options of what can happen next?

A
  • In quiescent T cells, HIV cDNA may remain in the cytoplasm in a linear episomal form.
  • In dividing T cells, the cDNA circularises, enters the nucleus, and is then integrated into the host genome.
  • After this integration, the provirus may be silent for months of years, a form a latent infection.
  • Alternatively, proviral DNA may be transcribed, with the formation of complete viral particles that bud from the cell membrane. Such productive infection, when associated with extensive viral budding, leads to death of infected cells.
708
Q

What type of T cells does HIV infect?

A

HIV infects memory and activated T cells but is ineffecient at productively infecting naive (unactivatived T cells).

709
Q

Why can HIV not productively infect naive T cells? How does this change in activated T cells?

A
  • Naive T cells contain an active form of an enzyme that introduces mutations in the HIV genome.
  • This enzyme is called APOBEC3G. It is a cytidine deaminase that introduces cytosine-to-uracil mutations in the viral DNA that is produced by reverse transcription.
  • These mutations inhiti further DNA replication.
  • Activation of T cells converts cellular APOBEC3G into an inative, high-molecular-mass complex, which explains why the virus can replicate in previously activated (memory) T cells and T-cell lines.
710
Q

How is HIV linked to NF-κB?

A
  • Activation of T cells upregulates several transcription factors, including NF-κB, which stimulate transcription of genes encoding cytokines such as IL-1
  • The long-terminal-repeat sequences that flank the HIV genome also contain NF-κB-binding sites that can be triggered by the same transcription factors.
  • Induction of NF-κB-in latently infected CD4+ cells activates the transcription of HIV proviral DNA and leads ultimately to the production of virions and to cell lysis.
  • It seems that HIV thrives when the host T cells and macrophages are physiologically activates, an act that can best be described as ‘subversion from within’
711
Q

How does infection effect HIV infection?

A
  • HIV-infected people are at increased risk for recurrent exposure to other infections, which lead to increased lymphocyte activation and production of proinflammatory cytokines.
  • These, in turn, stimulate more HIV production, loss of additional CD4+ T cells, and more infection.
  • A vicious cycle may be set up that cluminates in inexorable destruction of the immune system.
712
Q

What is the main mechanism of T-cell depletion in HIV infection?

A
  • Loss of CD4+ T cells is mainly because of infection of the cells and direct cytopathic effects of the replicating virus.
  • Many infected cells may be in mucosal and other peripheral lymphoid organs and death of these cells is a major cause of the relentless, and eventually profound, cell loss
713
Q

In addition to firect killing of cells by the virus, other mechanisms may contribute to the loss of T cells. What are they?

A
  • Chronic activation of uninfected cells, responding to HIV itself or to infections that are common in individuals with AIDS, leads to apoptosis of these cells by the process of activation-induced cell death.
  • Non-cytopathic (abortive) HIV infection activates the inflammasome pathway and leads to a form of cell death called pyroptosis - inflammatory cytokines and cellular contents are released.
  • HIV infects cells in lymphoid organs (spleen, lymph nodes and tonsils) and may cause progressive destruction of the architecture and cellular composition of lymphoid tissues.
  • Loss of immature precursors of CD4+ T cells, either by direct infection of thymus progenitor cells or by infection of accessory cells that secrete cytokines.
  • Fusion of infected and uninfected cells with formation of giant cells
  • Defects in Th1-type responses relative to the Th2 type, defects in intracellular signaling.
  • Selective loss of memory CD4+ helper T cells.
714
Q

In addition to infection and loss of CD4+ T cells, infection of macrophages and dendritic cells is also important in the pathogenesis of HIV infection. What are some aspects of HIV infection of macrophages?

A
  • HIV-1 can infect and multiply in terminally differentiated nondividing macrophages. THe Vpr protein allows nuclear targeting of the HIV preintegration complex through the nuclear pore.
  • Infected macrophages bud relatively small amounts of virus from the cell surface, but these cells contain large numbers of virus particles often located in intracellular vacuoles.
  • Macrophages are quire resistant to the cytopathic effects of HIV, so in late stages, when CD4+ T cell numbers are low, macrophages are an important site of continued viral replication.
  • They have functional defects such as impaired microbicidal activity, decreased chemotaxis, decreased secretion of IL-1, inappropriate secretion of TNF, and poor capacity to present antigens.
715
Q

In addition to macrophages, two types of dendritic cells are also important targets for the initiation and maintenance of HIV infection. What are they and what do they do?

A
  • Mucosal dendritic cells are infected by the virus and may transport it to regional lymph nodes, where the virus is transmitted to CD4+ T cells
  • Dentritic cells also express a lectin-like receptor that specifically binds HIV and displays it in an intact, infectious form to T cells, thus promoting infection of T cells.
  • Follicular dendritic cells in the germinal centers of lymph nodes are potential reservoirs of HIV.They have receptors for the Fc portion of immunoglobulins and hence they trap HIV virions coated with anti-HIV antibodies. These virions retain their ability to infect CD4+ T cells as they traverse the intricate meshwork formed by the dendritic processes of the follicular dendritic cells.
716
Q

How is the function of B cells affected by HIV infection?

A
  • There is polyclonal activation of B cells, resulting in germinal center B-cell hyperplasia, bone marrow plasmacytosis, hypergammaglobulinaemia, and formation of circulating immune complexes.
  • This activation may result from: reactivation of or reinfection with CMV and/or EBV, both of which are polyclonal B-cell activators; gp41 itself can promote B-cells growth and differentiation; HIV-infected macorphages produce increased amounts of IL-6, which stimulates proliferation of B cells.
717
Q

What is the pathogenesis of CNS involvement in HIV infection?

A
  • Macrophages and microglia are the predominant cell types in the brain that are infected with HIV
  • The neurological deficit is likely caused indirectly by viral products and by soluble factors produced by infected microglia, e.g. IL-1, TNF and IL-6
718
Q

What is the natural history of HIV infection?

A
  • Virus typically enters through mucosal epithelia
  • An acute retroviral syndrome
  • A middle, chronic phase, in which most individuals are asymptomatic
  • Clinical AIDS
719
Q

What happens during the acute infection of HIV?

A
  • Acute infection is characterised by infection of memory CD4+ T cells (which express CCR5) in mucosal lymphoid tissues, and death of many infected cells.
  • Mucosal infection is often associated with damage to the epithelium, defects in mucosal barrier functions, and translocation of microbes across the epithelium.
720
Q

Mucosal infection is followed by dissemination of the virus and the development of host immune responses. How does this happen?

A
  • Dendritic cells in epithelia at sites of virus entry capture the virus and then migrate into the lymph nodes.
  • Once in lymphoid tissue, dentritic cells may pass HIV on to CD4+ T cells through direct cell-t-cell contact.
  • Within days after the first exposure to HIV, viral replication can be detected in the lymph nodes
  • This replication leads to viremia. The virus disseminates throughout the body and infects helper T cells, macrophages, and dendritic cells in peripheral lymphoid tissues.
  • As the infection. spreads, the individual mounts antiviral humoral and cell-mediated immune responses evidenced by seroconversion and by the development of virus-specific CD8+ cytotoxic T cells.
721
Q

What immune responses to HIV infection occur at what time?

A
  • A cytotoxic T lymphocyte response to HIV is detectable by 2-3 weeks after the initial ifnection, and it peaks by 9-12 weeks.
  • Marked expansion of virus-specific CD8+ T cell clones occurs during this time, and up to 1-% of patients CTLs may be specific at 12 weeks.
  • The humoral immune response to HIV peaks at about 12 weeks.
722
Q

What is the acute retroviral syndrome in HIV infection?

A
  • It is the clinical presentation of the initial spread of the virus and the host response.
  • 40-90% if individuals who acquire a primary infection develop this syndrome
  • It typically occurs 3-6 weeks after infection, and resolves spontaneously in 2-4 weeks.
  • Clinically, this phase is associated with a self-limited acute illness with nonspecific symptoms, including sore throat, myalgias, fever, weight loss and fatigue, resembling a flulike syndrome.
723
Q

What does the viral set point in HIV mean and what does it predict?

A
  • The viral load at the end of the acute phase reflects the equilibrium reached between the virus and the host response, and in a given patient it may remain fairly stable for several years.
  • The level, called the viral set point, is a predictor of the rate of decline of CD4+ T cells, and, therefore, profression of HIV disease.
724
Q

Because the loss of HIV immune containment is associated with declining CD4+ T cell counts, the CDC classification of HIV infection stratifies three categories on the basis of CD4+ cell counts. What are they and what levels are there?

A
725
Q

What happens during the chronic phase of HIV?

A
  • Lymph nodes and the spleen are sites of continuous HIV replication and cell destruction
  • During this period, few or no clinical manifestations of the HIV infection are present.
  • Although the majority of peripheral blood T cells do not harbor the virus, destruction of CD4+ T cells within lymphoid tissues continues and the numer of circulating blood CD4+ T cells steadily declines.
  • Host defenses begin to wane, and the proportion of the surviving CD4+ cells infected with HIV increases, as does the viral burden per CD4+ cell.
726
Q

The final phase of HIV infection is AIDS. What is this characterised by?

A
  • A breakdown of host defence, a dramatic increase in plasma virus, and severe, life-threatening clinical disease.
  • Long-lasting fever (>1 month), fatigue, weight loss and diarrhoea.
  • After a variable period, serious opportunistic infections, secondary neoplasms, or clinical neurologic disease emerge, and the patient is said to have developed AIDS.
727
Q

In the absence of treatment, most patients with HIV infection progress to AIDS after how long?

A
  • After a chronic phase lasting 7-10 years
  • Exceptions to this typical course are exemplified by rapid progressors and long-tern nonprogressors
  • In rapid progressors the midd,e chronic phase in telescoped to 2-3 years after primary infection.
  • About 5-15% of infected individuals are long-term nonprogressors, defined as untreated HIV-1-infected individuals who remain asymptomatic for 10 years or more, with stable CD4+ T-cell counts and low levels of plasma viremia.
728
Q

What are the clinical features of AIDS?

A
  • They range from a mild acte illness ro severe disease.
  • In the US, the typical adult patient presents with fever, weight loss, diarrhoea, generalised lymphadenopathy, multiple opportunistic infections, neurologic disease, and , in many cases, secondary neoplasms
729
Q

What are the AIDS-defining opportunistic infections?

A

Protozoal and Helminthic infections
Cryptosporidiosis or isosporidiosis (enteritis)
Pneumocystis jireoveci (pneumonia or disseminated infection)
Toxoplasmosis (pneumonia or CNS infection)
Fungal infections
Candidiasis (oesophageal, tracheal, or pulmonary)
Cryptococcosis (CNS infection)
Coccidiodomycosis (disseminated)
Histoplasmosis (disseminated)
Bacterial infections
Mycobacteriosis tuberculosis and mycobacterium avium-intracellulare
Nocardiosis (pneumonia, meningitis, disseminated)
Salmonella infections, disseminated
Viral infections
CMV (pulmonary, intestinal, retinitis, or CNS infections)
HSV (localised or disseminated infection)
VZV (localised or disseminated infection)
Progressive multifocal leukoencephalopathy

730
Q

What are some AIDS-defining neoplasms?

A

Kaposi sarcoma
Primary lymphoma of brain
Invasive cancer of uterine cervix - likely secondary to HPV

731
Q

What is Kaposi sarcoma?

A
  • A vascular tumour
  • The lesions of KS are characterised by the proliferation of spindle-shaped cells that express markers of both endothelial cells (vascular or lymphatic) and smooth muscle cells.
  • The tumour is usually widespread in AIDS, affecting the skin, mucous membranes, GI tract, lymph nodes and lungs.
  • There is also a profusion of slitlike vascular spaces, suggesting that the lesions may arise from primitive mesenchymal precursors of vascular channels.
  • In addition, KS lesions display chronic inflammatory cell infiltrates.
732
Q

What is the pathogenesis of KS?

A
  • The spindle cells produce proinflammatory and angiogenic factors, which recruit the inflammatory and neovascular components of the lesion, and the latter components supply signals that aid in spindle cell survival and growth
733
Q

What causes Kaposi sarcoma? How?

A
  • It is caused by the KS herpesvirus, also called human herpesvirus 8 (HHV8).
  • HHV8 establishes latent infection, during which several proteins are produced with potential roles in stimulating spindle cell proliferation and preventing apoptosis. These include a viral homologue of cyclin D and several inhibitors of p53
734
Q

Why lymphoma is linked with Kaposi Sarcoma? why?

A
  • KSHV infection is not restricted to endothelial cells.
  • This virus is related phylogenetically to the lymphotropic subfamily of herpesvirus (γ-herpesvirus). Its genome is found in B cells of infected subjects
  • It is linked to rare B-cell lymphomas in AIDS patients (primary effusion lymphoma) and to multicentric Castleman disease, a B-cell lymphoproliferative disorder
735
Q

What percentage of people with AIDS develop lymphoma?

A

Roughly 5% present with lymphoma, and approx another 5% develop lymphoma

736
Q

What are the mechanisms of lymphoma development in AIDS?

A
  • Unchecked proliferation of B cells infected with oncogenic herpesvirus in the setting of profound T cell depletion (AIDS). T cell immunity is required to restrain the proliferation of B cells infected with oncogenic viruses such as VBD and KSHV. AIDS patients are at high risk of developing aggressive B cell lymphomas composed of tumour cells infected by oncogenic viruses, particularly EBV.
  • Germinal center B-cell hyperplasia in the setting of early HIV infection. In germinal centers, B cells diversify their immunoglobulin genes via lesions introduced into their DNA by the enzyme activation-induced deaminase (AID). AID can cause mutations in oncogenes implcated in B-cell lymphomagenesis.
737
Q

How does EBV in HIV cause lymphomas?

A
  • Once EBV immunity is established, it persists as a latent infection in memory B cells.
  • Activation of such cells, by antigen or by cytokines, reawakens an EBV-encoded program of gene expression that drives B-cell proliferation.
  • Patients with AIDS have high levels of several cytokines, some of which, including IL-6 are growth factors for B cells.
  • In the absence of T-cell immunit, these activated, EBV infected clones proliferate and eventually acquire additional somatic mutations, leading to their outgrowth as full-blown EBV positive B-cell lymphomas.
738
Q

Apart from B-cell lymphoma, what are some other EBV-related proliferations that are common in AIDS?

A
  • Hodgkin lymphoma - all instances of HIV-associated Hodgkin lymphoma, the characteristic tumour cells (Reed-Sternberg cell) are infected with EBV.
  • Oral hair leukoplakia (white projections on the tongue), which results from EBV-driven sqaumour cell proliferation of the oral mucosa.
739
Q

What are some CNS diseases in AIDS?

A
  • Self-limited meningo-encephalitis occuring at the time of seroconversion
  • Aseptic meningitis
  • Vaculoar myelpathy
  • Peripheral neuropathies
  • Most commonly, a progressive encephalopathy
740
Q

In very broad terms, what do the antiretroviral drugs do for HIV?

A
  • They target the viral reverse transcriptase, protease, and integrase.
  • They are given in combination to reduce the emergence of mutants that develop resistance to any one
  • Treatment regimens are commonly called highly active antiretroviral therapy (HAART) or combination antiretrovoral therapy.
741
Q

What is the immune reconstitution inflammatory syndrome that may occur with antiretrovirals? Why does it happen?

A
  • Some patients with advanced disease who are given antiretroviral therapy develop a paradoxical clinical deterioration during the period of recovery of the immune system. This occurs despite increasing CD4+ T cell counts and decreasing viral load.
  • It is postulated to be a poorly regulated host response to the high antigenic burden of persistent microbes.
742
Q

What are the adverse effects of HAART?

A
  • Lipoatrophy (loss of facial fat)
  • Lipoaccumulation (excess fat deposition centrally)
  • Elevated lipids
  • Insulin resistance
  • Peripheral neuropathy
  • Premature cardiovascular kidney and liver disease
743
Q

What is the morphology of early stage HIV infected lymph nodes?

A
  • A marked hyperplasia of B cell follicles. The follicles are enlarged and often take on unusual, serpiginous shapes
  • The mantle zones that surroun the follicles are attenuated, and teh germinal centers impinge on interfollicular T cell areas.
  • This hyperplasia of B cells is the morphologic reflection of the polyclonal C-cell activation and hypergammaglobulinaemia seen in HIV-infected individuals.
744
Q

How does the morphology of lymph nodes change throughout HIV infection?

A
  • With disease progression, the frenzy of B-cell proliferation subsides and gives way to a pattern of severe lymphoid involution.
  • The lymph nodes are depleted of lymphocytes, and the organised network of follicular dendritic cells is disrupted. The germinal centers may even become hyalinised.
  • These ‘burn-out’ lymph nodes are atrophic and small and may harbor numerous opportunistic pathogens, often with macrophages.
745
Q

What are some modifiable and non-modifiable risk factors for atherosclerosis?

A

NON-MODIFIABLE
* Genetics - familial hypercholesterolaemia, diabetes risk
* Age - between ages 40-60, the incidence of MI increases five-fold. Death rates from IHD rise with each decade
* Gender - very low risk in premenopausal women. After menopause however, the incidence increases in women and at older ages actually exceeds that of men

MODIFIABLE
* Hyperlipidaemia - specificially LDL levels
* HTN - both systolic and diastolic levels - chronic HTN is the most common cause of LV hypertrophy
* Smoking
* Diabetes mellitus induces hypercholesterolemaeia and markedly increases the risk of atherosclerosis

746
Q

What are some additional risk factors for atherosclerosis?

A
  • Inflammation is present during all stages of atherogenesis and is intimately linked with atherosclerotic plaque formation and rupture. CRP correlates with IHD risk.
  • Hyperhomocystinemia is associated with premature vascular disease. Although low folate and vit G12 levels can ingrease homocystiene, supplements don’t affect the CVD risk
  • Metabolic syndrome associated with central obesity, is characterised by insulin resistance, HTN, dyslipidaemia, hypercoagulability, and a proinflammatory state
  • Lipoprotein a is an altered form of LDL and is associated with coronary and cerebrovascular disease risk, independent of total cholesterol or LDL levels.
  • Factors affecting hemostasis (plasminogen activator inhibitor 1, thrombin)
747
Q

What is CRP? How does it work?

A

CRP is an acute phase reactant synthesisted primarily by the liver.
Its expression is increased by a number of inflammatory mediators, particularly IL-6, and it augmetns the innate immune response by binding to bacteria and activating the classical complement cascade.

748
Q

What is the pathogenesis pathway of atherosclerosis?

A
  • Endothelial injury and dysfunction, causing increased vascular permeability, leukocyte adhesion and thrombosis
  • Accumulation of lipoproteins (mainly LDL and its oxidised forms) in the vessel wall
  • Monocyte adhesion to the endothelium, followed by migration into the intima and transformation into macrophages and foam cells
  • Platelet adhesion
  • Factor release from activated platelets, macrophages and vascular wall cells, inducing smooth muscle cell recruitment, either from the media or from circulating precursors
  • Smooth muscle cell proliferation, extrcellular matrix production and recruitment of T cells
  • Lipid accumulation both extracellularly and within cells (macrophages and smooth muscle cells)
749
Q

How does endothelial injury precipitate atherosclerosis?

A
  • Early human lesions begin at sites of morphologically intact endothelium. Thus, endothelial dysfunction underlies most atherosclerosis.
  • The intact but dysfunctional endothelial cells exhibit increased endothelial permeability, enhanced leukocyte adhesion, and altered gene expression.
750
Q

Endothelial injury can be caused by toxins from cigarette smoke, infectious agent and inflammatory cytokines. But what are the two most important causes of endothelial dysfunction?

A
  • Haemodynamic disturbances such as stasis or flow turbulence
  • Hypercholesterolaemia
751
Q

What are the different types of hypercholesterolaemia?

A
  • Lipids are transported in the bloodstream bound to specific apoproteins (forming lipoprotein complexes)
  • Dyslipoproteinemias include 1) increased LDL cholesterol levels, 2) decreased HDL cholesterol levels, and 3) increased levels of the abnormal lipoprotein (a)
  • Familial hypercholesterolaemia, caused by defective LDL receptors and inadequate hepatic LDL uptake, can precipitate MIs before age 20.
752
Q

What are the mechanisms by which hyperlipidaemia contributes to atherogenesis?

A
  • Chronic hyperlipidaemia can directly impair endothelial cell function by increasing local reactive oxygen species production; besides causing membrane and mitochondrial damage, oxygen free radicals accelerate nitric oxide decay, dampening its vasodilator activity.
  • Lipoproteins accumualte within the intima, where they may aggregate or become oxidised by free radicals produced by inflammatory cells. Such modified LFL is then accumulated by macrophages. Because the modified lipoproteins cannot be completely degraded, chronic ingestion leads to the formation of lipid-filled macrophages ‘foam cells; smooth muscle cells can similarly transform into lipid-laden foam cells by ingesting modified lipids through LDL-receptor related proteins.
  • Not only are the modified lipoproteins toxic to endothelial cells, smooth muscle cells, and macrophages, but their binding and uptake also stimulates the release of growth factors, cytokines, and chemokines that create a vicious cycle of monocyte recruitment and activation
753
Q

How does inflammation cause atherosclerosis?

A
  • It causes endothelial damage (you know how).
  • Activated macrophages produce ROS that enhance LDL oxidation, and elaborate growth factors that drive smooth muscle cell proliferation.
  • Activated T cells in the growing intimal lesions elaborate inflammatory cytokines, e.g. interferon-γ, which , in turn, can activate macrophages as well as endothelial cells and smooth muscle cells
  • These leukocytes and vascular wall cells release growth factors that promote smooth muscle cell prolfieration and syntehsis of extracellular matrix proteins. Thus, many of the lesions of atherosclerosis are atrributable to the chronic inflammatory reaction in the vessel wall.
754
Q

How does smooth muscle proliferation and matrix synthesis take place in atherosclerosis?

A
  • Intimal smooth muscle cell proliferation and extracellular matrix deposition convert a fatty streak into a mature atheroma and contribute to the progressive growth of atherosclerotic lesions.
  • Intimal smooth muscle cells have a proliferative and synthetic phenotype distinct from the underlying medial smooth muscle cells.
  • Several growth factors are implicated in smooth muscle cell proliferation, including platelet-derived growth factor (PDGF), FGF and TGF-α. These factors also stimulate smooth muscle cells to syntehsis extracellular matrix (notably collagen), which stabilised atherosclerotic plaques.
  • In contract, activated inflammatory cells in atheromas may increase breakdown of extracellular matrix components, resulting in unstabel plaques
755
Q

What are atheromas?

A

They are dynamic lesions consisting of dysfunctional endothelial cells, proliferating smooth muscle cells, and admixed T lymphocytes and macrophages.

756
Q

How does the make-up of atheromas change over time?

A
  • At early stages, intimal plaques are little more than aggregates of smooth muscle cells, macrophages, and foam cells; death of these cells releases lipids and necrotic debris
  • With progression, the atheroma is modified by extracellular matrix synthesised by smooth muscle cells; connective tissue is particularly prominent on the intimal aspect forming a fibrous cap, although lesions typically retain a central core of lipid-laden cells and fatty debris that can become calcified.
757
Q

What is the outcome of an atheroma?

A

The intimal plaque may progressively encroach on the vessel lumen, or may compress the underlying media, leading to its degeneration this in turn may expose thrombogenic factors, resulting in thrombus formation and acute vascular occlusion

758
Q

What are fatty streaks in atherosclerosis?

A
  • Fatty streaks are composed of lipid-filled foamy macrophages.
  • Beginning as multiple minute flat yellow spots, they eventially coalesce into elongated streaks 1cm long or longer
  • These lesions are no sufficiently raised to cause significant flow disturbances.
  • Although fatty streaks can evolve into plaques, not all are destined to become advanced lesions
759
Q

What are the key processes in atherosclerosis?

A

Intimal thickening and lipid accumulation, which together form plaques

760
Q

How do atherosclerotic plaques and lesions present morphologically?

A
  • Atheromatous plaques are white-yellow and encroach on the lumen of the artery; superimposed thrombu over ulcerated plaques is red-brown.
  • Atherosclerotic lesions are patchy, usually involving only a portion of any given arterial wall adn are rarely circumferential; on cross-section, the lesions therefore appear “eccentric”. The focality of atherosclerotic lesions is attributable to the vagaries of vascular haemodynamics.
761
Q

What are the most common vessels prone to atherosclerosis?

A

The most extensively involved vessels are the lower abdominal aorta, the coronary arteries, the popliteal arteries, the internal carotid arteries, and the vessels of the circle of Willis.

762
Q

Atherosclerotic plaques have three principal components. What are they?

A

1) Smooth muscle cells, macrophages and T cells
2) Extracellular matrix, including collagen, elastic fibers, and proteoglycans
3) Intracellular and extracellular lipids

763
Q

How are the components of an atherosclerotic plaque lay out?

A
  • Typically, there is a superficial fibrous cap composed of smooth muscle cells and relatively dense collagen
  • Beneath and to the side of the cap (the “shoulder”) is a more cellular area containing macrophages, T cells, and smooth muscle cells.
  • Deep to the fibrous cap is a necrotic core, containing lipid (primarily cholesterol and cholesterol esters), debris from dead cells, foam cells (lipid-laden macrophages and smooth muscle cells), fibrin, variably organised thrombus, and other plasma proteins; the cholesterol content is frequently present as crystalline aggregates that are washed out during routine tissue processin and leave behind only empty “clefts”.
764
Q

Atherosclerotic plaques generally continue to change and progress over time, what are the processes that allow this?

A

Through cell death and degradation, synthesis and degradation (remodeling) of ECM, and organisation of any superoimproved thrombus.
Moreover, atheromas often undergo calcification.

765
Q

Atherosclerotic plaques are susceptible to which clinically important pathologic changes?

A
  • Rupture, ulceration, or erosion of the surface of atheromatous plaques exposes highly thrombogenic substances and leads to thrombosis, which may partially or completely occlude the vessel lumen.
  • Haemorrhage into a plaque - rupture of the overlying fibrous cap, or of the thin-walled vessels in the areas of neovascularisation, can cause intraplaque haemorrhage; a contained haemtoma may expand the plaque or induce plaque rupture
  • Atheroembolism - plaque rupture can discharge atherosclerotic debris into the blood stream, producing microemboli
  • Aneurysm formation - atherosclerosis-induced pressure or ischaemic atrophy of the underlying media, with loss of elastic tissue, causes weakness and potential rupture
766
Q

What is atherosclerotic stenosis?

A
  • In small arteries, the atherosclerotic plaques can gradually occlude vessel lumina, compromising blood flow and causing ischaemic injury.
  • At early stages of stenosis, outward remodeling of the vessel media tends to preserve the size of the lumen. However, there are limits of the extent of remodeling, and eventually the expanding atheroma impinges on the lumen to such a dgeree that blood flow is compromised.
767
Q

What is critical atherosclerotic stenosis?

A
  • The stage at which the occlusion is sufficiently severe to produce tissue ischaemia.
  • In the coronary circulations, this typically occurs at when the occlusion produces a 70% decrease in luminal cross-scetional area.
768
Q

In what conditions does a plaque rupture?

A

When they are unable to withstand mechanical stresses generated by vascular shear forces.
The events that trigger abrupt changes in plaques and subsequent thrombosis are complex and include both intrinsic factors (e.g. plaque structure and composition) and extrinsic elements (e.g. blood pressure, platelet reactivity, vessel spasm)

769
Q

The composition of atherosclerotic plaques is dynamic and can contribute to risk of rupture. What compositions increase the risk of rupture?

A

Plaques that contain large areas of foam cells and extracellular lipid, and those in which the fibrous caps are thin or contain few smooth muscle cells of have clusters of inflammatory cells, are more likely to rupture; there are referred to as “vulnerable plaques”

770
Q

What is the major structural component of the fibrous cap in atherosclerotic caps? What affects its integrity?

A

Collagen accounts for its mechnical strength and stability.
Thus, the balance of collagen synthesis versus degradation affects cap integrity.
Collagen in atherosclerotic plaque is produced primarily by smooth muscle cells so that loss of these cells results in a less sturdy cap

771
Q

What controls collagen turnover in atherosclerotic plaques?

A
  • Collagen turnover is controlled by metalloproteinases (MMPs), enzymes elaborated largely by macrophages and smooth muscle cells within the atheromatous plaque
  • Conversely, tissue inhibitors of metalloproteinases (TIMPs) produced by endothelial cells, smooth muscle cells and macrophages modulate MMP activity.
772
Q

How does cholesterol deposits affect atherosclerotic plaques?

A
  • In general, plaque inflammation results in a net increase in collagen degradation and reduced collagen synthesis, thereby destabilising the mechanical integrity of the fibrous cap.
  • The inflammation induced by cholesterol deposits themselves may contribute to plaque destabilisation.
773
Q

Influencs extrinsic to plaques also contribute to acute plaque changes. Like what?

A
  • Adrenergic simulation can increase systemic BP or induce local vasoconstriction, thereby increasing the physical stresses on a given plaque.
  • The adrenergic stimulation associated with wakening can cause BP spikes that have causally inked to the pronounced circadian periodicity for onset of acute MI.
774
Q

Vasoconstriction compromises lumen size, and, by increasing the local mechanical forces, can potentiate plaque disruption. What may stimualte vasoconstriction at sites of atheroma?

A
  • Circulating adrenergic agonist
  • Locally released platelet contents
  • Endothelial cell dysfunction with impaired secretion of endothelial-derived relaxing factors (NO) relative to contracting factors (endothelin)
  • Mediators released from peri-vascular inflammatory cells
775
Q

What is an aneurysm?

A

A localised abnormal dilation of a blood vessle or the heart that may be congenital or acquried

776
Q

What are the different types of aneurysm? Give examples

A
  • A ‘true’ aneurysm is when it involves an attenuated but intact arterial wall or thinned ventricular wall of the heart - atheroscleroric, syphilitic and congenital vascular aneurysms, ventricular aneurysms that follow MIs
  • A false aneurysm is a defect in the vascular wall leading to extravascular haematoma that freely communicates with the intravascular space “pulsating haematoma” - ventricular rupture after MI or a leak at the sutured junction of a vascular graft with a natural artery
  • An arterial dissection arises when blood enters a defect in the arterial wall and tunnels between its layers. Dissections are often but always aneurysmal.

All of these can rupture, often with catastrophic consequences

777
Q

Descriptively, aneurysms are classified by macroscopic shape and size. How would you do this?

A
  • Saccular aneurysms are spherical outpouchings involving only a portion of the vessel wall; they may vary from 5 to 20 cm in diameter and often contain thrombus
  • Fusiform aneurysms are diffuse, circumferential dilations of a long vascular segment; they vary in diameter (up to 20cm) and in length and can involve extensive portions of the aortic arch, abdominal aorta or even the iliacs.
778
Q

When do aneurysms occur?

A
  • To maintain their structural and functional integrity, arterial walls constantly remodel by synthesising, degrading, and repairing damage to their ECM constituents.
  • Aneurysms can occur when the structure or function of the connective tissue within the vascular wall is compromised.
779
Q

What are some inherited defects in connective tissues that increase the risk of aneurysm and dissection? How?

A
  • In Marfan syndrome, defective synthesis of the scaffolding protein fibrillin leads to aberrant TGF-β activity and weakening of elastic tissue; in the aorta, this may result in progressive dilation.
  • In Loeys-Dietz syndrome mutations in TGF-β receptors lead to defective synthesis of elastin and collagens I and III. Aneurysms in such individuals can rupture fairly easily (even at small size) and are thus considered to follow an “aggresive” course
  • Weak vessel walls due to defective type III collagen synthesis are also a hallmark of the vascular forms of Ehlers-Danlos syndrome
  • Altered collagen cross-linking associated with vitamin C deficiency (scurvy) is an example of a nutritional basis for aneurysm formation
780
Q

How is aneurysm formation linked to collagen synthesis and degradation? What enzymes are also related?

A
  • Increased matrix metalloprotease (MMP) expression, particularly by macrophages in atherosclerotic plaque or vasculitis, likely contributes to aneurysm development; these enzymes have the capacity to degrade virtually all components of the ECM in the arterial wall (collagens, elastin, proteoglycans, laminin, fibronectin).
  • Decreased expression of tissue inhibitors of metalloproteases (TIMPs) can also contribute to the ECM degradation.
  • The risk of aneurysm formation in the setting of inflammatory lesions (atherosclerosis) may be associated with MMP and/or TIMP polymorphisms
781
Q

In development of aneurysms, the vascular wall is weakened through loss of smooth muscle cells or the synthesis of non-collagenous or nonelastic extracellular matrix. How does this happen?

A
  • Ischaemia of the inner media occurs when there is atherosclerotic thickening of the intima, which increases the distance that oxygen and nutrients must diffuse.
  • Systemic hypertension can also cause significant narrowing of arterioles of the vasa vasorum (e.g. in the aorta), which causes outer medial ischaemia
  • Medial ischaemia may lead to “degenerative changes” of the aorta, whereby smooth muscle cell loss - or change in the synthetic phenotype - leads to scarring (and loss of elastic fibers), inadequate extracellular matrix synthesis, and production of increasing amoutns of amorphous ground substance (glycosaminoglycan).
782
Q

Histologically, what is cystic medial degeneration?

A

It is smooth muscle cell loss leading to scarring (and loss of elastic fibers), inadequate ECM synthesis, and production of increasing amounts of amorphous ground substance (glycosaminoglycan) that occurs in Marfan syndrome and scurvy

783
Q

How does tertiary syphilis cause aortic aneurysms>

A

The obliterative endarteritis characteristic of late-stage syphilis shows a predilection for small vessels, including those of the vasa vasorum of the thoracic aorta.
This leads to ischaemic injury of the aortic media and aneurysmal dilation, which sometimes involves the aortic valve annulus.

784
Q

The two most important causes or aortic aneurysms are atheroscleosis and HTN. Where do they often affect the aorta?

A

Atherosclerosis is a greater factor in AAAs, while HTN is the most common etiology associated with ascending aortic aneurysms.

785
Q

Other factors that weaken vessel walls and lead to aneurysms include trauma, vasculitis, congenital defects (fibromuscular dysplasia and berry aneurysms) and infections such as mycotic aneurysms. Where can mycotic aneurysms originate?

A

1) from embolisation of a septic embolus, usually as a complication of infective endocarditis
2) as an extension of an adjacent suppurative process
3) by circulating organisms directly infecting the arterial wall

786
Q

In what populations do AAAs occur more frequently?

A
  • Men
  • Smokers
  • Age >50
787
Q

Where in the aorta is an AAA? How big can they be?

A

Usually positioned below the renal arteries and above the bifurcation of the aorta. They can occasionally affect the renal and superior or inferior mesenteric arteries, either by direct extensior of by occluding vessel ostia with mural thrombi.
AAA can be saccular or fusiform, up to 15cm in diameter and up to 25cm in length

788
Q

What is the morphology of a AAA?

A

There is severe complicated atherosclerosis and destruction and thinning of the underlying aortic media; the aneurysm frequently contains a bland, laminated, poorly organised mural thrombus.

789
Q

Although they are less common than the usual atherosclerotic anuerysm, what are three AAA variants thet merit special mention because of their unusual features? tell me about them

A
  • Inflammatory AAA account for 5-10% of all AAA; they typically occur in younger patients, who often present with back pain and elevated inflammatory markers (elevated CRP).
  • A subset of inflammatory AAA may be a vascular manifestation of an entity called immunoglobulin G4 (IgG4)-related disease. A disorder marked by high plasma levels of IgG4 and tissue fibrosis associated with frequent infiltrating IgG4-expressing plasma cells
  • Mycotic AAA are lesions that have become infected by the lodging of circulating microorganisms in the wall. In such cases, suppuration further destroys the media, potentiating rapid dilation and rupture
790
Q

How are inflammatory AAA characterised morphologically? What causes it?

A
  • Inflamatory aneurysms are characterised by abundant lymphoplasmacytic inflammation with many macrophages (and even giant cells) associated with dense periaortic scarring that can extend into the anterior retroperioneum.
  • The cause is a presumed localised immune response to the abdominal aortic wall; remarkably, most cases are not associated with inflammation of other arteries.
791
Q

What are the clinical features of AAA?

A

Most cases of AAA are asymptomatic and are discovered incidentally on physical exam as an abdominal mass (often palpably pulsating) that may mimic a tumour. The other clinical manifestations of AAA include:
* rupture into the periotoneal cavity of retroperitoneal tissues with massive, potentially fatal haemorrhage
* obstruction of a vessel branching off from the aorta, resulting in ischaemic injury to the supplied tissue; for example, iliac, renal, mesenteric or vertebral arteries
* embolism from atheroma or mural thrombus
* impingement on an adjacent structure, for example, compression of a ureter or erosion of vertebrae

792
Q

The risk of rupture is directly related to the size of the aneurysm. Tell me about the risk related to the size:

A
  • 4cm or less - no risk
  • 4-5cm - 1% per year
  • 5-6 cm - 11% per year
  • > 6cm - 25% per year
793
Q

How quickly do aneurysms expand?

A

Most expand at a rate of 0.2 to 0.3 cm/year but 20% expand more rapidly.

794
Q

How are AAA managed?

A

In general, aneurysms 5cm or larger are managed aggresively, usually by surgical bypass with prosthetic grafts, although treatment via endoluminal approaches using stent grafts rather than surgery is now available for selected patients

795
Q

Timely surgery for AAA is critical. Why?

A

Operative mortality for unruptured aneurysms is approx 5%, whereas emergency surgery after rupture carries a mortality rate of >50%

796
Q

What are the main associations for thoracic aortic aneurysms?

A

They are most commonly associated with HTN, although other causes such as Marfan syndrome and Loeys-Dietz syndrome are increasingly recognised.

797
Q

What are the clinical features of thoracic aortic aneurysm?

A

1) respiratory difficulties due to encroachment on the lungs and airways
2) difficulty in swallowing due to compression of the oesophagus
3) persistent cough due to compression of the recurrent laryngeal nerves
4) pain caused by erosion of bone (i.e. ribs and vertebral bodies)
5) cardiac disease as the aortic aneurysm leads to aortic valve dilation with valvular insufficiency or narrowing of the coronary ostia causing MI
6) rupture

798
Q

What is an aortic dissection?

A

Aortic dissection occurs when blood separates the laminar planes of the media to form a blood-filled channel within the aortic wall; this can be catastrophic if the dissection then ruptures through the adventitia and haemorrages into adjacent spaces.

799
Q

Aortic dissection occurs principally in two groups of patients. What are they? What are the rarer groups of populations

A

1) men aged 40-60 years with antecedent HTN (>90% of cases)
2) younger adults with systemic or localised abnormalities of connective tissue affecting the aorta (e.g. Marfan syndrome)

It can also be iatrogenic e.g. following arterial cannulations during coronary catheterisation or bypass.

800
Q

Rarely pregnancy is associated with aortic dissection. What trimester and why?

A
  • This typically occurs during or after third trimester
  • It may be related to hormone-induced vascular remodeling and the haemodynamic stresses of the perinatal period.
801
Q

What is the pathogenesis of aortic dissection?

A
  • HTN is the major risk factor for aortic dissection
  • Aortas of hypertensive patients have medial hypertrophy of vasa vasorum associated with degenerative changes such as loss of medial smooth muscle cells and disorganised ECM, suggesting that ischaemic injury (due to diminished flow through the vasa vasorum, possibly exacerbated by high wall pressures) is contributory.
  • The trigger for intimal tear and initial intramural aortic haemorrhage is not known in most cases.
  • Once a tear has occurred, blood flow under systemic pressure dissects through the media, leading to progression of the haematoma.
  • Accordingly, aggressive pressure-reducing therapy may be effective in liminiting an evolving dissection.
  • In some cases, disruption of penetrating vessels of the vasa vasorum can give rise to an intramural haematoma without an intimal tear
802
Q
A
803
Q

Morphologically, what changes occur prior to/at the beginning of an aortic dissection?

A
  • The most frequent preexisting histologically detectable lesion is cystic medial degeneration, and inflammation is characteristically absent.
804
Q

An aortic dissection usually initiates with an intimal tear. Where is the location that the vast majority of spontaneous dissections occur? What shape are they? Where do they go?

A
  • The tear often occurs in the ascending aorta, usually within 10cm of the aortic valve
  • Such tears are typically transverse with sharp, jagged edges up to 1-5cm in length.
  • The dissection can extend retrograde towards the heart as well as distally, sometimes into the iliac and femoral arteries
805
Q

Which layers of the aorta does a dissection often affect?

A

The dissecting haematoma spreads characteristally along the laminor planes of the aorta, usually between the middle and outer thirds.
It can rupture through the adventitia causing massive haemorrhage (e.g. into the thoracic or abdominal cavities) or cardiac tamponade (haemorrhage into the pericardial sac)

806
Q

What is a double-barreled aorta? What happens to this over time?

A

In some instances, the dissecting haematoma reenters the lumen of the aorta through a second distal intimal tear, creating a new false vascular channel - double-barreled aorta.
This averts a fatal extraaortic haemorrhage, and over time, such false channels can be endothelialised to become recognisable chronic dissections

807
Q

What are the classifications of aortic dissections?

A
  • The more common (and dangerous) proximal lesions (called type A dissections), involving either both the ascending and descending aorta (type 1 Debakey) or just the ascending aorta only (type II DeBakey)
  • Distal lesions not involving the ascending part and usually beginning distal to subclavian artery (called type B dissections or DeBakey type III)
808
Q

What are the clinical features of an aortic dissection?

A

The classic clinical symptoms or aortic dissection are the sudden onset of excruciating pain, usually beginning in the anterior chest, radiating to the back between the scapulae, and moving downward as the dissection progresses; the pain can be confused with that of an MI.
Common clinical manifestations also include cardiac tamponade and aortic insufficiency

809
Q

What is the most common cause of death from aortic dissection?

A

Rupture of the dissection into the pericardial, pleural, or peritoneal cavities. Retrograde dissection into the aortic root can also disrupt the aortic valve annulus.

810
Q

Where can aortic dissections extend into? What does it cause?

A

They can extend into the great arteries of the neck or into the coronary, renal, mesenteric, or iliac arteries, causing vascular obstruction and ischaemic consequences such as MI; involvement of spinal arteries can cause transverse myelitis.

811
Q

What is the treatment for type A dissections?

A

Rapid diagnosis and institution of intensive antihypertensive therapy coupled with surgical plication of the aortic intimal tear can save 65-85% of patients.

812
Q

What is the prognosis of type A dissections?

A

Mortality approaches 70% in those who present with haemorrhage or symptoms related to distal ischaemia, and the overall 10-year survival is only 40-60%.

813
Q

What is the prognosis and treatment of type B dissections?

A

Most type B dissections can be managed conservatively; patients have a 75% survival rate whether they are treated with surgery or antihypertensive medication only/

814
Q

What is ischaemic heart disease

A

IHD represents a group of physiologically related syndromes resulting from myocardial ischaemia - an imbalance between myocardial supply (perfusion) and cardiac demand for oxygenated blood.

815
Q

What is myocardial ischaemia vs hypoxia?

A

Ischaemia not only limits tissue oxygenation (and thus ATP generation), but also reduced the availability of nutrients and the removal of metabolic wastes.

816
Q

What are the main causes of myocardial ischaemia?

A

> 90% cases of myocardial ischaemia results from reduced blood flow due to obstructive atherosclerotic lesions in teh epicardial coronary arteries.
Consequently, IHD is frequently referred to as coronary artery disease

But it can also be caused by coronary emboli, myocardial vessel inflammation, or vascular spasm.

817
Q

Does IHD have a long or short period of progression?

A

In most cases there is a long period (up to decades) of silent, slow progression of coronary lesions before the sudden onset of symptoms.
Thus, IHD is often the late manifestatoin of coronary atherosclerosis that began during childhood or adolsecence.

818
Q

How can IHD present?

A

As one or more of the following clinical syndromes:
* Myocardial infarction, where ischaemia causes frank cardiac necrosis
* Angina pectoris, where ischaemia is not severe enough to cause infarction, but the symptoms nevertheless portend infarction risk
* Chronic IHD with heart failure
* Sudden cardiac death

819
Q

The number of deaths from IHD has significantly improved. Why?

A
  • Prevention - modifying important risk factors, such as smoking, blood cholesterol, and HTN, weight loss and increased exercise
  • Diagnostic and therapeutic advances such as statins, CCUs, thrombolysis, PCI, stents, CABG, implantable defibrillators
820
Q

More than 90% of patients with IHD have atherosclerosis involving one or more coronary arteries. What percentage surface area obstruction means significant coronary artery disease?

A

A fiex lesion obstructing greater than 75% of vascular cross-sectional area defines sigificant coronary artery disease; this is generally the threshold for symptomatic ischaemia precipitated by exercise

821
Q

Obstruction of what % of cross-sectional area of the coronary lumen can lead to inadequate coronary blood flow even at rest?

A

90%

822
Q

Progressive myocardial ischaemia induced by slowly developing occlusions may lead to what?

A

It may stimulate the formation of collateral vessels over time, which can often protect against myocardial ischaemia and infarction and mitigate the effects of high-grade stenoses.

823
Q

Clinically significant plaques can be located anywhere along the course of the coronary vessels. Where most commonly?

A

Particularly the RCA, although they tend to predominate within the first several centimeters of the LAD and LCX. Somtimes the major epicardial bracnhes are also involved (i.e. LAD diagonal bracnhes, LCX obtuse marginal branches, or posterior descending branch of the RCA), but the atherosclerosis of the intramural (penetrating) branches is rare.

824
Q

The risk of an individual developing clinically important IHD depends on what?

A

In part on the number, distribution, sturcture, and degree of obstruction of atheromatous plaques. Also the acute change of a plaque

825
Q

Acute coronary syndromes are typically initiated by what?

A

An unpredictable and abrupt conversion of a stable atherosclerotic plaque to an unstable and potentially life-threatening atherothrombotic lesion through rupture, superficial erosion, ulceration, fissuring, or deep haemorrhage.
In most instances, plaque changes - typically associated with intralesional inflammation - may precipitate the formation of a superimposed thrombus that partially or completely occludes the artery

826
Q

What are the consequences of myocardial ischaemia?

A
  • Stable angina results from increases in myocardial oxygen demand that outstrip the ability of stenosed coronary arteries to increase oxygen delivery; it is usually not associated with plaque disruption
  • Unstable angina is caused by plaque disruption that results in thrombosis and vasoconstriction, and leads to severe but transient reductions in coronary blood flow.
  • Myocardial infarction is often the result of acute plaque change that induces an abrupt thrombotic occlusion, resulting in myocardial necrosis
  • Sudden cardiac death may be caused by regional myocardial ischaemia a fatal ventricular arrhythmia.
827
Q

What is angina pectoris?

A

It is characterised by payxoysmal and usually recurrent attacks of substernal or precordial chest discomfort caused by transient (15 seconds to 15 minutes) myocardial ischaemia that is insufficient to induce myocyte necrosis.

828
Q

What causes the pain of angina?

A

The pain itself is likely a consequence of the ischaemia-induced release of adenosine, bradykinin, and other molecules that stimulate sympathetic and vagal afferent nerves.

829
Q

There are three overlapping patterns of angina pectoris caused by varying combinations of decreased perfusion, increased demand, and coronary arterial pathology. What are they and in what situations do they happen?

A
  • Stable angina is the most common form of angina; caused by an imbalance in coronary perfusion (due to chronic stenosing coronary atherosclerosis) relative to myocardial demand, such as physical activity, emotion or stress.
  • Prinzmetal variant angina is an uncommon form of episodic myocardial ischaemia; caused by coronary artery spasm.
  • Unstable or crescendo angina refers to a pattern of increasing frequent, prolonged (>20 mins), or severe angina or chest discomfort described as frank pain. In most patients, is it caused by the disruption of an atherosclerotic plaque with superimposed partial thrombosis and possibly embolisation or vasospasm (or both)
830
Q

How is stable angina often described and what usually relieves it?

A

As a deep, poorly localised pressure, squeezing, or burning sensation (like indigestion), but unusually as pain, and is usually relieved by rest (decreasing demand) or administering vasodilators, such as nitroglycerin and calcium channel blockers (increasing perfusion)

831
Q

What does Prinzmetal angina usually respond well to?

A

Generally responds promptly to vasodilators

832
Q

What does increases the incidence and risk factors of MI?

A
  • Age - Mi can occur at virtually any age; nearly 10% occur in people <40. 45% occur in people <65 years old.
  • Race Black and white people are equally affected
  • Through middle age male gender incrases the relative risk of MI
833
Q

What is the pathogenesis of coronary arterial occlusion?

A
  • A coronary artery atheromatous plaque undergoes an acute change consisting of intraplaque hemorrhage, erosion or ulceration, or rupture or fissuring
  • When exposed to subendothelial collagen and necrotic plaque contents, platelets adhere, become activated, release their granule contents, and aggregate to form microthrombi
  • Vasospasm is stimulated by mediators released from platelets
  • Tissue factor activates the coagulation pathway, adding to the bulk of the thromus
  • Within minutes, the thrombus can expand to completely occlude the vessel lumen
834
Q

In approximately 10% of cases, transmural MI occurs in the absence of the typical coronary atherothrombosis. In such situations, what happens?

A
  • Vasospasm with or without coronary atherosclerosis, perhaps in association with platelet aggregation or due to drug ingestion (e.g. cocaine or ephedrine)
  • Emboli from the left atrium in association with AF, a left-sided mural thrombus, vegetations of infective endocarditis, intracardiac prosthetic material or paradoxical emboli from the right side of the heart or the peripheral veins, traversing a patent foramen ovale and into the coronary rteries
  • Ischaemia without detectable or significant coronary atherosclerosis and thrombosis may be caused by disorders of small intramural coronary vessels (vasculitis), haematological abnormalities (sickle cell disease), amyloid deposition in vasular walls, vascular dissection, marked hypertrophy (AS), shock
835
Q

What is the myocardial response to coronary arterial obstruction?

A

Coronary arterial obstruction diminishes blood flow to a region of myocardiam, causing ischaemia, rapid myocardial dysfunction, and eventually - with prolonged vascular compromise - myocyte death.

836
Q

What does the outcome of myocardial infarction depend on?

A

Predominantly on the severity and duration of flow deprivation

837
Q

What are the early biological consequences of MI? How does this affect myocardial function?

A
  • The cessation of aerobic metabolism within seconds, leading to inadequate production of high energy phosphates (e.g. creatine phosphate and ATP) and accumulation of potentially noxious metabolites (e.g. lactic acid)
  • Because of the exquisite dependence of myocardial function on oxygen and nutrients, myocardial contractility ceases within a minute or so of the onset of severe ischaemia. Such loss of function actually precipitates heart failure long before myocyte death occurs
838
Q

What are the ultrastructural changes that occur in MI? How long do they take? are they irreversible?

A
  • Ultrastructural changes - myofibrillar relaxation, glycogen depletion, cell and mitochondrial swelling - develop within a few minutes of the onset of ischemia
  • There early manifestations of ischaemic injury are potentially reversible
  • Only severe ischemia (blood flow <10% of normal) lasting 20-30 minutes or longer leads to irreversible damage (necrosis) of cardiac myocytes.
839
Q

What is the earliest detectable feature of myocyte necrosis? What are these used for?

A
  • The disruption of the integrity of the sacrolemmal membrane, allowing intracellular macromolecules to leak out of necrotic cells into the cardiac interstitium and ultimately into the microvasculature and lymphatics
  • This escape of intracellular myocardial proteins into the circulation forms the basis for blood tests that can sensitively detect irreversible myocyte damage, and important for managing MI.
840
Q

What are approximate time of onset of key events in ischaemic cardiac myocytes?

A
  • Onset of ATP depletion - seconds
  • Loss of contractility - under 2 minutes
  • ATP reduced to 50% of normal - 10 minutes
  • ATP reduced to 10% of normal - 40 minutes
  • Irreversible cell injury - 20-40 minutes
  • Microvascular injury - over 1 hour
841
Q

Where is ischaemia most pronounced in the heart?

A
  • Due to the myocardial perfusion pattern from epicardium to endocardium, ischaemia is most pronounced in the subendocardium; thus, irreversibly injury of ischaemic myocytes occurs first in the subendocardial zone.
  • With more extended ischaemia, a wavefront of cell death moves through the myocardium to encompass progressively more of the transmural thickness and breadth of the ischaemic zone.
842
Q

The precise location, size, and specific morphologic features of an acute MI depend on what?

A
  • The location, severity, and rate of development of coronary obstructions due to atherosclerosis and thromboses
  • The size of the vascular bed perfused by the obstructed vessels
  • The duration of the occlusion
  • The metabolic and oxygen needs of the myocardium at risk
  • The extent of collateral blood vessels
  • The presence, site and severity of coronary arterial spasm
  • Other factors, such as heart rate, cardiac rhythm and blood oxygenation
843
Q

How long does it take for necrosis to involve half of the thickness of the myocardium and the full way through? What may change this?

A
  • Necrosis involves approximately half of the thickeness of the myocardium in 2-3 hours of the onset of severe MI, and is usually transmural within 6 hours.
  • However, in instances where chronic sublethal ischaemia has induced a more well-developed coronary collateral circulation, the progression of necrosis may follow a more protracted course (12 hours or longer)
844
Q

What does the LAD branch of the coronary artery supply?

A

Most of the apex of the heart, the anterior wall of the left ventricle, and the anterior two thirds of the ventricular septum.

845
Q

What is the “dominant” coronary artery?

A

Either RCA or LCX - that perfuses the posterior third of the septum is called ‘dominant’ even though the LAD and PCX perfuse the majority of the left ventricular myocardium

846
Q

What proportion of the population are right dominant circulation and what does this mean?

A
  • Present in 80% of individuals
  • The RCA supplies the entire right ventricular free wall, the posterobasal wall of the left ventricle, and the posterior third of the ventricular septum, while the LCX generally perfuses only the lateral wall of the left ventricle
  • Thus, RCA occlusions can potentially lead to left ventricular damage.
847
Q

How do coronary collaterals affect coronary blood supply?

A
  • Although most hearts have numerous intercoronary anastomoses, relatively little blood normally courses through these.
  • However, when a coronary artery is progressively narrowed over time, blood flows via the collaterals from the high- to low-pressure circulating causing the channels to enlarge.
  • Through such progressive dilation and growth of collaterals, stimulated by ischaemia, blood flow is provided to areas of myocardium that would otherwise be deprived of adequate perfusion.
  • Indeed, in the setting of extensive collateralisation, the normal epicardial perfusion terroties may be so expanded that subsequent occlusion leads to infarction in paradoxical distributions.
848
Q

The distribution of myocardial necrosis correlates with the location and cause of the decreased perfusion. How does the location affect myocardial necrosis?

A
  • Transmural infarction. MI caused by an epicardial vessel (in the absence of any therapeutic intervention) are typically transmural - the necrosis involves virtually the full thickness of the ventricular wall in the distribution of the affected coronary.
  • Subendocardial (nontransmural) infarction. As the subendocardial zone is normally the least perfused region of myocardium, this area is most vulnerable to any reduction in coronary flow. It typically involves roughly the inner third of the ventricular wall.
  • Multifocal microinfarction pattern is seen when there is pathology involving only smaller intramural vessels.
849
Q

What usually causes the different patterns of myocardial infarction?

A
  • Transmural infarction is usually associated with a combination of chronic coronary atherosclerosis, acute plaque change, and superimposed thrombosis
  • Subendocardial (nontransmural) infarction can occur as a result of plaque disruption followed by a coronary thrombus that becomes lysed (therapeutically or spontaneously) before myocardial necrosis extends across the full thicckness of the wall. They can also result from prolonged, severe reduction in systemic blood pressure, as in shock on superimpsoed on chronic, otherwise noncritical, coronary stenoses
  • Multifocal infarction may occur in the setting of microembolisation, vasculitis, or vascular spasm, for example, due to endogenous catechols (adrenaline) or drugs (cocaine)
850
Q

In the subendocardial infarcts that occur as a result of global hypotension rather than an acute plaque, how is the pattern of infarction different?

A

The myocardial damage is usually circumferential, rather than being limited to the distribution of a singele major coronary artery

851
Q

How do elevated levels of catechols (adrenaline, cocaine) cause multifocal microinfarctions? What is the outcome?

A

They increase heart rate and myocardial contractility, exacerbating ischaemia caused by the vasospasm.
The utcome of such vasospasm can be sudden cardiac death (usually caused by a fatal arrhythmia) or an ischaemic dilated cardiomyopathy, so-called takotsubo cardiomyopathy

852
Q

How do STEMIs and NSTEMIs relate to the pattern of infarction?

A

A transmural infarct is referred to as a STEMI and a subendocardial infarct as an NSTEMI

853
Q

What proportion of the artery perfusion zone do transmural myocardial infarcts effect?

A

Nearly all transmural infarcts involve at least a portion of the left ventricle (comprising the free wall and ventricular septum) and encompass nearly the entire perfusion zone of the occluded coronary artery save for a narrow rim (approx 0.1mm) of preserved subendocardial myocardium that is preserved by diffusion of oxygen and nutrients from the ventricular lumen.

854
Q

Of MIs caused by a right coronary obstruction, what proportion affect which parts of the heart?

A
  • 15-30% extend from the posterior free wall of the septal portion of the left ventricle into the adjacent right ventricular wall.
  • Isolated infarction of the right ventricle is unusual (only 1-3% of cases), as is infarction of the atria.
855
Q

What are the frequencies of involvement of each of the three main arterial trunks and the correspondint sites of myocardial lesions resulting in infarction (in the typical right dominant heart)?

A
  • Left anterior descending coronary artery (40-50%): infacrts involving the anterior wall of left ventricle near the apex, the anterior portion of the ventricular septum; and the apex circumferentially
  • Right coronary artery (30-40%): infarcts involving the inferior/posterior wall of left ventricle; posterior portion of ventricular septum; and the inferior/posterior right ventricular free wall in some cases
  • Left circumflex coronary artery (15-20%): infarcts involving the lateral wall of left ventricle except at the apex
856
Q

What are the gross morphological changes in MI over time?

A

0-4 hours - none
4-24 hours - dark mottling
1-3 days - mottling with yellow-tan infarct center
3-7 days - hyperemic border; central yellow-tan softening
7-10 days - maximally yellow-tan and soft, with depressed red-tan margins
10-14 days - red-gray depressed infarct borders
2-8 weeks - gray-white scar, progressive from border towards core of infarct
>2 months - scarring complete

857
Q

What are the light microscope morphological changes over time following an MI?

A

0-4 hours - usually none; variable waviness of fibers at border
4-12 hours - early coagulation necrosis; edema; haemorrhage
12-24 hours - ongoing coagulation ecrosis; pyknosis of nucli; myocyte hypereosinophilia; marginal contraction band necrosis; early neutrophilic infiltrate
1-3 days - coagulation necrosis, with loss of nuclei and striations; brisk intersititial infiltrate of neutrophils
3-7 days - beginning disintegration of dead myofibers, with dying neutrophils; early phagocytosis of dead cells by macrophages at infarct border
7-10 days - well-developed phagocytosis of dead cells; granulation tissue at margins
10-14 days - well-established granulation tissue with enw blood vessels and collagen deposition
2-8 weeks - increased collagen deposition, with decreased cellularity
>2 months - dense collagenous scar

858
Q

What are the morphological changes seen on an electron microscope after an MI?

A

0-30 minutes - relaxation of myofibrils; glycogen loss; mitochondrial swelling
30 minutes - 4 hours - sarcolemmal disurption; mitochondrial amorphous densities

859
Q

What is an overview of the progressive sequence of morphological changes following an MI?

A

They involve typical ischaemic coagulative necrosis (although apoptosis may also occur), followed by inflammation and repair that closely parallels responses to injury in other tissues

860
Q

Early morphological recognition of acute MI can be difficult. But if the infarct preceded death by 2-3 hours, how is it possible to highlight the area of necrosis? What does this show?

A

By immersion of tissue slices in a solution of triphenyl-tetrazolium chloride. This stain imparts a brick-red colour to intact, noninfarcted myocardium where LDH activity is preserved. Because dehydrogenases leak out through the damaged membranes of dead cells, an infarct appears as an unstained pale zone

861
Q

Once an MI lesion is completely healed, can you determine its age?

A

No, the dense fibrous scar of 8-week-old and 10-year-old infarcts look virtually identical

862
Q

What is cardiac reperfusion?

A

Reperfusion is the restoration of blood flow to ischaemic myocardium threatened by infarction; the goal is to slavage cardiac muscle at risk and limit infarct size

863
Q

How can prompt cardiac reperfusion be accomplished after an MI?

A

By a host of coronary interventions, that is , thrombolysis, angioplasty, stent placement, or CABG surgery. The foal is to dissolve, mechanically alter or bypass the lesion that precipitated the acute infarction.

864
Q

What do the benefits of reperfusion following an MI correlate with?

A

1) the rapidity of re-establishing coronary blood (the first 3-4 hours following obstruction are critical)
2) the extent of restoration of blood flow and correction of the underlying causeal lesion

865
Q

What are the mechanisms of reperfusion of thrombolysis, PCI and CABG? How do they differ?

A
  • Thrombolysis can remove a thrombus, but does not alter the underlying atherosclerotic plaque that initiated it
  • PCI with stent placement not only eliminated a thrombotic occlusion but also relieves some of the original obstruction and instability caused by the underlying disrupted plaque
  • CABG provides a new conduit for flow bypassing the area of vessel blockage
866
Q

Reperfused MIs are usually hemorrhagic. Why?

A

Because the vascular is injured during ischaemia and there is bleeding after flow is restored.

867
Q

What does microscopic examination of reperfused cardiac muscle reveal?

A
  • Irreversibly injured myocytes exhibit contraction bands, intensely eosinophilic intracellular “stripe” composed of closely packed sarcomeres
  • These result from the exaggerated contraction of sarcomeres when perfusion is re-established, at which time the interior of cells with damaged membranes is exposed to a high concentration of calcium ions from the plasma
  • Thus, **reperfusion not only salvages reversibly injured cells but also alters the morphology of lethally injured cells.
868
Q

Although clearly beneficial, reperfusion can trigger deleterious complications such as what?

A

Arrhythmias, as well as damage superimposed on the original ischaemia, so-called reperfusion injury.

869
Q

What is reperfusion injury?

A

This term encompasses various forms of damage that can occur after restoration of flow to “vulnerable” myocardium that is ischaemic but not yet irreversibly damaged

870
Q

What causes reperfusion injury and what are the results of it?

A
  • Reperfusion injury may be mediated by oxidative stress, calcium overload, and inflammatory cells recruited after tissue reperfusion
  • Reperfusion-induced microvascular injury not only results in haemorrhage but can also cause endothelial swelling that occludes capillaries and may limit the reperfusion of criticall injured myocardium (called no-reflow)
871
Q

What is a stunned myocardium? How long does it last?

A

Biochemical abnormalities (and their functional consequences) may also persist for days to weeks in reperfused myocytes. Such changes are thought to underlie a phenomenon referred to as stunned myocardium, a state of prolonged cardiac failure induced by short-term ischaemia that usually recovers after several days

872
Q

What is hibernating myocardium? How do you get rid of it?

A

Myocardium that is subjected to chronic sublethal ischaemia may also enter into a state of lowered metabolism and function called hibernation.
Subsequent revascularisation (e.g. by CABG surgery, angiopasty or stenting) often restores normal function to such hibernating myocardium.

873
Q

What are the classic clinical features of an MI?

A
  • Patients with MI characteristically present with prolonged (>30 minutes) chest pain described as crushing, stabbing, or squeezing, associated with a rapid, weak pulse; profuse sweating (diaphoresis), and nausea and vomiting are common, and can suggest involvement of the posterior-inferior ventricle with secondary vagal stimulation.
  • Dyspnoea due to impaired contractility of the myocardium and the resultant pulmonary congestion and edema is a frequent symptom.
874
Q

The laboratory evaluation of MI is based on measuring the proteins that leak out of irreversibly damaged myocytes. What are these?

A
  • The most useful are cardiac specific troponins T and I, and the MB fraction of CK.
  • The diagnosis of MI is established when blood levels of these cardiac biomarkers are elevated.
875
Q

What does the rate of appearance of cardiac markers in the peripheral circulation following MI depend on?

A
  • their intracellular location and molecular weight
  • the blood flow and lymphatic drainage in the area of the infarct
  • the rate of elimination of the marker from the blood
876
Q

Following MI, how does the troponin level change over time?

A
  • Troponins I and T are not normally detectable in the circulation.
  • Following an MI, levels of both begin to rise at 3-12 hours
  • cTnT levels peak somewhere between 12-46 hours
  • cTnI levels are maimal at 24 hours
877
Q

Creatinine kinase is an enzyme expressed in brain, myocardium and skeletal muscle. It is a dimer composed of two isoforms. What are they and where are they found?

A
  • It is a dimer composed of two isoforms designated “M” and “B”.
  • MM homodimers are found predominantly in cardiac and skeletal muscle
  • BB homodimers in brain, lung and may other dissues
  • MB heterodimers are principally localised to cardiac muscle. Thus, the MB form of CK (CK-MB) is sensitive but not specific, sincis can also be elevated after skeletal muscle injury
878
Q

When do CK-MB, cTnI and cTnT return to normal following an MI?

A
  • CK-MB returns to normal in 48-72 hours
  • cTnI in 5-10 days
  • cTnT in 5-14 days
879
Q

What are factors associated with a poorer prognosis of MI?

A
  • Advanced age
  • Female gender
  • Diabetes mellitus
  • Previous MI
880
Q

How long after an MI do most deaths occur? Why/

A
  • Half of the deaths associated with acute MI occur within 1 hour of onset
  • Most commonly due to a fatal arrhythmia; most of the individuals never reach the hospital
881
Q

Mi therapeutic interventions include what?

A
  • Morphine to relieve pain and improve dyspneic symptoms
  • Prompt reperfusion to salvage myocardium
  • Antiplatelet agents such as aspirin
  • Anticoagulant therapy with unfractionated heparin LMWH
  • Nitrates to induce vasodilation and reverse vasospasm
  • Beta blockers to decrease myocardial oxygen demand and to reduce risk of arrhythmias
  • Antiarrhythmics to manage arrhythmias
  • ACE inhibitors to limit ventricular dilation
  • Oxygen supplementation to improve blood oxygen saturation
882
Q

Despite interventions, many patients have one of more of what complications following an MI?

A
  • Contractile dysfunction - MIs produce abnormalities in left ventricular function roughly proportional to their size.
  • Arrhythmias - many patients have myocardial irritability and/or conduction disturbances following MI that lead to potentially fatal arrhythmias
  • Myocardial rupture - the various forms of cardiac rupture typically occur when there is transmural necrosis of a ventricle
  • Ventricular aneurysm - true aneurysms of the ventricular wall are bounded by myocardium that has become scarred
  • Pericarditis - a fibrinous or fibrinohaemorrhagic pericarditis can occur (Dressler syndrome)
  • Infarct expansion - as a result of the weakening of necrotic muscle, there may be disproportionate stretching, thinning, and dilation of the infarct region, which is often associated with mural thrombus
  • Mural thrombus - the combination of a local abnormality in contractility (causing stasis) and endocardial damage (pro-thrombotic) can cause thrombus
  • Papillary muscle dysfunction
  • Progressive late heart failure
883
Q

How often does cardiogenic shock follow an MI? and what type of infarcts? What is the prognosis of this?

A
  • Severe “pump failure” (cardiogenic shock) occurs in 10-15% of patients following acute MI, generally with large infarcts involving more than 40% of the LV
  • Cardiogenic shock has a nearly 70% mortality rate
  • Right ventricular infarcts can cause right-sided heart failure associated with pooling of blood in the venous circulation and systemic hypotension
884
Q

What are some MI-associated arrhythmias?

A
  • Sinus bradycardia
  • AF
  • Heart block
  • Tachycardia
  • Ventricular premature contractions
  • VT
  • VF
885
Q

What type of MIs are associated with arrhythmias?

A

Because of the location of portions of the AV conduction system (bundle of His) in the inferoseptal myocardium, infarcts involving this site can also be associated with heart block

886
Q

What are the different types of cardiac rupture that occur post-MI?

A
  • Rupture of the ventricular free wal (most common), with haemopericardium and cardiac tamponade (A)
  • Rupture of the ventricular septum (less common), leading to an acute VSD and left-to-right shunting (B)
  • Papillary muscle rupture (least common), resulting in the acute onset of severe mitral regurgitation (C)
887
Q

How long after an MI does free-wall rupture occur? Where in the heart is at the most risk?

A
  • Free-wall rupture occurs most frequently 2 to 4 days after MI, when coagulative necrosis, neutrophilic infiltration, and lysis of the myocardial connective tissue have appreciably weakened the infarcted myocardium.
  • The anterolateral wall at the mid-ventricular level is the most common site
888
Q

What are some risk factors for free wall rupture post-MI?

A

Age >60
First MI
Large, transmural and anterior MI
Absence of LVH
Pre-existing frequency

889
Q

Why is ventricular rupture less common after your first MI?

A

Because associated fibrotic scarring tends to inhibit myocardial tearing

890
Q

What is a false aneurysm after a myocardial rupture? What does it consist of?

A

While acute free-wall ruptures are usually rapidly fatal, a fortuitously lcoated pericardial adhesion can abort a rupture and result in a false aneurysm (localised haematoma communicating with the ventricular cavity). The wall of a false aneurysm consists only of epicardium and adherent parietal pericardium and thus may still ultimately rupture

891
Q

Aneurysms of the ventricular wall are a late complication of what type of infarct? How do they occur and what are their complications?

A
  • They are a late complication of large transmural infarcts that experience early expansion
  • The thin scar tissue wall of an aneurysm pardoxically bulges during systole.
  • Complications of ventricular aneurysms include mural thrombus, arrhythmias, and heart failure; rupture of the tough fibrotic wall does not usually occur
892
Q

When does pericarditis often occur after MI?

A

About the second or third day following a transmural infarct as a result of underlying myocardial inflammation (Dressler sydrome)

893
Q

Why does papillary muscle dysfunction occur following MI?

A

Although papillary muscle rupture after an MI may certainly result in precipitous onset of mitral (or tricuspid) valve incompetence, most post-infarct regurgitation results from ischaemic dysfunction of a papillary muscle (and underlying myocardium), or later from ventricular dilation or from papillary msucle fibrosis and shortening

894
Q

The risk of postinfarct complications and the prognosis of the patient depend primarily on the infarct size, location, and fraction of the wall thickness involved (subendocardial or transmural). What infarcts lead to which complications?

A
  • Large, transmural infarcts yield a higher probability of cardiogenic shock, arrhythmias and late CHF.
  • Patient with anterior transmural infarcts are at greatest risk for free-wall rupture, expanson, mural thrombi and aneurysm
  • Posterior transmural infarcts are more likely to be complicated by conduction blocks, right ventricular involvement, or both; when acute CSDs occur in this area, they are more difficult to manage
895
Q

What is ventricular remodelling post-MI?

A

In addition to the sequence of repair in the infarcted tissues, the noninfarcted segments of the ventricle undergo hypertrophy and dilation; collectively, these changes are termed ventricular remodelling

896
Q

Why does ventricular remodelling occur post-MI? What are the complications of it? what medication helps?

A
  • The compensatory hypertrophy of noninfarcted myocardium is initially haemodynamically beneficial.
  • However, this adaptive effect may be overwhelmed by ventricular dilation (with or without aneurysm) and increased oxygen demand, which can exacerbate ischaemia and depress cardiac function.
  • There may also be changes in ventricular shape and stiffening of the ventricle due to scar formation and hypertrophy that further diminish cardiac output.
  • Some of these deleterious effects appear to be reduced by ACE inhibitors, which lessen the ventricular remodeling that occurs after infarction.
897
Q

Long-term prognosis after MI depends on many factors, but what is the most important?

A

The residual left ventricular function and the extent of any vascular obstructions in vessels that peruse the remaining viable myocardium

898
Q

What is the prognosis of MIs? What have we been doing to improve that?

A
  • The overall total mortality within the first year can be as high as 30%; thereafter, each passing year is associated with an additional 3-4% mortality among survivors
  • Infarct prevention (through control of risk factors) in individuals who have never experienced MI (primary prevention) and prevention of reinfarction in MI survivors (secondary prevention) are important strategies that have received much attention and achieved considerable success.
899
Q

What is chronic IHD/ischaemia cardiomyopathy?

A

A progressive congestive heart failure as a consequence of accumulated ischaemic myocardial damage and/or inadequate compensatory responses.

900
Q

In what situations does chronic IHD occur?

A
  • In most instances, there has been prior MI and sometimes previous coronary arterial interventions and/or bypass surgery
  • Chronic IHD usually appears post-infarction due to the functional decompensation of hypertrophied noninfarcted myocardium. However, in other cases severe obstructive coronary artery disease may present as chronic congestive heart failure in the absence of prior infarction.
  • Patients with chronic IHD account for almost 50% of cardiac transplant receipients.
901
Q

What is the morphology of chronic heart failure?

A
  • Hearts from patients with chronic IHD have cardiomegaly, with left ventricular hypertrophy and dilation.
  • Invariably, there is some degree of stenotic coronary atherosclerosis.
  • Discrete scars representing healed infarcts are usually present.
  • the mural endocardium often has patchy fibrous thickenings (due to abnormal wall shear forces), and mural thrombi may be present.
  • Microscopic findings include myocardial hypertrophy, diffuse subendocardial vacuolisation, and fibrosis.
902
Q

What is infective endocarditis?

A

A microbial infection of the heart valves or the mural endocardium that leads to the formtion of vegetations composed of thrombotic debris and organisms, often associated with destruction of the underlying cardiac tissues.
The aorta, aneurysms, other blood vessels and prosthetic devices can also become infected.

903
Q

What usually causes infective endocarditis?

A

Although funghi and other classes of microorganisms can be responsible, most infections are bacterial (bacterial endocarditis)

904
Q

Traditionally, infective endocarditis has been classified on clinical grounds into acute and subacute forms. This subdivision relfects the range of the disease severity and tempo, which are determined in lareg part by the virulence of the infecting microorganism and whether underlying cardiac disease is present. Tell me about these types.

A
  • Acute infective endocarditis is typically caused by infection of a previously normal heart valve by a highly virulent organism (e.g. Staphylococcus aureus), that rapidly produces necrotising and destructive lesions. These infections may be difficult to cure with antibiotics alone, and usually require surgery. Despite appropriate treatment, death can ensue within days to weeks.
  • Subacute infective endocarditis is characterised by organisms with lower virulence (e.g. viridans streptococci) that cause insidious infections of deformed valves with overall less destruction. In such cases the disease may pursue a protracted course of weeks to months and can be achieved with antibiotics.
905
Q

Although highly virulent organisms can infect previously normal valves, a variety of cardiac and vascular abnormalities increase the risk of developing IE. What are they?

A

Rheumatic heart disease with valvular scarring has historically been the major antecedent disorder; as RHD becomes less common, it has been supplanted by mitral valve prolapse, degenerative calcific valvular stenosis, bicuspid aortic valve (whether calcified or not), artifical (prosthetic) valves, and unrepaired and repaired congenital defects.

906
Q

The causal organisms of infective endocarditis differ among the major high-risk groups. Tell me how…

A
  • Endocarditis of native but previously damaged or otherwise abnormal valves is caused most commonly (50-60% of cases) by Streptococcus viridans, a normal component of the oral cavity flora
  • Most virulent Staphylococcus aureus is the major offender in IE among IVDUs
  • Other bacterial causes include enterococci and the so-called HACEK group (Haemophilus, Actinobacillus, Cardiobacterium, Eikenella and Kingella), all commensals in the oral cavity.
  • Prosthetic valve endocarditis is cause most commonly by coagulase-negative staphylococci (e.g Staph epidermidis.
  • Other agents causing endocarditis include gram-negative bacilli and funghi
907
Q

In about 10% of all cases of infective endocarditis, no organism can be isolated from the blood (“culture-negative” endocarditis). What are the reasons for this?

A
  • Prior antibiotic therapy
  • Difficulties in isoalting the offending agent
  • Because deeply embedded organisms within the enlarging vegetation are not released into the blood
908
Q

Foremost among the factors predisposing to infective endocarditis are those that cause microorganism seeding into the blood stream (bacteraemia or fungaemia). What are some examples it this? How can it be managed?

A

The source may be an obvious infection elsewhere, a dental or srugical procedure, a contaminated needle shared by IVDUs, or seemingly trivial breaks in the epithelial barriers of the gut, oral cavity, or skin.
In patients with valve abnormalities, or with known bacteraemia, IE risk can be lowered by antibiotics prophylaxis.

909
Q

Vegetations on heart valves are the classic hallmark of IE. How do they present morphologically?

A

Vegetations on heart valves are the classic hallmark of IE; these are friable, bulky, potentially destructive lesions containing fibrin, inflammatory cells, and bacteria or other organisms.

910
Q

What valves are the most common sites of infective endocarditis? Is it only one valve they happen in?

A

The aortic and mitral valves are the most common sites of infection, although the valves of the right heart may also be involved, particularly in IVDUs.
Vegetations can be single or multiple and may involve more than one valve.

911
Q

What are some of the consequelae of infective endocarditis vegetations?

A

They can occasionally erode into the underlying myocardium and produce an abscess (ring abscess Fig B).
Vegetations are prone to embolisation; because the embolic fragments often contain virulent organisms, abscesses frequently develop where they lodge, leading to sequelae such as septic infarcts or mycotic aneurysms.

912
Q

How do the vegetations of subacute endocarditis differ from acute endocarditis? Both in terms of destruction and microscopically

A
  • The vegetations of subacute endocarditis are associated with less valvular destruction that those of acute endocarditis, although the distinction can be subtle.
  • Microscopically, the vegetations of subacute IE typically exhibit granulation tissue at their bases indicative of healing. With time, fibrosis, calcification, and a chronic inflammatory infiltrate can develop.
913
Q

What are the clinical features of infective endocarditis?

A
  • Acute endocarditis has a stormy onset with rapidly develpoing fever, chills, weakness, and lassitude. although fever is the most consistent sign of IE, it can be slight or absent, particularly in odler adults, and the only manifestations may be non-specific fatigue, loss of weight, and a flu-like syndrome.
  • Murmurs are present in 90% of patients with left-sided IE< either from a new valvular defect or from a pre-existing abnormality.
914
Q

What is the diagnostic criteria for infective endocarditis called and what are the points in it?

A

Duke’s criteria
Pathological criteria
* Microorganisms, demonstrated by culture or histological examination, in a vegetation, embolus from a vegetation, or intracardiac abscess
* Histological confirmation of active endocarditis in vegetation or intracardiac abscess

Clinical Criteria - major
* Positive blood cultures for a characteristic organism or persistently postive for an unusual organism
* Echo identification of a valve-related or implant-related mass or abscess, or partial separation of artificial valve
* New valvular regurgitation

Clinical Criteria - minor
* Predisposing heart lesion or IVDU
* Fever
* Vascular lesions, including arterial petechiae, subungual/splinter haemorrhages, emboli, septic infarcts, mycotic aneurysm, intracranial heamorrhage, Janeway lesions
* Immunologic phenomena including glomerulonephritis, Osler nodes, Roth spots, rheumatoid factor
* A single postitive culture for an unusual organism
* Echo findings consistent with but not diagnostic of endocarditis, including worsening or changing of a preexistent murmur

915
Q

What are cardiomyopathies?

A

Cardiomyopathies are a hetergenous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually (but not invaruably) exhibit inappropriate ventricular hypertrophy or dilatation and are due to a variety of causes that frequently are genetic.
Cardiomyopathies either are confined to the heart or are part of generalised systemic disorders, often leading to cardiovascular death of progressive heart failure-related disability

916
Q

How do cardiomyopathies manifest?

A

As failure of myocardial performance; this can be mechanical (eg., diastolic or systolic dysfunction) leading to CHF, or can culminate in life-threatening arrhythmias

917
Q

What are primary and secondary cardiomyopathies?

A
  • Primary cardiomyopathies can be genetic or acquired diseases of myocardium
  • Secondary cardiomyopathies have myocardial involvement as a component of a systemic or multiorgan disorder.
918
Q

What are the three pathological patterns of cardiomyopathy? and which ones are most/least common?

A
  • Dilated cardiomyopathy (including arrhythmogenic right ventricula cardiomyopathy) - 90% of cases
  • Hypertrophic cardiomyopathy
  • Restrictive cardiomyopathy - least common
919
Q

What is the left ventricular ejection fraction for the following cardiomyopathies:
* Dilated
* Hypertrophic
* Restrictive

A

Dilated < 40%
Hypertrophic - 50-80%
Restrictive - 45-90%

920
Q

What are the mechanisms of heart failure in the following cardiomyopathies?
* Dilated
* Hypertrophic
* Restrictive

A

Dilated - impairment of contractility (systolic dysfunction)
Hypertrophic - impairment of compliance (diastolic dysfunction)
Restrictive - impairment of compliance (diastolic dysfunction)

921
Q

What are the causes of the following cardiomyopathies:
* Dilated
* Hypertrophic
* Restrictive

A
  • Dilated - genetic, alcohol, peripartum, myocarditis; haemochromatosis; chronic anaemia; sarcoidosis; idiopathic
  • Hypertrophic - genetic ; Friedrich ataxia; storage disease; infants of diabetic mother
  • Restrictive - amyloidosis; radiation-induced fibrosis; idiopathic
922
Q

What are the some indirect myocardial dysfunctions associated with the following cardiomyopathies:
* Dilated
* Hypertrophic
* Restrictive

A
  • Dilated - IHD; valvular heart disease; hypertensive heart disease; congenital heart disease
  • Hypertrophic - hypertensive heart disease; aortic stenosis
  • Restrictive - pericardial constriction
923
Q

What are the characteristics of dilated cardiomypathy?

A

Dilated cardiomyopathy is characterised morphologically and functionally by progressive cardiac dilation and contractile (systolic) dysfunction, usually with concomitant hypertrophy.

924
Q

What percentage of dilated cardiomyopathy are familial? What genes are specific for this?

A
  • DCM is familial in at least 30-50% of cases, in which it is caused by mutations in a diverse group of more than 20 genes encoding porteins involved in the cytoskeleton, sarcolemma and nuclear envelope.
  • In particular, mutations in TTN, a gene that encodes titin, may account for approximately 20% of all cases of dilated cardiomyopathy
925
Q

What is the difference in presentationg ages between dilated cardiomyopathy caused by mitochondrial defects and those that are X-linked?

A
  • Mitochondrial defects typically mannifest in the paediatric population, while X-linked DCM typically presentes after puberty and into early adulthood.
926
Q

How does alcohol cause dilated cardiomyopathy?

A
  • Alcohol abuse is strongly associated with the development of dilated cardiomyopathy, raising the possibility that ethanol toxicity or a secondary nutritional disturbance can underlie myocardial injury.
  • Alcohol or its metabolites (especially acetaldehyde) have a direct toxic effect on the myocardium.
  • Moreover, chronic alcoholism may be associated with thiamine deficiency, which can lead to beriberi heart disease.
927
Q

A special form of dilated cardiomyopathy, termed peripartum cardiomyopathy can occur late in pregnancy or up to months postpartum. What is the mechanism of this?

A
  • The mechanism is poorly understood but is probably multi-factorial. Pregnancy-associated hypertension, volume overload, nutritional deficiency, other metabolic derangements, or immunological reactions have been proposed as causes.
  • The primary defect suggested is a microvascular angiogenic imbalance within the myocardium leading to functional ischaemic injury.
928
Q

How does iron overload cause dilated cardiomyopathy?

A
  • Dilated cardiomyopathy is the most common manifestation of iron overload from either haemochromastosis or from multiple transfusions..
  • It may be caused by interference with metal-dependent enzyme systems or to injury from iron-mediated production of reactive oxygen species.
929
Q
A
930
Q

What is takotsubo cardiomyopathy?

A
  • An entity characterised by left ventricular contractile dysfunction following extreme psychological stress
  • Affected myocardium may be stunned or show multi-focal contraction band necrosis.
  • The left ventricular apex is most often affected leading to “apical ballooning” that resembles a “takotsubo” - Japanese for “fishing pot for trapping octopus”
931
Q

What is the mechanism of carecholamine cardiotoxicity?

A
  • It likely relates either to direct myocyte toxicity due to calcium overload or to focal vasoconstriction in the coronary arterial macro- or microcirculation in the face of an increased heart rate.
932
Q

What is the gross morphology of dilated cardiomyopathy?

A
  • In dilated cardiomyopathy, the heart is usually enlarged, heavy (often weighing 2-3 times normal), and flabby, due to dilation of all chambers.
  • Mural thrombi are common and may be a source of thromboemboli
  • There are no primary valvular alterations; if mitral (or tricuspid) regurgitation is present, it results from left (or right) ventricular chamber dilation (functional regurgitation)
  • Either the coronary arteries are free of significant narrowing or the obstructions present are insufficient to explain the degree of cardiac dysfunction.
933
Q

What are the histological changes of dilated cardiomyopathy?

A
  • The histological abnormalities in DCM are nonspecific and usually do not point to a specific etiology
  • Most muscle cells are hypertrophied with enlarged nuclei, but some are attenuated, stretched, and irregular
  • Interstitial and endocardial fibrosis of variable degree is present, and small subendocardial scars may replace individual cells or groups of cells, probably reflecting healing of previous ischaemic necrosis of myocytes caused by hypertrophy-induced imbalance between perfusion and demand
  • Morever, the severity of morphological changes may not reflect either the degree of dysfunction or the patient’s prognosis
934
Q

At what age does dilated cardiomyopathy often occur?

A

It can occur at any age, including in childhood, but it mostly commonly affects individuals between the ages of 20 and 50.

935
Q

How does dilated cardiomyopathy tend to present?

A
  • It presents with slowly progressive signs and symptoms of chronic heart failure including dyspnoea, easy fatiguability, and poor exertional capacity
  • At the end stage, ejection fractions are typically less than 25%
  • Secondary mitral regurgitation and abnormal cardiac rhythms are common, and embolism from intracardiac thrombi can occur.
936
Q

How does death usually occur from dilated cardiomyopathy? How is it treated?

A
  • Death usually results from progressive cardiac failure or arrhythmia, and can occur suddenly
  • Although the annual mortality is high (10-50%), some severely affected patients respond well to pharmacologic therapy
  • Cardiac transplantation is also increasingly performed, and long-term ventricular assis can be beneficial.
937
Q

What is arrhythmogenic right ventricular cardiomyopathy? What does it cause?

A
  • Arrhythmogenic right ventricular cardiomyopathy is an inherited disease of myocardium causing right ventricular failure and rhythm distrubances (particularly ventricular tachycardia or fibrillation) with sudden death
  • Left sided involvement with left-sided heart failure may also occur.
938
Q

What is the morphology of arrhythmogenic right ventricular cardiomyopathy?

A
  • Morphologically, the right ventricular wall is severely thinned due to loss of myocytes, accompanied by extensive fatty infiltration and fibrosis.
  • Although myocardial inflammation may be present, ARVC is nor considered an inflammatory cardiomyopathy.
939
Q

What are the genetic links associated with arrhythmogenic right ventricular cardiomyopathy?

A
  • Classic ARVC has autosomal dominant inheritance with a variable penetrance.
  • The disease has been attributed to defective cell adhesion proteins in the desmosomes that link adjacent cardiac myocytes.
  • Naxos syndrome is a disorder characterised by arrhythmogenic right ventricular cardiomyopathy and hyperkeratosis of plantar palmar skin surfaces specifically associated with mutations in the gene encoding the desmosome-associated protein plakoglobin.
940
Q

What is hypertrophic cardiomyopathy? What is it’s incidence?

A

Hypertrophic cardiomyopathy (HCM) is a common (incidence, 1 in 500), clinically heterogenous, genetic disorder characterised by myocardial hypertrophy, poorly compliant left ventricular myocardium leading to abnormal diastolic filling, and (in about 1/3 of cases) intermittent ventricular outflow obstruction.

941
Q

What are the most common diseases that must be distinguished clinically from hypertrophic cardiomyopathy?

A
  • Depositiondiseases such as amyloidosis, Fabry disease
  • Hypertensive heart disease coupled with age-related subaortic septal hypertrophy.
  • Occasionally, valvular or congenital subvalvular aortic stenosis can also mimic HCM
942
Q

What are the genetic links associated with hypertrophic cardiomyopathy?

A
  • In most cases, the pattern of transmission is autosomal dominant with variable penetrance.
  • HCM is caused by mutations in any one of the several genes that encode sarcomeric proteins; there are more than 400 different known mutations in nine different genes, most being missense mutations
  • Mutations causing HCM are found most commonly in the gene encoding β-myosin heavy chains, following by genes coding for cardiac TnT, α-tropomyosin, and myosin-binding protein C.
  • The prognosis of HCM varies widely and correlates strongly with specific mutations
943
Q

What is the gross morphology of hypertrophic cardiomyopathy?

A
  • The essential feature of HCM is massive myocardial hypertrophy, usually without ventricular dilation.
  • The classic pattern involves disproportionate thickening of the ventricular septum relative to the left ventricle free wall (with a ratio of septum to free wall greater than 3:1), termed asymmetric septal hypertrophy. In about 10% of cases, the hypertrophy is concentric and symmetrical.
  • On longitudinal sectioning, the normally round-to-ovoid left ventricular cavity may be compressed into a “banana-like” configuration by bulging of the ventricular septum into the lumen.
  • The left ventricular outflow tract often exhibits a fibrous endocardial plaque associated with thickening of the anterior mitral leaflet.
944
Q

In hypertrophic cardiomyopathy, where is the hypertrophy?

A

Although marked hypertrophy can invovle the entire spetum, it is usually most prominent in the subaortic region.

945
Q

In hypertrophic cardiomyopathy, the left ventricular outflow tract often exhibits a fibrous endocardial plaque associated with thickening of the anterior mitral leaflet. Why? Will you see this on echo?

A

Both findings result from contact of the anterior mitral leaflet with the septum during ventricular systole; they coorelate with the echocardiographic “systolic anterior motion” of the anterior leaflet, with functional left ventricular outflow tract obstruction during mid-systole.

946
Q

What are the most important histological features of the myocardium in hypertrophic cardiomyopathy?

A

1) massive myocyte hypertrophy, with transverse myocyte diametes frequently greater than 40μm (normal, approx 15μm)
2) haphazard disarray of bundles of myocytes, individual myocytes, and contractile elements in sarcomeres within cells (termed myofiber disarray)
3) interstitial and replacement fibrosis

947
Q

What in the pathological changes that occur in hypertrophic cardiomyopathy? How does this present clinically?

A
  • The central abnormalities in HCM is reduced stroke volume due to impaired diastolic filling.
  • This is a consequence of a reduced chamber size, as well as the reduced compliance of the massively hypertrophied left ventricle.
  • In addition, approximately 25% of patients with HCM have dynamic obsutrction to the left ventricular outflow
  • The compromsied cardiac output in conjunction with a secondary increase in pulmonary venous pressure explains the exertional dyspnoea seen in these patients.
948
Q

What do you hear on auscultation of hypertrophic cardiomyopathy? Why?

A

Auscultation discloses a harsh systolic ejection murmur, caused by the ventricular outflow obstruction as the anterior mitral leaflet moves toward the ventricular septum during systole.

949
Q

Why does focal myocardial ischaemia commonly occur in hypertrophic cardiomyopathy, even in the absence of concomitant coronary artery disease?

A

Because of the massive hypertrophy, high left ventricular chamber pressure, and frequently thick-walled intramural arteries.

950
Q

What are the major clinical problems in hypertrophic cardiomyopathy?

A

AF, mural thrombus formation leading to embolisation and possible stroke, intractable cardiac failure, ventricular arrhythmias, and not infrequently, sudden death, especially with certain specific mutations.

951
Q

What is the course of progression of hypertrophic cardiomyopathy? How is it treated?

A
  • The natural history of HCM is highly variable.
  • Most patients can be helped by pharmacological intervention (eg, β-blockers) to decrease heart rate and contractility.
  • Some benefit can also be gained by reducing the septal myocardial mass, thus relieving the outflow tract obstruction. This can be achieved either by surgical excision of muscle or by carefully controlled septal infarction through a catheter-based infusion of alcohol
952
Q

What are the characteristics of restrictive cardiomyopathy? What can it be confused with?

A
  • It is characterised by a primary decrease in ventricular compliance, resulting in impaired ventricular filling during diastole.
  • Because the contractile (systolic) function of the left ventricle is usually unaffected, the function abnormality can be confused with that of constrictive pericarditis or HCM.
953
Q

What diseases in restrictive cardiomyopathy associated with?

A

It can be idiopathic or associated with distinct diseases or processes that affect the myocardium, pricipally radiation fibrosis, amyloidosis, sarcoidosis, metastatic tumours, or the deposition of metabolites that accumulate due to inborn errors of metabolism.

954
Q

What are the gross morphological features of restrictive cardiomyopathy?

A
  • The morphological features are not distinctive
  • The ventricles are of approximately normal size or slightly enlarged, the cavities are not dilated, and the myocardium is firm and non-compliant.
  • Biatrial dilation is commonly observed.
955
Q

What are the microscopic features of restrictive cardiomyopathy?

A

Microscopically, there may be only patchy or diffuse interstitial firbosis, which can vary from minimal to extensive.
Endomyocardial biopsy can often reveal a specific etiology.

956
Q

What are some important subgroups of restrictive cardiomyopathy?

A
  • Amyloidosis
  • Endomyocardial fibrosis
  • Loeffler endomyocarditis
  • Endocardial fibroelastosis
957
Q

What is endomyocardial fibrosis? Where is it common?

A

Endomyocardial fibrosis is principally a disease of children and young adults in Africa and other tropical areas, characterised by fibrosis of the ventricular endocardium and subendocardium that extends from the apex upward, often involving the tricuspid and mitral valves.

958
Q

What are the pathological outcomes of endomyocardial fibrosis?

A
  • The fibrous tissue markedly diminishes the volume and compliance of affected chambers and so causes a restrictive functional defect.
  • Ventricular mural thrombi sometimes develop, and indeed the endocardial fibrosis may result from thrombus organisation
959
Q

What is the pathological sequence of Loeffler endomyocarditis? How is it similar and different to endomyocardial fibrosis?

A
  • It results in endomycocardial fibrosis, typically with large mural thrombi, with an overall morphology similar to the tropical disease.
  • However, in addition to the cardiac changes, there is often a peripheral eosinophilia and eosinophilic infiltrates in multiple organs, including the heart.
  • The release of toxic products of eosinophils especially major basic protein, is postulated to initiate endomyocardial necrosis, followed by scarring of the necrotic area, layering of the endocardium by thrombus and finally organisation of the thrombus.
960
Q

What disease is associated with Loeffler endomyocarditis and how do we treat it? What happens if we dont?

A
  • Many patients with Loeffler endomyocarditis have a myeloproliferative disorder associated with chromosomal rearrangements involving either the platelet-derived growth factor receptors (PDGFR)-α or -β genes.
  • These rearrangmenets produce fusion genes that encode constitutively active PDGFR tyrosine kinases.
  • Treatment of such patients with the tyrosine kinase inhibitor imatinib has resulted in haematologic remissions associated with reversal of the endomyocarditis, which is otherwise often rapidly fatal.
961
Q

What is endocardial fibroelastosis? At what age is it most common and in what sub-type of the age?

A
  • It is an uncommon heart disease characterised by fibroelastic thickening that typically involved the left ventricular endocardium.
  • It is most common in the first 2 years of life; in a third of cases, it is accomopanied by aortic valve obstruction or other congenital cardiac anomalies?
962
Q

Endocardial fibroelastosis may actually represent a common morphological end-point of several different insults. What do these include?

A
  • Viral infections (eg, intrauterine exposure to mumps)
  • Mutations in the gene for tafazzin, which affected mitochondrial inner membrane integrity
  • Diffus involvement may be responsible for rapid and progressive cardiac decompensation and death
963
Q

What is myocarditis?

A

A diverse group of pathological entities in which infectious microorganisms and/or a primary inflammatory process causes myocardial injury.

964
Q

What are the major causes of myocarditis?

A
  • In the US, viral infections are the most common cause of myocarditis. Coxsackie viruses A/B and other enteroviruses account for most causes.
  • Other less common etiologic agents include CMV, HIV, influenza, chlamydia, rickets, meningococcus, candida
  • Immune-mediated reactions that cause it are post-viral, post-streptococcal (rheumatic fever), SLE, drug hypersensitivity and transplant rejections
  • Other cuases include sarcoidosis, giant cell myocarditis.
965
Q

How can a virus cause myocarditis?

A
  • Depending on the pathogen and the host, viruses can potentially cause myocardial injury either as a direct cytopathic effect, or by eliciting a destructive immune response.
  • Inflammatory cytokines produced in response to myocardial injury can also cause myocardial dysfunction that is out of proportion to the degree of actual myocyte damage.
966
Q

What is the gross morphology of myocarditis?

A
  • Grossly, the heart in myocarditis may appears normal or dilated; some hypertrophy may be present depending on disease duration.
  • In advanced stages, the ventricular myocardium is flabby and often mottled by either pale focci or minute haemorrhagic lesions.
  • Mural thrombi may be present
967
Q

What is the histological morphology of myocarditis?

A
  • Active myocarditis is characterised by an interstitial inflammatory infiltrate associated with focal myocyte necrosis.
  • A diffuse, mononuclear, predominantly lymphocytic infiltrate is most common.
  • Although endomyocardial biopsies are diagnostic in some causes, they can be spuriosly negative because inflmmatory involvement of the myocardium may be focal or patchy.
  • If the patient survives the acute phase, the inflammatory lesions either resolve, leaving no residual changes, or heal by progressive fibrosis
968
Q

Nonviral agents are also an important cause of infectious myocarditis, particularly the protozoan Typanosoma cruzi. What disease does this cause? Where? What is its prognosis?

A

Chagas disease is endemic in some regions of South America, with myocardial involvement in most infected individuals.
About 10% of patients die during an acute attack; others develop a chronic immune-mediated myocarditis that may progress to cardiac insufficiency in 10-20 years.

969
Q

What is the histological morphology of immune-mediated/hypersensitivity myocarditis?

A

Hypersensitivity myocarditis has interstitial infiltrates, principalle perivascular, composed of lymphocytes, macrophages, and a high proportion of eosinophils

970
Q

What is the histological morphology of giant-cell myocarditis? What is its prognosis?

A
  • It is characterised by a widespread inflammatory cellular infiltrate containing multinucleate giant cells (fused macrophages) interspersed with lymphocytes, eosinophils, plasma cells, and macrophages.
  • Focal to frequently extensive necrosis is present.
  • This variant likely represents the fulminant end of the myocarditis spectrum and carries a poor prognosis
971
Q

What is the histological morphology of Chagas disease myocarditis?

A

It is distinctive by virute of the parasitisation of scattered myofibers by trypanosomes accompanied by a mixed inflammatory infiltrate of neutrophils, lymphocytes, macrophages, and occasional eosinophils

972
Q

What are the clinical features of cardiomyopathy?

A
  • The clinical spectrum of myocarditis is broad.
  • At one end, the disease is entirely asymptomatic, and patients can expect a complete recovery without sequelae.
  • At the other extreme is the precitious onset of heart failure or arrhtyhmias, occasionally with sudden death,
  • Between these extremes are the many levels of involvement associated with symptoms such as fatigue, dyspnoea, palpitations, precordial discomfort and fever
  • Patients can develop dilated cardiomyopathy as a late complication of myocarditis.
973
Q

Which cardiotoxic cancer drugs can cause myocardial disease? What do they cause? At what levels is the most common one?

A
  • Cardiotoxicity has been associated with conventional chemotherapeutic agents, tyrosine kinase inhibitors, and certain forms of immunotherapy.
  • The anthracyclines doxorubicin and daunorubicin are the chemotherapeutic agents most often associated with toxic myocardial injury; they cause dilated cardiomyopathy with heart failure attributed primarily to peroxidation of lipids in myocyte membranes.
  • Anthra cycline toxicity is dose-dependent, with the cardiotoxicity risk increasing when cumuluative life-time doses exceed 500mg/m2
974
Q

Many therapeutic agents, including lithium, phenothiazine and chloroquine can idiosyncractically induce myocardial injury and sometimes death. What are some common histological findings in affected myocardium? How do you treat it?

A
  • Myofiber swelling, cytoplasma vacuolisation, and fatty change.
  • Discontinuining the offending agent often leads to prompt resolution, without apparent sequelae.
  • Occasionally, however, more extensive damage produces myocyte necrosis that can evolve to a dilated cardiomyopathy.
975
Q

What is pathogenesis of amyloidosis?

A

Amyloidosis results from the extracellular accumulation of protein fibrils that are prone to forming insoluble β-pleated sheets.

976
Q

How can cardiac amyloidosis occu?

A

It can appear as a consequence of systemic amyloidosis (eg, due to myeloma or inflammation-associated amyloid) or can be restricted to the heart, particularly in the elderly (senile cardiac amyloidosis)

977
Q

Who does senile cardiac amyloidosis occur in? What is the prognosis?

A

Senile cardiac amyloidosis characteristically occurs in individuals over 70 years old, and has a far better prognosis that systemic amyloidosis

978
Q

What is the pathogensis of senile cardiac amyloidosis?

A
  • Senile cardiac amyloid deposits are largely composed of transthyretin, a normal serum protein synthesised in the liver that transports thyroxine and retinol-binding protein.
  • Mutant formed of transthyretin can accelerate the cardiac (and associated systemic) amyloid deposition.
979
Q

What are the clinical features of cardiac amyloidosis?

A
  • Cardiac amyloidosis most frequently produces a restrictive cardiomyopathy, but it can also be asymptomatic, manifest as filation or arrhythmias, or mimic ischaemic or valvular disease.
  • The varied presentations depend on the predominant location of the deposits, for example, intersititium, conduction system, vasculature, or valves.
980
Q

What is the gross morphology of cardiac amyloidosis?

A

In cardiac amyloidosis the heart varies in consistency from normal to firm and rubbery.
The chambers are usually of normal size, but can be dilated and have thickced walls.
Small, semitranslucent nodules resembling drips of wax may be seen on the atrial endocardial surface, particularly on the left.

981
Q

What is the histology of cardiac amyloidosis?

A
  • Histologically, hyaline eosinophilic deposits of amyloid may be found in the interstitium, conduction tissues, valves, endocardium, pericardium, and small intramural coronary arteries
  • They can be distinguished from other deposits by special stains such as Congo red, which produces classic apple-green bifriendence when viewed under polarised light.
  • Intramural arteries and arterioles may have sufficient amyloid in their walls to compress and occlude their lumens, inclduing myocardial ischaemia
982
Q

What are the most important pericardial disorders?

A

Ones that cause fluid accumulation, inflammation, fibrous constriction or some combination of these processes, usually in association wiht other cardiac pathology or a systemic disease

983
Q

What are the different types of pericardial effusion? (Give me the normal volume of fluid in the pericardium).

A
  • Normally, the pericardial sac contains less than 50mL of thin, clear, straw-coloured fluid
  • Under various circumstances that parietal pericardium may be distended by serous fluid (pericardial effusion), blood (haemopericardium) or pus (purulent pericarditis)
984
Q

What is the difference between a chronic pericardial effusion and an acute one?

A
  • With long-standing cardiac enlargement or with slowly accumulating fluid, the pericardium has time to dilate. This permits a slowly accumulating pericardial effusion to become quite large without interfering with cardiac function. thus, with chronic effusions of less than 500mL, the only clinical significance is a characteristic globular enlargement of the heart shadow of chest radiographs.
  • In contract, rapidly developing fluid collections of as little as 200-300mL (eg, due to haemopericardium caused by a ruptured MI or aortix dissection) can produce clinically devastating compression of the thin-walled atria and venae cavae, or the ventricles themselves; cardiac filling is thereby restricted, producing potentially fatal cardiac tamponase
985
Q

Pericarditis can be split into primary and secondary. What are they and what causes them?

A
  • It can occur secondary to a variety of cardiac, thoracic, or systemic disorders, metastases from remote neoplasms, or cardiac surgical procedures
  • Primary percarditis is unusual and almost always of viral origin
986
Q

What are the different causes of percarditis?

A

Infectious agents
viruses
pyogenic bacteria
TB
funghi
Presumable immunologically mediated
rheumatic fever
SLE
scleroderma
postcardiotomy
post-MI (Dressler’s syndrome)
drug hypersensitivity reaction
Miscellanous
MI
uraemia
post-cardiac surgery
neoplasia
trauma
radiation

987
Q

What are the two types of acute percarditis?

A

Serous and fibrinous

988
Q

What causes serous pericarditis? How?

A
  • It is characteristically produced by non-infectious inflammatory diseases, including rheumatic fever, SLE, and scleroderma, as well as tumours or uraemia.
  • An infection in the tissues contiguous to the pericardium may incite sufficient irritation of the parietal pericardial serosa to cause a sterile serous effusion that can progress to serofibrinous pericarditis and ultimately to frank suppurative reaction.
  • In some instances a well-defined viral infection elsewhere - URTI, pneumonia, parotitis - antedates the percarditis and serves as the primary focus of infection
989
Q

In what age group does primary pericarditis often present?

A

Infrequently, usually in young adults, a viral pericarditis occurs as an apparent primary infection that may be accompanied by myocarditis

990
Q

How can tumours cause a serous pericarditis?

A

Tumours can cause a serous pericarditis by lymphatic invasion or direct contiguous extension into the pericardium.

991
Q

What is the histological morphology of acute serous pericarditis?

A

Histologically, serous pericarditis elicits a mild inflammatory infiltrate in the epipericardial fat consisting predominantly of lymphocytes; tumour-associated pericarditis may also exhibit neoplastic cells. Organisation into fibrous adhesions rarely occurs.

992
Q

What is fibrinous and serofibrinous pericarditis? Are they common? What causes them?

A
  • They are the most frequent types of pericarditis
  • They are composed of serous fluid variably admixed with a fibrinous exudate.
  • Common causes include acute MI, postinfarction (Dressler) syndrome, uraemia, chest radiation, rheumatic fever, SLE, and trauma. A fibrinous reaction also follows routine cardiac surgery
993
Q
A
994
Q

What is the morphology of fibrinous and serofibrinous pericarditis?

A
  • In fibrinous pericarditis the surface is dry, with a fine granular roughening.
  • In serofibrinous pericarditis a more intense inflammatory process inuced the accumulation of larger amounts of yellow to brown turbid fluid, conatining leukocytes, erythrocytes, and fibrin.
  • As this all inflammatory exudates, fibrin may be lysed with resolution of exudate, or can become organised.
995
Q

What are the symptoms of fibrinous pericarditis?

A
  • They characteristically include pain (sharp, pleuritic, and position dependent) and fever; congestive failure may also be present.
  • A loud pericardial friction rub is the most striking clinical finding.
996
Q

Purulent or suppurative pericarditis reflects an active infection caused by microbial invasion of the pericardial space. How can this occur?

A

Through:
* direct extension from neighbouring infections, such as empyema of the pleural cavity, lobar pneumonia, mediastinal infections, or extension of a ring abscess through the myocardium or aortic root
* seeding from the blood
* lymphatic extension
* direct introduction during cardiotomy.

997
Q

What are the gross morphological features or purulent pericarditis?

A
  • The exudate ranges from a thin cloudy fluid to frank pus up to 400-500mL in volume
  • The serosal surfaces are reddened, granular, and coated with the exudate.
998
Q

What are the microscopic features of purulent pericarditis?

A

Microscopically, there is an acute inflammatory reaction, which sometimes extends into surrounding structures to induce mediastinopericarditis.

999
Q

What are the clinical sequelae of purulent pericarditis?

A
  • Complete resolution is infreuent, and organised by scarring is the usual outcome
  • The intense inflammatory response and the subsequent scarring frequently produce constrictive pericarditis, a seious consequence
1000
Q

What is haemorrhagic pericarditis? What is it commonly caused by?

A
  • It has an exudate composed of blood mixed with a fibrinous or suppurative effusion
  • It is most commonly caused by the spread of a malignant neoplasm to the pericardial space. In such cases, cytologic examination of fluid removed through a pericardial tap often reveals neoplastic cells.
  • It can also be found in bacterial infections, in patients with an undering bleeding diathesis, and in TB.
  • It often follows cardiac surgery and os occasionally responsible for significant blood loss of even tamponade, requiring re-operation.
1001
Q

What is chronic pericarditis?

A
  • In some cases organisation merely produces plaque-like fibrous thickenings of the serosal membranes (“soldier’s plaque”) or thin, delicate adhesions that rarely cause impairment of cardiac function.
  • In other cases, fibrosis in the form of mesh-like stringy adhesions completely obliterates the pericardial sac. In most instances, this adhesive pericarditis has not effect on cardiac function.
1002
Q

What is adhesive mediastinopericarditis? When does it happen?

A
  • Adhesive mediastinopericarditis may follow infectious pericarditis, previous cardiac surgery, or mediastinal irradiation.
  • The pericardial sac is obliterated, and adherence of the external aspect of the parietal layer to surrounding structures strains cardiac function.
  • With each systolic contraction, the heart pulls not only against the parietal pericardium but also against the attached surrounding structures.
  • Systolic retraction of the rib cage, and diaphragm, pulsus paradoxus, and a vairety of other characteristic clinical findings may be observed.
  • The increased workload causes occasionally severe cardiac hypertrophy and dilation.
1003
Q

What is constrictive pericarditis?

A
  • The heart is encased in a dense, fibrous or fibrocalcific scar that limits diastolic expansion and cardiac output, features that mimic a restrictive cardiomyopathy.
  • A prior history of pericarditis may or may not be present.
1004
Q

How thick can the fibrous scar in constrictive pericarditis be? What does this mean for cardiac output?

A
  • The fibrous scar can be up to a centimeter in thickness, obliterating the pericardial space and sometimes calcifying; in extreme cases it can resemble a plaster mold (concretio cordis)
  • Because of the dense enclosing scar, cardiac hypertrophy and dilation cannot occur.
  • Cardiac output may be reduced at rest, but more importnatly the heart has little if any capacity to increase its output in reponse to increased systemic demands.
1005
Q

What are the clinical features and treatments of constrictive pericarditis?

A
  • Signs of pericarditis include distant or muffled heart sounds, elevated jugular venous pressure, and peripheral oedema
  • Treatment consists of surgical resection of the shell of constricting fibrous tissue (pericardectomy).
1006
Q

What is valvular stenosis and insufficency/regurgitation?

A
  • Stenosis is the failure of a valve to open completely, which impedes forward flow.
  • Insufficiency results from failure of a valve to close completely, thereby allowing reversed flow
1007
Q

What is function valve regurgitation?

A

It is used to descibre the incompetence of a vlave stemming from an abnormality in one of its support structures, as opposed to a primary valve defect.
For example, dilation of the right or left ventricle can pull the venticular papillary muscles down and outward, thereby preventing proper closure of otherwise normal mitral or tricuspid leaflets.

1008
Q

What are the clinical consequences of valve dysfunction?

A

They vary of the valve involved, the degree or impariemtn, the tempo of disease onset, and the rate and quality of compensatory mechanisms.
* For example, sudden destruction of an aortic valva cusp by infective endocarditis can cause acute, massive and rapidly fatal regurgitation.
* In contrast, rheumatic mitral stenosis typically develops indolently over yeats, and its clinical effects can be well tolerated for extended periods.

1009
Q

Valvular stenosis or insufficiency often produces secondary changes, both proximal and distal to the affected valve. What are these?

A
  • Generally, valvular stenosis leads to pressure overload cardiac hypertrophy, where mitral or aortic valvular insufficiency leads to volume overload.
  • Both situations can culminate in heart failure
  • In addition, the ejection of blood through narrowed stenotic valves can produce high speed “jets” of blood that injure the endocardium where they impact.
1010
Q

Valvular abnormalities can be congenital or acquired. Tell me about acquired valvular stenosis and acquired valvular insufficiency.

A
  • Acquired valvular stenosis has relative few causes; it is almost always a consequence of a remote or chronic injury of the valve cusps that declares itself clinically only after many years.
  • In contrast, acquired valvular insufficiency can result from intrinsic disease of the valve cuspss or damage to or distortion of the supporting structures (eg, the aorta, mitral annulus, tendinous cords, papillary muscles, ventricular free wall)
1011
Q

What are the most freuqent causes of the major functional valvular lesions?

A
  • Aortic stenosis: calcification and sclerosis of anatomically normal or congenitally bicuspid aortic valves
  • Aortic insuffiency: dilation of the ascending aorta, often secondary to HTN and/or aging
  • Miral stenosis: rheumatic heart disease
  • Miral insufficiency: myxomatous denegeration (mitral valve prolapse)
1012
Q

What is the most common of all valvular abnormalities? What is the usual cause?

A
  • Calcific aortic stenosis is usually the consequence of age-associated “wear and tear” of either anatomically normal valves or congenitally bicuspid valves (in approx 1% of the population).
  • It is likely a consequence of recurrent chronic injury due to hyperlipidaemia, HTN, inflammation, and other factors similar to those implicated in atherosclerosis.
1013
Q

What is the prevalence of aortic stenosis? Is it changing?

A

The prevalence of aortic stenosis is estimated at 2% and is increasing as the general population ages.

1014
Q

Aortic stenosis of previously normal valves usually comes to attention in the 7th-9th decades of life, whereas stenotic bicuspid valves tend to become clinically significant 1-2 decades earlier. Why?

A

Bicuspid valves incur greater mechanical stress than normal tricuspid valves, which may explain their accelerated stenosis.
The chronic progressive injury leads to valvular degeneration and incites the deposition of hydroxyapatite.

1015
Q

What is the gross morphology of aortic stenosis?

A

The gross morphologic hallfmark of non-rheumatic calcific aortic stenosis is mounded calcified masses within the aortic cusps that ultimately protrude through the outflow surfaces into the sinuses of Valvalva and prevent cuspal opening. The free edges of the cusps are usually not involved.

1016
Q

What is the microscopic morphology of calcific aortic stenosis?

A
  • Microscopically, the layered architecture of the valve is largely preserved.
  • The calcific process begins in the valvular fibrosa on the outflow surface of the valve, at the points of maximal cusp flexion (near the margins of attachment).
  • Inflammation is variable, and metplastic bone may be seen
1017
Q

What are the functional consequences of aortic stenosis?

Give me numbers please

A
  • In aortic stenosis, the obstruction to left ventricualr outflow leads to gradual narrowing of the valve orifice (valve area approx 0.5-1cm2 in severe aortic stenosis, normal approx 4cm2) and an increasing pressure gradient across the calcified valve, reaching 75 - 100 mmHg in severe cases.
  • Left ventricular pressures rise to 200 mmHg or more in such instances, producing concentric left ventricular (pressure overload) hypertrophy.
  • The hypertrophied myocardium tends to be ischaemic (as a result of diminished microcirculatory perfusion) and angine may occur.
  • Both systolic and diastolic myocardiacl function may be impaired; eventually, cardiac decompensation and CHF can ensue.
1018
Q

How does mitral involvement in rheumatic aortic stenosis and calcific aortic stenosis differ?

A

In calcific aortic stenosis, the mitral valve is generally normal,although some patient may have direct extension of aortic valve calcific deposits onto the anterior mitral leaflet.
In contrast, virtually all patients with rheumatic aortic stenosis also have concomitant and characteristic structural abnormalities of the mitral valve.

1019
Q

What is the prognosis of calcific aortic stenosis? How is it treated?

A
  • The onset of symptoms (angina, CHF, or syncope) in aortic stenosis heralds cardiac decompensation and carries an extremely poor prognosis.
  • If untreated, most patient with aortic stenosis will die within 5 years of developing angina, within 3 years of developing syncope, and within 2 years of CHF onset.
  • Treatment requires surgical valve replacement, as medical therapy is ineffective in severe symptomatic aortic stenosis.
1020
Q

What is the prevalence of a congenitally bicuspid aortic valve? Is it genetic? How so? What is it associated with?

A
  • Bicuspid aortic valve is a development of abnormality with prevalnce in teh population of approx 1%.
  • Some cases of BAV show familial clustering, often with associated aorta or left ventricular outflow tract malformations.
1021
Q

What is the pathology of a congenitally bicuspid aortic valve? What area is a major site for calcific deposits?

A
  • There are only two functional cusps, usually of unequal size, with the larger cusp having a midline raphe resulting from incomplete commissural separation during development; less frequently the cusps are of equal size and the raphe is absent.
  • The raphe is frequently a major site of calcific deposits.
1022
Q

Aortic valves can become bicuspid because of an acquired deformity. How? By what? and how can we tell?

A
  • Valves that become bicuspid because of an acquired deformity (e.g. rheumatic valve disease) have a fused commissure that produces a conjoined cusp that is generally twice the size of the non-conjoined cusp.
1023
Q

What are the clinical features of a bicuspid aortic valve?

A
  • Although BAV is usually asymptomatic early in life, late complications include aortic stenosis or regurgitation, infective endocarditis, and aortic dilation and/or dissection.
  • In particular, BAVs are predisposed to progressive calcification, similar to that occurring in aortic valves with initially normal anatomy.
1024
Q

Sturctural abnormalities of the aortic wall also commonly accompany bilateral aortic valves. What is the consequence of this?

A

It may potentiate aortic dilation and aortic dissection.

1025
Q

Where do calcific deposits usually deposit in the mitral valve? How do they appear?

A
  • As opposed to the predominantly cuspal involvement in aortic valve calcification, degenerative calcific deposits in the mitral valve typically develop in the fibrous annulus.
  • Grossly, these appear as irregular, stony hard, occasionally ulcerated nodules (2-5mm in thickness) at the base of the leaflets (fig C and D).
1026
Q

How does mitral annular calcification affect valvular function?

A

Mitral annular calcification usually does not affect valvular function. However, in exceptional cases it can lead to
* Regurgitation by interfering with physiologic contraction of the valve ring
* Stenosis by impairing opening of the mitral leaflets
* Arrhythmias and occasionally sudden death by penetration of calcium deposits to a depth sufficienc to impinge on the AV conduction system.

1027
Q

What are some of the clinical consequences of calcific mitral stenosis?

A

Because calcific nodules may provide a site for thrombus formation, patients with mitral annular calcification have an increased risk of embolic stroke, and the calcific nodules can become a nidus for infective endocarditis

1028
Q

What population does mitral annular calcification occur in?

A

Mitral annular calcification is most common in women older than 60 and individuals with mitral valve prolapse

1029
Q

What happens during a mitral valve prolapse? What is its prevalence and who does it effect?

A
  • One or both mitral valve leaflets are “floppy” and prolapse, or balloon back into the left atrium during systole.
  • It affects approximately 2-3% of adults in the US with an approximate 7:1 female:male ratio.
1030
Q

What is the pathogenesis of mitral valve prolapse?

A
  • The etiologic bases is unknown in most cases.
  • Uncommonly, MVP is associated with heritable disorders of connective tissue including Marfan syndrome, caused by fibrillin-1 mutations. Fibrillin-1 defects alter cell-matrix interactions and dysregulate TGF-β signaling.
1031
Q

What are the gross morphological changes in mitral valve prolapse?

A
  • The characteristic anatomic change in MVP in interchordal ballooning (hooding) of the mitral leaflets or portions thereof.
  • The affected leaflets are often enlarged, redundant, thick and rubbery.
  • The associated tendinous cords may be elongated, thinned, or even ruptured, and the annulus may be dilated.
  • The tricuspid, aortic or pulmonary valves may also be affected.
1032
Q

What are the key histological changes associated with mitral valve prolapse?

A
  • Marked thickening of the spongiosa layer with deposition of mucoid (myxomatous) material, called myxomatous degeneration
  • There is also attenuation of the collagenous fibrosa layer of the valve, on which the structural integrity of the leaflet depends.
1033
Q

In mitral valve prolapse, secondary changes reflect the stresses and tissue injury indicent to the billowing leaflets. What are these changes?

A

1) fibrous thickening of the valve leaflets, particularly where they rub against each other
2) linear fibrous thickening of the left ventricular endocardial surface where the abnormally long cords snap or rub against it
3) thickening of the mural endocardium of the left ventricle or atrium as a consequence of friction-induced injury induced by the prolapsing, hypermobile leaflets
4) thrombi on the atrial surfaces of the leaflets or the atrial walls (B)
5) focal calcifications at the base of the posterior mitral leaflet (C)

1034
Q

What are the clinical features of mitral valve prolapse?

A

Most individuals diagnosed with MVP are asymptomatic; in such cases the condition is discovered incidentally by auscultation of mid-systolic clicks, sometimes followed by a mid-late systolic murmur.
A minority of patients have chest pain mimicking angina (although not exertional in nature), and a subset have dyspnoea, presumably related to vascular insufficiency.

1035
Q

Although the great majority of patients with mitral valve prolapse have no untoward effects, approximately 3% develop on of four serious complications. What are they?

A

1) infective endocarditis
2) mitral insufficiency, sometimes with chordal rupture
3) stroke or other systemic infarct, resulting from embolism of leaflet thrombi
4) arrhythmias, both ventricular and atrial

Rarely, MVP is the only finding in sudden cardiac ceath

1036
Q

The risk of serious complications of mitral valve prolapse is high and low in which populations? What do we do to treat this?

A
  • The risk is very low in MVP discovered incidentally in young asymptomatic patients; the risk is higher for mel, older patients, and those with arrhythmias or mitral regurgitation.
  • Valve repair or replacement surgery can be done for symptomatic patients or those with increased risk for significant complications; indeed, in the US, MVP is the most common cause for mitral valve surgery
1037
Q

What is rheumatic fever?

A

It is an acute, immunologically mediated, multisystem inflammatory disease classically occuring a few weeks after an episode of group A strep pharyngitis, occasionally, it can follow strep infections at other sites, such as the skin.

1038
Q

What is acute rheumatic carditis?

A

It is a common manifestation of active rheumatic fever and may progress over time to chronic rheumatic heart disease (RHD), mainly manifesting as valvular abnormalities.

1039
Q

How is rheumatic fever characterised?

A

Principally by deforming fibrotic valvular disease, particularly involving the mitral valve; RHD is virtually the only cause of mitral stenosis.

1040
Q

What is the pathogenesis of rheumatic fever?

A
  • Acute rheumatic fever results from host immune responses to group A streptococcal antigens that cross-react with host proteins.
  • In particular, antibodies and CD4+ T cells directed against streptococcal M proteins can also in some cases recognise cardiac self-antigens.
  • Antibody binding can activate complement, as well as recruit Fc-receptor bearing cells (neutrophils and macrophages); cytokine production by the stimulated T cells leads to macrophage activation.
  • Damage to heart tissue may thus be caused by a combination of antibody- and T-cell-mediated reactions.
1041
Q

What are the key microscopic morphological features of rheumatic fever?

A
  • During acute RF, focal inflammatory lesions are found in various tissues.
  • Distinctive lesions occur in the heart, called Aschoff bodies, consisting of foci of T-lymphocytes, occasional plasma cells, and plump activated macrophages called Anitschkow cells (pathognomic for RF).
  • These macrophages have abudant cytoplasm and central round-to-ovoid nuclei (occasionally binucleate) in which the chromatin condenses into a central slender, wavy ribbon
1042
Q

What are some of the clinical consequences of rheumatic fever and how you they appear histologically?

A
  • During acute RF, diffus inflammation and Ashocc bodies may be found in any of the three layers of the heart, resulting in pericarditis, myocarditis, or endocarditis (pancarditis).
  • Inflammation of the endocardium and the left-sided valves typically results in fibroid necrosis within the cusps or tendinous cords. Overlying these necrotic foci and along the lines of closure are small (1-2mm) vegetations, called verrucae.
  • subendocardial lesions, prehaps exacerbated by regurgitant jets, can induce irregular thickenings called MacCallum plaques, usually in the left atrium
1043
Q

What are the cardinal anatomic changes of the mitral valve in chronic rheumatic heart disease?

A

Leaflet thickening, commissural fusion and shortening, and thickening and fusion of the tendinous cords (D).

1044
Q

What valves are normally effected in rheumatic heart disease?

A

In chronic disease, the mtiral valve is virtually always involved.
The mitral valve is affected in isolation roughly 2/3rds of RHD, and along with aortic valve in another 25% of cases.
Tricuspid valve involvement is infrequent, and the pulmonary valve is only rarely affected

1045
Q

How is the valve affected in chronic rheumatic mitral stenosis?

A
  • Calcification and fibrous bridging across the valvular ommissures create “fish mouth” or “buttonhole” stenoses.
  • With tight mitral stenosis, the left atrium progressively dilates and may harbor mural thrombi that can embolise.
1046
Q

What are the microscopic features of chronic rheumatic heart disease?

A

Valves show organised of the acute inflammation, with post-inflammatory neovascularisation and transmural fibrosis that obliterate the leaflet architecture.
Aschoff bodies are rarely seen in surgical specimens or autopsy tissue from patients with chronic RHD, as a result of the long intervals between the initial insult and the development of the chronic deformity

1047
Q

What are the clinical features of rheumatic fever? How do you diagnose it?

A

It is characterised by a constellation of findings:
1) migratory polyarthritis of the large joints
2) pancarditis
3) subcutaneous nodules
4) erythema marginatum of the skin
5) Sydenham chorea, a neurological disorder with involuntary rapid, purposeless movements.

The diagnosis is via the Jones criteria: evidence of a preceding group A strep infection, with the presence of two of the major manifestations above or one major and two minor manifestations (non-specific signs and symptoms that include fever, arthralgia, or elevated blood levels of acute-phase reactants)

1048
Q

When and in what age group does acute rheumatic fever often occur?

A

It typically appears 10 days to 6 weeks after a group A strep infection in about 3% of patients.
It occurs most often in children between ages 5 and 15, but first attacks can occur in middle to later life.

1049
Q

What antibodies are present in rheumatic fever and when?

A

Although pharyngeal cultures for strep are negative byt the time the illness begins, antibodies to one or more streptococcal enzymes, such as streptlysin O and DNase B can be detected in the serum of most patients with RF.

1050
Q

What are the predominant clinical manifestations of rheumatic fever in adults and children?

A

The predominant clinical manifestations are carditis and arthritis, the latter more common in adults than in children.
Arthritis typically begins with a polymigratory polyarthritis (accompanied by fever) in which one large joint after another becomes painful and swollen for a period of days and then subsides spontaneously, leaving no residual disability.

1051
Q

What are the clinical features related to acute carditis?

A

Pericardial friction rubs, tachycardia, and arrhythmias.
Myocarditis can cause cardiac dilation that may culminate in functional mitral valve insufficiency or even heart failure.
Approximately 1% of affected individuals die of fulminant RF involvement of the heart.

1052
Q

What happens in recurrent attacks of rheumatic fever?

A
  • After an initial attack there is increased vulnerability to reactivation of the disease with subseuquent pharyngeal infections, and the same manifestations are likely to appear with each recurrent attack.
  • Damage to the valves is cumulative. Turbulence induced by ongoing valvular deformities leads to additional fibrosis.
1053
Q

How do the lungs develop embryologically?

A
  • The respiratory system is an outgrowth from the ventral wall of the foregut.
  • The midline trachea develops two lateral outpocketings, the lung buds
  • The lung buds eventually divide into branches called lobar bronchi, three on the right and two on the left, thus giving rise to three lobes on the right and two on the left.
1054
Q

Developmental anomalies of the lung are rare. What are some of the more common ones?

A
  • Pulmonary hypoplasia is the defective development of both lungs, resulting in decreased weight, volume, and acini for body weight and gestational age
  • Foregut cysts arise from abnormal detachments of primitive foregut and are most often located in the hilum or middle mediastinum.
  • Pulmonary sequestration refers to a discrete area of lung tissue that 1) lacks any connection to the airway system and 2) has an abnormal blood supply arising from the aorta or its branches
1055
Q

What causes pulmonary hypoplasia?

A

It is caused by abnormalities that compress the lung or impede normal lung expansion in utero, such as CDH and oligohydramnios.

1056
Q

Foregut cysts are classfied depending on the wall structure. What are these classifications? What are the microscopic characteristics of the cyst?

A
  • They are classified as bronchogenic (most common), oesophageal, or enteric. A bronchogenic cyst is rarely connected to the tracheobronchial tree.
  • Microscopically, the cyst is lined by ciliated pseudostratified columnar epithelium. The wall contains bronchial glands, cartilage, and smooth muscle.
1057
Q

What are intralobar vs extralobar pulmonary sequestrations? When and why do they occur?

A
  • Extralobar sequestrations are external to lung and most commonly come attention in infants as mass lesions. They may be associated with other congenital anomalies.
  • Intralobar sequestrations occur within the lung. They usually present in odler childre, often due to recurrent localised infection or bronchiectasis.
1058
Q

What is atelectasis?

A

Atelectasis refers either to incomplete expansion of the lungs (neonatal atelectasis) or to the collapse of previously inflated lung, producing areas of relatively airless pulmonary parenchyma.

1059
Q

What are the main types of acquired atelectasis, which is encountered principally in adults? What causes each one each?

A
  • Resorption atelectasis stems from complete obstruction of an airway. It is most often caused by excessive secretions (mucus plugs) or exudates within smaller bronchi, as may occur in bronchial asthma, chronic bronchitis, bronchiectasis, and post-op states. Aspiration, foreign bodies and rarely tumours may also lead to airway obstruction
  • Compression atelectasis results whenever significant volumes of fluid (transudate, exudate, or blood), tumor or air accumulated within the pleural cavity.
  • Contraction atelectasis occurs when focal or generalised pulmonary or pleural fibrosis prevents full lung expansion
1060
Q

How do resorption and compression atelectasis effect the mediastinum?

A

In resorption atelectasis, the lung volume is diminshed and the mediastinum shifts toward the atelectatic lung
In compression atelectasis, the mediastinum is pushed away from the affected lung

1061
Q

What is the difference between obstructive and restrictive lung diseases?

A
  • Obstructive lung diseases are characterised by an increase in resistance to airflow due to partial or complete obstruction at any level from the trachea and larger bronchi to the terminal and respiratory bronchioles
  • Restrictive diseasess are characterised by reduced expansion of lung parenchyma and decreased total lung capacity
1062
Q

The distinction between obstructive and restrictive lung diseases is based primarily on lung function tests. How do these differ?

A
  • In individuals with diffuse obstructive disorders, pulmonary functions tests show decreased maximal airflow rates during forced expiration, usually expressed as a reduced FEV1/FVC ratio (less than 0.7)
  • Restrictive diseases are associated with proportionate decreases in both total lung capacity and FEV1, leading to normal FEV1/FVC ratio
1063
Q

Restrictive lung diseases occur in two broad kinds of conditions. What are they?

A

1) Chest wall disorders (e.g. severe obesity, pleural disease, hyphoscoliosis, and neuromuscular diseases such as poliomyelitis)
2) Chronic interstitial and infiltrative diseases, such as pneumoconioses and ILD.

1064
Q

What are some common obstructive lung diseases?

A

Emphysema
Chronic bronchitis
Asthma
Bronchiectasis

1065
Q

What is the anatomic site of:
* chronic bronchitis
* bronchiectasis
* asthma
* emphysema
* small airway disease, bronchiolitis

A

Chronic bronchitis - bronchus
Bronchiectasis - bronchus
Asthma - bronchus
Emphysema - acinus
Small airway disease, bronchiolitis - bronchiole

1066
Q

What are the main pathological changes of:
* chronic broncitis
* bronchiectasis
* asthma
* emphysema
* small airway disease, bronchiolitis

A

Chronic bronchitis - mucous gland hyperplasia, hypersecretion
Bronchiectasis - airway dilation and scarring
Asthma - smooth muscle hyperplasia, excess mucus, inflammation
Emphysema - airspace enlargement, wall destruction
Small airway disease, bronchiolitis - inflammatory scarring/obliteration

1067
Q

What is the etiology of:
* chronic bronchitis
* bronchiectasis
* asthma
* emphysema
* small airway disease, bronchiolitis

A

Chronic bronchitis - tobacco smoke, air pollutants
Bronchiectasis - persistent or severe infections
Asthma - immunologic or undefined causes
Emphysema - tobacco smoke
Small airway disease, bronchiolitis - tobacco smoke, air pollutants, miscellaneous

1068
Q

What are the signs/symptoms of:
* chronic bronchitis
* bronchiectasis
* asthma
* emphysema
* small airway disease, bronchiolitis

A

Chronic bronchitis - cough, sputum production
Bronchiectasis - cough, purulent sputum, fever
Asthma - episodic wheezing, cough, dyspnoea
Emphysema - dyspnea
Small airway disease, bronchiolitis - cough, dyspnoea

1069
Q

What does COPD consist of?

A

Emphysema and chronic bronchitis are often clinically grouped together and referred to as COPD, since most patients have features of both.;

1070
Q

What are the classic populations who get COPD?

A

There is a clear-cut association b etween heavy cigarette smoking and emphysema, and women and African Americans are more susceptible than other groups.

1071
Q

What is emphysema?

A

Emphysema is characterised by irreversible enlargement of the airspaces distal to the terminal bronchiole, accompannied by destruction of their walls without obvious fibrosis

1072
Q

Based on the segments of the respiratory units that involved emphysema is classified into four major types. What are they? Which ones cause significant obstruction? Which is most common?

A

1) Centriacinar
2) Panacinar
3) Paraseptal
4) Irregular

Of these, only the first two cause clinically significant airflow obstruction.
Centriacinar emphysema is the most common form, consistuting more than 95% of clinically significant cases.

1073
Q

What parts of the acini (the terminal respiratory units) does centriacinar emphysema effect? Where in the lung are the lesions commonly found?

A
  • The central or proximal parts of the acini, formed by respiratory bronchioles, are affected, whereas distal alveoli are spared.
  • Thus, both emphysematous and normal arispaces exist within the same acinus and lobule.
  • The lesions are more common and usually more severe in the upper lobes, particularly in the apical segements.
  • Inflammation around bronchi and bronchioles is common.
1074
Q

What parts of the acini are affected in panacinar emphysema? Where does it tend to happen?

A
  • The acini are uniformly enlarged from the level of the respiratory bronchiole to the terminal blind alveoli.
  • In contrast to centriacinar emphysema, panacinar emphysema tends to occur more commonly in the lower zone and in the anterior marghins of the lungs, and it is usually most severe at the bases
1075
Q

What part of the acini does distal acinar (paraseptal) emphysema usually happen? Where in the lungs does it happen?

A
  • The proximal portion of the acinus is normal, and the distal part is predominantly involved.
  • The emphysema is mroe striking adjacent to the pleura, along the lobular connective tissue septa, and at the margins of the lobules.
  • It occurs adjacent to areas of fibrosis, scarring or atelectasis and is usually more severe in the upper half of the lungs
1076
Q

What are the morphological characteristic findings in distal acinar (paraseptal) emphysema?

A

The characteristic findings are of multiple, continuous, enlarged airpsaces from less than 0.5cm to more than 2.0cm in diameter, sometimes forming cystlike structures.

1077
Q

Where and when is irregular emphysema found?

A
  • The acinus is irregularly involved, and is almost invariably associated with scarring.
  • In most instances it occurs in small foci and is clinically insignificant
1078
Q

What diseases are often associated with centriacinar, panacinar and distal acinar emphysema?

A
  • Centriacinar emphysema occurs predominantly in heavy smokers, often in association with chronic bronchitis (COPD)
  • Panacinar emphysema is associated with α1-antitrypsin deficiency
  • Distal acinar emphysema probably underlies many cases of spontaneous pneumothorax in young adults
1079
Q

In broad terms, what is the pathogenesis of emphysema?

A
  • Inhaled cigarette smoke and other noxious particles cause lung damage and inflammation
  • This result in parenchymal destruction (emphysema) and airway disease (bronchiolitis and chronic bronchitis).
1080
Q

What are the factors that influence the development of emphysema?

A
  • Inflammatory mediators and leukocytes including leukotriene B4, IL-8, TNF, are released by resident epithelial cells and macrophages and attract inflamatory cells, amplify the inflammatory process and induce structural changes
  • Protease-antiprotease imbalance - several proteases are released from the inflammatory cells and epithelial cells that break down connective tissue components
  • Oxidative stress - substances in tobacco smoke, alveolar damage, and ifnlammatory cells all produce oxidants, which may beget more tissue damage and inflammation
  • Infection may exacerbate the associated inflammation and chronic bronchitis
1081
Q

How do oxidants cause tissue damage in emphysema?

A
  • The gene NRF2 encodes a transcription factor that serves as a sensor for oxidants in alveolar epithelial cells and many other cell types
  • Intracellular oxidants activate MRF2, which upregulates the expression of multiple genes that protect cells from oxidant damage.
1082
Q

The idea that proteases are important in emphysema is based on the observation that patients with a deficientcy int eh antiprotease α1-antitrypsin have a markedley enhanced tendency to develop pulmonar emphysema. What is the pathogensis of α1-antitrypsin deficiency?

A

It is postulated that any injury (eg, that induced by smoking) that increases the activation and influx of neutrophils into the lung leads to local release of proteases, which in the absence of α1-antitrypsin activity result in excessive digestion of elastic tissue and emphysema.

1083
Q

Where is α1-antitrypsin usually found and what is its role?

A

α1-antitrypsin, normally present in serum, tissue fluids and macrophages, is a major inhibitor of proteases (particularly elastase) secreted by neutrophils during inflammation.

1084
Q

Where is the gene code from α1-antitrypsin?

A

α1-antitrypsin is encoded by teh proteinase inhibitor (Pi) locus on chromosome 14.

1085
Q

A number of factors contribute to airway obstruction in emphysema. What are they?

A
  • Small airways are normall held open by the elastic recoil of the lung parenchyma, and the loss of elastic tissue in the walls of alveoli that surround respiratory bronchioles reduces radial traction and thus causes the respiratory bronchioles to collapse during expiration.
  • This leads to functional airflow obstruction despite the absence of mechanical obstruction.
1086
Q

Even young smokers often have small airway inflammation associated with what changes?

A
  • Goblet cell hyperplasia, with mucus plugging of the lumen
  • Inflammatory infiltrates in bronchial walls consisting of neutrophils, macrophages, B cells (sometimes forming follicles) and T cells
  • Thickening of the bronchiolar wall due to smooth muscle hypertrophy and peribronchial fibrosis

Together these changes narrow the bronchiolar lumen and contribute to airway obstruction

1087
Q

What is the gross morphology of advanced emphysema?

A
  • Advanced emphysema produces voluminous lungs, often overlapping the heart and hiding it when the anterior chest wall is removed.
  • Generally, the upper two thirds of the lungs are more severely affected.
  • Large apical blebs or bullae are more characteristic of irregular emphysema secondary to scrring and ofdistal acinar emphysema
  • Large alveoli can easily be seen on the cut surface of fixed lungs
1088
Q

What is the microscopic morphology of emphysema?

A
  • Microscopically, abnormally large alveoli are separated by thin septa with only focal centriacinar fibrosis.
  • There is loss of attachments of the alveoli to the outer wall of small airways.
  • The pores of Kohn are so large that septa appear to be floating or protruding blindly into alveolar spaces with a club-shaped end
  • Prolonged vasoconstriction leads to changes of pulmonary arterial hypertension
  • As alveolar walls are destroyed, there is a decrease in the capillary bed area
  • With advanced disease, there are even larger abnormal airspaces and possibly bleds or bullae, which often deform and compress the respiratory bronchioles and vasculature of the lung
1089
Q

What proportion of the lung has to be damaged by emphysema before you get symptoms?

A

Symptoms do not appear until at least one third of the functioning piulmonary parenchyma is damaged

1090
Q

What symptoms occur in what order in emphysema?

A
  • Dyspnea usually appears first, beginning insidiously but progressing steadily
  • In some patients, cough or wheezing is the chief complaint, easily confused with asthma
  • Cough and expectoration are extremely variable and depend on the extent of the associated bronchitis
  • Weight loss is common and can be so severe as to suggest occult cancer.
1091
Q

Classically, how does a patient with severe emphysema appear?

A

Barrel-chested and dyspneic, with obviously prolonged expiration, sits forward in a hunched-over position, and breathes through pursed lips.

1092
Q

What are the symptoms and appearances of severe emphysema?

A

Cough is often slight, overdistention is severe, diffusion capacity is low, and blood gas values are relatively normal at rest.
Such patients may overventilate and remain well oxygenated, and therefore are somewhat ingloriously designated pink puffers.

1093
Q

How can emphysema effect the heart? How does this change prognosis?

A

Development of cor pulmonale and eventually congestive heart failure, related to secondary pulmonary HTN, is associated with poor prognosis

1094
Q

What is death in most patients with emphysema caused by?

A

1) coronary artery disease
2) respiratory failure
3) right-sided heart failure
4) massive collapse of the lungs secondary to pneumothorax

1095
Q

What are the treatment options for emphysema?

A
  • Smoking cessation
  • Oxygen therapy
  • Long-acting bronchodilaters with inhaled corticosteroids
  • Physical therapy
  • Bullectomy
  • Lung volume reduction surgery
  • Lung transplantation
1096
Q

Between predominantly bronchitis and predominantly emphysema, how do the following things differ:
* Age
* Dyspnea
* Cough
* Infections
* Respiratory insufficiency
* Cor pulmonale
* Airways resistance
* Elastic recoil
* CXR
* Appearance

A
1097
Q

What is compensatory hyperinflation?

A

Compensatory hyperinflation is sometimes used to designate dilation of alveoli in response to loss of lung substance elsewhere. It is best exemplified by the hyperexpansion of residual lung parenchyma following surgical removal of a diseased lung or lobe

1098
Q

What is obstructive overinflation? Why does it happen?

A

In this condition the lung expands because air is trapped within it. A common cause is subtotal obstruction of the airways by a tumour or foreign object.
It occurs either:
(1) because the obstructive agent acts as a ball valve, allowing air to enter on inspiration while preventing its exodus on expiration or
(2) because collaterals bring in air behind the obstruction. These collaterals consist of the pores of Kohn and other direct accessory bronchioalveolar connections

1099
Q

Is obstructive overinflation serious?

A

Yes! It can be a life-threatening emergency, because the affected portion distends sufficiently to compress the remaining lung

1100
Q

What is bullous emphysema?

A

This is a descriptive term for large subpleural blebs or bullae (spaces greater than 1cm in diameter in the distended state) that can occur in any form of emphysema
These localised accentuations of emphysema occur near the apex, sometimes near old TB scarring.
On occasion, rupture of the bullae may give rise to PTx

1101
Q

What is interstitial emphysema? What causes it?

A
  • Entrace of air into the connective tissue stroma of the lung, mediastinum, or subcutaneous tissue produces interstitial emphysema.
  • In most instances, alveolar tears into pulmonary emphysema provide the avenue of entrance of air into the stroma of the lung, but rarely, chest wounds that allow entry of air or fractured ribs that puncture the lung substance underlie this disorder.
  • Alveolar tears are usually caused by rapid increases in pressure within alveolar sacs, such as occurs when there is a combination of coughin and bronchiolar obstruction.
1102
Q

What is chronic bronchitis?

A

Chronic bronchitis is defined clinically as persistent cough with sputum production for at least 3 months in at least 2 consecutive years, in the absence of any other causes

1103
Q

What are the consequences of chronic bronchitis that lasts for years?

A

It may accelerate decline in lung function, lead to cor pulmonale and heart failure, or cause atypical metaplasia and dysplasia of the respiratory epithelium, providing a rich soil for cancerous transformation

1104
Q

What are the primary or initiating factors of chronic bronchitis?

A

The primary or initiating factor in the genesis of chronic bronchitis is exposure to noxious or irritating inhaled substances such as tobacco smoke (90% of patients are smokers) and dust from grain, cotton and silica.

1105
Q

What is the pathogenesis of chronic bronchitis?

A
  • Mucus hypersecretion - the earliest feature is hypersecretion of mucus in the large airways, associated with hypertrophy of the submucosal glands in the trachea and bronchi. With time, there is also a marked increase in goblet cells in small airways leading to excessive mucus production that contributes to airway obstruction.
  • Inflammation - inhalants that induce chronic bronchitis cause cellular damage, eliciting both acute and chronic inflammatory responses involving neutrophils, lymphocytes, and macrophages
  • Infection does not initiarte chronic bronchitis, but is probably significant in maintaining it and may be critical in producing acute exacerbations
1106
Q

What are the gross morphological features of chronic bronchitis?

A

Grossly, there is hyperemia, swelling and edema of the mucous membranes, frequently accompanied by excessive mucinous or mucopurulent secretions.
Sometimes, heavy casts of secretions and pus fill the bronchi and bronchioles.

1107
Q

What are the microscopic changes associated with chronic bronchitis?

A

The characteristic features are mild chronic inflammation of the airways (predominantly lymphocytes) and enlargement of the mucus-secreting glands of the trachea and bronchi.
Although the numbers of goblet cells increase slightly, the major change is in the size of the mucous glands (hyperplasia).
The bronchial epithelium may exhibit squamous metaplasia and dysplasia. There is marked narrowing of bronchioles caused by mucus plugging, inflammation, and fibrosis.

1108
Q

What is the Reid index and how does it change in chronic bronchitis?

A

The Reid index is the ratio of the thickness of the mucous gland layer to the thickness of the wall between the epithelium and the cartilage.

The Reid index (normally 0.4) is increased in chronic bronchitis, usually in proportion to the severity and duration of the disease.

1109
Q

What are the clinical features of chronic bronchitis?

A
  • The cardinal symptom of chronic bronchitis is a persistent cough productive of sparse sputum.
  • For many years no other respiratory functional impairment is present, but eventually dyspnea on exertion develops.
  • With the passage of time, and usually continued smoking, other elements of COPD may appear, including hypercapnia, hypoxaemia, and mild cyanosis
  • Long standing severe chronic bronchitis commonly leads to cor pulmonale and cardiac failure.
  • Death may also result from further impairment of respiratory function due to superimposed acute infections.
1110
Q

What is asthma?

A

Asthma is a chronic disorder of the conducting airways, usually caused by an immunological reaction, which is marked by episodic bronchoconstriction due to increased airway sensitivity to a variety of stimuli; inflammation of the bronchial walls; and increased mucus secretion

1111
Q

What are the main symptoms of asthma?

A

The disease is manifested by recurrent episodes of wheezing, breathlessness, chest tightness, and cough, particularly at night and/or in the early morning.

1112
Q

What are the two categories of asthma?

A

Asthma may be categorised as atopic - evidence of allergen sensitisation and immune activation, often in a patient with allergic rhinitis or eczema
OR
non-atopic - no evidence of allergen sensitsation

1113
Q

In either types of asthma, episodes of bronchospasm can have diverse triggers. Give some examples of what?

A

Respiratory infections (especially viral infections), exposure to irritants (eg, smoke, fumes), cold air, stress and exercise

1114
Q

Asthma may also be classified according to the agents or events that trigger bronchoconstriction. What are the classifications?

A

Seasonal, exercise-induced, drug-induced (eg, aspirin), and occupational asthma, and asthmatic bronchitis in smokers

1115
Q

What is the most common type of asthma? What type of reaction is this?

A

Atopic asthma is the most common type of asthma and is a classic example of IgE-mediated (type I) hypersensitivity reaction.

1116
Q

When does atopic asthma usually begin? Is it linked with family history?

A
  • The disease usually begins in childhood and is triggered by environmental allergens, such as dusts, pollens, cockroach or animal dander, and foods, which most frequently act in synergy with other proinflammatory environmental cofactors, most notably viral infections
  • A positive family history of asthma is common
1117
Q

How do you diagnose atopic asthma?

A
  • A skin test with the offending antigen in these patients results in an immediate wheal-and-flare reaction.
  • It may also be diagnosed based on high total serum IgE levels or evidence of allergen sensitisation by serum radioallergosorbent tests (called RAST), which can detect the presence of IgE antibodies that are speciufic for individual allergens.
1118
Q

What do the allergen sensitisation and skin tests show with non-atopic asthma? Do they often have a family history?

A

Individuals with non-atopic asthma do not have evidence of allergen sensitisation and skin test results are usually negative.
A positive family history of asthma is less common in these patients

1119
Q

What are the common triggers for non-atopic asthma?

A

Respiratory infections due to viruses (eg, rhinoviruses, parainfluenza virus and RSV) are common triggers in non-atopic asthma.
Inhaled air pollutants, such as smoking, sulfur dioxide, ozone, and nitrogen dioxide, may also contribute to the chronic airway inflammation and hyperreactivity in some cases.

1120
Q

What are the symptoms of aspirin-sensitive asthma?

A

It is an uncommon type, occurring in individuals with recurrent rhinitis and nasal polyps. These individuals are exquisitely sensitive to small doses of aspirin as well as other NSAIDs, and they experience not only asthmatic attacks but also urticaria.

1121
Q

How does aspirin trigger asthma?

A

Aspirin and NSAIDs trigger asthma in these patients by inhibiting the cyclooxygenase pathway of arachidonic acid metabolism, leading to a rapid decrease in prostaglandin E2.
Normally prostaglandin E2 inhibits enzymes that generate proinflammatory mediators such as leukotrienes B4, C4, D4 and E4, which are believed to have central toles in aspirin-induced asthma

1122
Q

What might trigger occupational asthma?

A

This form of asthma may be triggered by fumes (epoxy resins, plastics), organic and chemical dusts (wood, cotton, platinum), gases (toluene), or other chemicals (formaldehyde, penicillin products)
Only minute quantities of chemicals are required to induce the attack, which usually occurs after repeated exposure.

1123
Q

Broadly, what is the pathogenesis of atopic asthma?

A
  • Atopic asthma is cause by a TH2 and IgE response to environmental allergens in genetically pre-disposed individuals.
  • Airway inflammation is central to disease pathophysiology and causes airway dysfunction partly through the release of potent inflammatory mediators and partly through remodeling of the airway wall.
  • As the disease becomes more severe, there in increased local secretion of growth factors, which induce mucous gland hypertrophy, smooth muscle proliferation, angiogenesis, fibrosis and nerve proliferation.
1124
Q

A fundamental abnormality in asthma is an exaggerated TH2 reponse to normally harmless environmental antigens. What happens in this process?

A
  • TH2 cells secrete cytokines that promote inflammation and stimulate B cells to produce IgE and other antibodies.
  • These cytokines include IL-4, which stimulates the production of IgE; IL-5, which activates locally recruited eosinophils; and IL-13, which stimulates mucus secretion from bronchial submucosal glands and also promotes IgE production by B cells.
  • The T cells and epithelial cells secrete chemokines that recruit more T cells and eosinophils, thus exacerbating the reaction.
  • IgE binds to the Fc receptors on submucosal mast cells, and repeat exposure to the allergen triggers the mast cells to release granule contents and produce cytokines and other mediators, which collectively induce the early-phase (immediate hypersnesitivity) reaction and the **late-phase reaction.
1125
Q

What happens during the early reaction in asthma?

A
  • The early reaction is dominated by bronchoconstriction, increased mucus production, variable degrees of vasodilation, and increased vascular permeability
  • Bronchoconstriction is triggered by direct stimulation of subepithelial vagal (parasympathetic) receptors through both central and local reflexes trigerred by mediators produced by mast cells and other cells in the reaction.
1126
Q

What happens during the late-phase reaction in asthma?

A

The late-phase reaction is dominated by recruitment of leukocytes, notably eosinophils, neutrophils, and more T cells.

1127
Q

Many mediators produced by leukocytes and epithelial cells have been implicated in the asthmatic response. The long list of “suspects in acute asthma can be ranked based on the clinical efficacy of pharmacological intervention with antagonists of specific mediators. Tell me about these…

A
  • Mediators whose role in bronchospasm is clearly supported by efficacy of intervention are: 1) leukotrienes C4, D4, E4,, which cause prolonged bronchonconstriction as well as increased vascular permeability and mucus secretion and 2) acetylcholine, released from intrapulmonary parasympathetic nerves, which can cause airway smooth muscle constriction by directly stimulating muscarinic receptors
  • Agents present in asthma but whose role seems fairly minor: 1) histamine, a potent bronchoconstrictor; 2) prostaglandin D2, which elicits bronchoconstriction and vasodilation; and 3) platelet-activating factor, which causes aggregation of platelets and release of serotonin from their granules
1128
Q

Susceptibility to atopic asthma is multigenic and often associated with increased incidence of other allergic disorders, such as allergic rhinitis and eczema. What are some of the stronger assocations?

A
  • One susceptibility locus for asthma is located on chromosome 5q. Among the genes in this cluster, polymorphisms in the IL13 gene have the strongest and most consistent associations with asthma or allergic disease.
  • Particular class II HLA alleles are linked to production of IgE antibodies against some antigens, such as ragweed pollen.
  • Polymorphisms in the gene encoding ADAM33, a metalloproteinase, may be linked to increased proliferation of bronchial smooth muscle cells and fibroblasts, thus contributing to bronchial hyperreactivity and subepithelial fibrosis.
  • β2-adrenergic receptor gene variants are associated with differential in vivo airway hyper-responsiveness and in vitro response to β-agonist stimulation
1129
Q

Asthma is a disease of industrialised societies where the majority of people live in cities. This likely hasv two main explanations. What are they?

A
  • Firstly, industralised environments contain many airborne pollutants that can serve as allergens to initiate the TH2 response.
  • Secondly, city life tends to limit the exposure of very young children to certain antigens, particularly microbial antigens, and exposure to such antigens seems to protect children from asthma and atopy. This protective effect is even more apparent if the microbial exposure occurred throughout the mother’s pregnancy.
1130
Q

What is the hygiene hypothesis?

A

The idea that microbial exposure during early development reduces the later incidence of allergic (and some autoimmune) diseases has been popularised as the hygiene hypothesis.

1131
Q

What happens during “airway remodelling” in asthma?

A

Over time, repeated bouts of allergen exposure and immune reactions result in structural changes in the bronchial wall, referred to as “airway remodelling”. These changes include:
* Thickening of the airway wall
* Subbasement membrane fibrosis (due to deposition of type I and III collagen)
* Increased vascularity
* An increase in the size of submucosal glands and number of airway goblet cells
* Hypertrophy and/or hyperplasia of the bronchial wall muscles

1132
Q

What is the morphology of patients dying of severe asthma (status asthmaticus)?

A
  • The lungs are distended by overinflation and contain small areas of atelectasis.
  • The most striking gross finding is occlusion of bronchi and bronchioles by thick, tenscious mucous plugs, which often contain shed epithelium.
  • A characteristic finding in sputum and bronchoalveolar lavage specimens is Curschmann spirals, which may result from extrusion of mucus plugs from subepithelial mucous gland ducts or bronchioles
  • Also present are numerous eosinophils and Charcot-Leyden crystals; the latter are composed of an eosinophil protein called galectin-10.
1133
Q

What is the clinical course of asthma?

A
  • An acute attack can last up to several hours.
  • In some patients, however the cardinal symptoms of chest tightness, dyspnea, wheezing and coughing (with or without sputum production) are present at a low level constantly
  • In its most severe form, status asthmaticus, the paroxysm persists for days and even weeks, sometimes causing airflow obstruction that is so extreme that makred cyanosis or even death ensues.
1134
Q

What is the diagnosis of asthma based on?

A

The diagnosis is based on demonstration of an increase in airflow obstruction (from baseline levels), difficulty with exhalation (prolonged expiration, wheeze), peripheral blood eosinophilia, and the finding of eosinophils, Curschmann spirals, and Charcot-Leyden crystals in the sputum (particularly in patients with atopic asthma)

1135
Q

What is bronchiectasis?

A

Bronchiectasis is a disorder in which destruction of smooth muscle and elastic tissue by chronic necrotising infections leads to permanent dilation of bronchi and bronchioles

1136
Q

Is bronchiectasis common? What diseases does it usually occur with?

A

Because of better control of lung infections, bronchiectasis is now uncommon. It may still develop in association with a variety of conditions, including the following:
* Congenital or hereditary conditions such as CF, immunodeficiency states, primary ciliary dyskinesia
* Infections, including necrotising pneumonia caused by bacteria, viruses, or funghi
* Bronchial obstruction, due to tremor, foreign bodies, or mucus impaction
* Other conditions, including rheumatoid arthritis, SLE, IBD, COPD and post-transplantation

1137
Q

Obstruction and infection are the major conditions associated with bronchiectasis, and it is likely that both are necessary for the development of full-fledged lesions. How do they cause it?

A
  • After bronchial obstruction, normal clearing mechanisms are impaired, resulting in pooling of secretions distal to the obstruction and secondary infection and inflammation
  • Conversely, severe infections of the bronchi lead to inflammation, often with necrosis, fibrosis and eventually dilation of airways.
1138
Q

How does cystic fibrosis cause bronchiectasis?

A
  • In CF, the primary defect in ion transport leads to defective mucociliary action and airway obstruction by thick viscous secretions.
  • This sets the stage for chronic bacterial infections, which cause widespread damage to airway walls.
  • With destruction of supporting smooth muscle and elastic tissue, the bronchi become markedly dilated, while smaller bronchioles are progressively obliterated as a result of fibrosis (bronchiolitis obliterans)
1139
Q

How is primary ciliary dyskinesia inherited? How common is it?

A

It is an autosomal recessive syndrome with a frequency of 1 in 15,000 to 40,000 births

1140
Q

How does primary ciliary dyskinesia cause bronchiectasis?

A

Ciliary dysfunction due to defects in ciliary motor proteins (eg, mutations involving dynein) contributes to the retention of secretions and recurrent infections that in turn lead to bronchiectasis.

1141
Q

What is Kartagener syndrome? How often does it occur with primary ciliary dyskinesia?

A

It is marked by situs inversus or a partial lateralising abnormality associated with bronchiectasis and sinusitis. The lack of ciliary activity interferes with bacterial clearance, predisposes the sinuses and bronchi to infection, and affects cell motility during embyrogenesis, resulting in the situs inversus.
Males with this condition tend to be infertile, as a result of sperm dysmotility.

1142
Q

What is allergic bronchopulmonary aspergillosis? What patient population does it occur in?

A

It is a condition that results from a hypersensitivity reaction to the fungus Aspergillus fumigatus.
It occurs in patients with asthma and CF who develop periods of exacerbation and remission that may lead to proximal bronchiectasis and fibrotic lung disease.

1143
Q

What is the pathogenesis of allergic bronchopulmonary aspergillosis? How does this show in the bloods?

A

Sensitisation to Aspergillus in the allergic host leads to activation of TH2 cells, which play a key role in recruiting eosinphils and other leukocytes.
Characteristically, there are high serum IgE levels, serum antibodies to Aspergillus, intense airway inflammation with eosinophils, and the formation of mucus plugs, which play a primary role in its pathogenesis.

1144
Q

Where in the lung does bronchiectasis usually occur?

A

It usually affects the lower lobes bilaterally, particularly air passages that are vertical, and is most severe in more distal bronchi and bronchioles.
When tumours of aspiration of foreign bodies lead to bronchiectasis, the involvement may be localised to a single lung segment.

1145
Q

How does bronchiectasis effect the size of the airways?

A

The airways are dilated, sometimes up to four times the normal size.
Characteristically, the bronchi and bronchioles are so dilated that they can be followed almost to the pleural surfaces.
On the cut surface of the lung, the dilated bronchi appears cystic and are filled with mucopurulent secretions

1146
Q

What are the histological findings in bronchiectasis?

A
  • The histologic findings vary with the activity and chronicity of the disease
  • In the fullblown, active case there is an intense acute and chronic inflammatory exudation within the walls of the bronchi and bronchioles, associated with desquamation of the lining epithelium and extensive areas of ulceration.
  • There may be pseudostratification of the columnar cells or squamous metaplasia of the remaining epithelium.
  • In some instances necrosis destroys the bronchial or bronchial walls and forms a lung abscess.
  • Fibrosis of the bronchial and bronchiolar walls and peribronchiolar fibrosis develop in the more chronic cases, leading to varying degrees of subtotal or total obliteration of bronchiolar lumens
1147
Q

A large variety of bacteria can be found in the usual case of bronchiectasis. What are they?

A

They include staphylococci, streptococci, pneumococci, enteric organisms, anaerobis and micro-aerophilic bacteria, and (particularly in children) Haemophilus influenzae and Pseudomonas aerunginosa.

1148
Q

What is acute lung injury and acute respiratory distress syndrome?

A

Acute lung injury is characterised by the abrupt onset of significant hypoxaemia and bilateral pulmonary infiltrates in the absence of cardiac failure.
Acute respiratory distress syndrome is a manifestation of severe ALI.

1149
Q

What is the mechanisms behind behind ARDS and ALI?

A

Both ARDS and ALI are associated with inflammation-associated increases in pulmonary vascular permeability, oedema and epithelial cell death

1150
Q

Acute Lung Injury (ALI) is a well-recognised complication of diverse conditions. Name me some

A

Infection
Sepsis
Diffuse pulmonary infections
Gastric aspiration
Physical/Injury
Mechanical trauma, including head injuries
Pulmonary contusions
Near-drowning
Fractures with fat embolism
Burns
Ionising radiation
Inhaled irritants
oxygen toxicity
smoke
irritant gases and chemicals
Chemical injury
heroin or methadone overdose
acetylsalicylic acid
barbiturate overdose
paraquat
Other things
DIC
Pancreatitis
Uraemia
CABG

1151
Q

ALI/ARDS is initiated by injury of pneumocytes and pulmonary endothelium, setting in motion a vicious cycle of increasing inflammation and pulmonary damage. What are the steps involved in this?

A

Endothelial activation
Adhesion and extravasation of neutrophils
Accumulation of intraalveolar fluid and formation of hyaline membranes
Resolution of injury

1152
Q

What happens in endothelial activation during ARDS?

A
  • In some instances, endothelial activation is secondary to pneumocyte injury, which is sensed by resident alveolar macrophages.
  • In response, these immune sentinels secrete mediators such as TNF that act on the neighbouring endothelium.
  • Alternatively, circulating inflammatory mediators may activate pulmonary endothelium directly in the setting of severe tissue injury or sepsis.
  • Some of these mediators injure endothelial cells, while others (notably cytokines) activate endothelial cells to express increased levels of adhesion molecules, procoagulant proteins and chemokines
1153
Q

What happens during adhesion and extravasation of neutrophils in ARDS?

A
  • Neutrophils adhere to the activated endothelium and migrate into the interstitium and the alveoli, where they degranulate and release inflammatory mediators, including proteases, ROS and cytokines.
  • Macrophage migration inhibitory factor (MIF) released into the local milieu also helps to sustain the ongoing pro-inflammatory response.
  • The result is increased recruitment and adhesion of leukocytes, causing more endothelial injury, and local thrombosis.
  • This cycle of inflammation and endothelial damage lies at the heart of ALI/ARDS.
1154
Q

What happens regarding accumulation of alveolar fluid and formation of hyaline membranes during ARDS?

A
  • Endothelial activation and injury make pulmonary capillaries leaky, allowing interstitial and intraalveolar oedema fluid to form.
  • Damage and necrosis of type II alveolar pnuemocytes leads to surfactant abnormalities, further compromising alveolar gas exchange.
  • Ultimately, the inspissated protein-rich oedema fluid and debris from dead alveolar epithelial cells organise into hyaline membranes, a characteristic feature of ALI/ARDS.
1155
Q

What happens regarding resolution of injury during ARDS?

A
  • It is impeded in ALI/ARDS due to epithelial necrosis and inflammatory damage that impairs the ability of remaining cells to assist with oedema resorption
  • Eventually, however, if the inflammatory stimulus lessens, macrophages remove intraalveolar debris and release fibrogenic cytokines such as transforming growth factor β and platelet-derived growth factor (PDGF).
  • These factors stimulate fibroblast growth and collagen deposition, leading to fibrosis of alveolar walls.
  • Bronchiolar stem cells proliferate to replace pneumocytes. Endothelial restoration occurs through proliferation of uninjured capillary endothelium
1156
Q

What populations is ARDS worse in?

A

More common and associated with a worse prognosis in chronic alcoholics and in smokers

1157
Q

What is the morphology in the acute stage on ARDS?

A

In the acute stage, the lungs are heavy, firm, red and boggy.
They exhibit congestion, interstitial and intra-alveolar oedema, inflammation, fibrin deposition, and diffuse alveolar damage.
The alveolar walls become lined with waxy hyaline membranes that are morphologically similar to those seen in hyaline membrane disease of neonates.
Alveolar hyaline membranes consist of fibrin-rich oedema fluid mixed with the cytoplasmic and lipid remnants of necrotic epithelial cells.

1158
Q

What is the morphology of the organising stage of ARDS?

A

Type II pneumocytes proliferate, and granulation tissue forms in the alveolar walls and spaces.
In most cases the granulation tissue resolves, leaving minimal functional impairment.
Sometimes, however, fibrotic thickening (scarring) of the alveolar septa ensues.

1159
Q

What are the clinical and radiographic symptoms of ALI/ARDS?

A
  • Profound dyspnoea and tachypnoea herald ALI, followed by increasing cyanosis and hypoxaemia, respiratory failure
  • The appearance of diffuse bilateral infiltrates on radiographic examination
1160
Q

Does ALI/ARDS effect the whole lung equally?

A

The functional abnormalities in ALI are not evenly distributed throughout the lungs.
The lungs have areas that are infiltrated, consolidated, or collapsed (and thus poorly aerated and poorly compliant) and regions that have nearly normal levels of compliance and ventilation.
Poorly aerated regions continue to be perfused, producing ventilation-perfusion mismatch and hypoxaemia

1161
Q
A